Falls in older people with type 2 diabetes mellitus : implications for specific and generic risk detection by Roman de Mettelinge, Tine
Falls in Older People 
with Type 2 Diabetes Mellitus
Implications for specific and generic risk detection
Tine Roman de Mettelinge
ISBN
978-90-9027545-1
Cover design and layout
Promotie In Zicht, Arnhem
Print
Ipskamp Drukkers, Enschede
© 2013 Tine Roman de Mettelinge
Falls in Older People 
with Type 2 Diabetes Mellitus
Implications for specific and generic risk detection
Tine Roman de Mettelinge
Thesis submitted in fulfillment of the requirements for the degree of Doctor  
in Motor Rehabilitation and Physiotherapy
Ghent 2013
Faculty of Medicine and Health Sciences
Department of Rehabilitation Sciences and Physiotherapy
Promotor
 Prof. Dr. D. Cambier Ghent University, Belgium
Copromotor 
 Prof. Dr. P. Calders Ghent University and Artevelde University College, Belgium
Examination Board 
 Prof. Dr. M. Petrovic Ghent University, Belgium
 Prof. Dr. J. Ruige Ghent University, Belgium
 Prof. Dr. Ph. Roosen Ghent University and Artevelde University College, Belgium
 Prof. Dr. K. Milisen Catholic University of Leuven, Belgium
 Prof. Dr. K. Meijer Maastricht University, The Netherlands
 Prof. Dr. G. Vanderstraeten Ghent University, Belgium
Supervisory Committee 
 Prof. Dr. N. Van Den Noortgate Ghent University, Belgium
 Prof. Dr. D. Cambier Ghent University, Belgium
 Prof. Dr. P. Calders Ghent University and Artevelde University College, Belgium


Contents
Preface
Chapter 1  General Introduction 1
Part One Fall Risk Factors 51
Chapter 2   Understanding the Relationship between  
Type 2 Diabetes Mellitus and Falls in Older Adults:  
a Prospective Cohort Study
53
Part Two Additional Screening as Part of Fall Prevention Strategies 69
Chapter 3   Vibration Perception Threshold in Relation  
to Postural Control and Fall Risk Assessment  
in Elderly
71
Chapter 4   The Impact of Peripheral Neuropathy and  
Cognitive Decrements on Gait in Older Adults  
with Type 2 Diabetes Mellitus
87
Chapter 5   Does Footwear Matters in Spatiotemporal  
Gait Analysis among Older Women?
105
Chapter 6   General Discussion 123
Chapter 7   Nederlandstalige Samenvatting 145
Chapter 8   Appendix 153
Acknowledgements 177
List of abbreviations 181
The leaves fall, the wind blows, and the farm country slowly 
changes from the summer cottons into its winter wools.
Henry Beston, Northern Farm
PREFACE
Preface
For the first time in human history, the population of older adults (60+) is about to 
outnumber all other (younger) age categories. This enormous boom of the ageing 
population poses some major challenges to the older individual, his/her surroundings, 
health care services and society. In any age category but especially in older adults, 
a satisfying quality of life starts with a good physical health. Initiatives to ensure or 
optimize the quality of life of the aged are therefore required.
This doctoral thesis takes a closer look at fall risk factors among older adults with 
Type 2 Diabetes Mellitus (T2DM). As falls and T2DM are both very common in the 
older population and form major threats to one’s quality of life, prevention strategies 
for falls, T2DM and especially the detrimental association seem mandatory. Before 
appropriate and specific prevention programs can be developed, a proper 
understanding and identification of population specific risk factors should however 
be obtained. In the initial Chapter 1 the background on falls and diabetes and its inter-
relationships will be outlined based on the extensive existing scientific literature. Part 
One and Part Two contain our own studies. Part One presents our main paper in 
which risk factors for falls are identified among a mixed cohort of older adults with 
and without T2DM by means of an extensive baseline assessment in combination 
with a one-year follow-up for falls (Chapter 2). In Part Two some potentially crucial and 
intriguing but often less focused interfering fall risk factors are scrutinized. The 
influence of peripheral nerve function and cognition on gait and postural control were 
assessed in older adults with and without T2DM (Chapter 3 and 4) whereas the 
impact of different types of footwear on gait was assessed in healthy older women 
(Chapter 5). The final chapter (Chapter 6) provides a critical reflection of the findings 
of this doctoral thesis in relation to the existing literature. Important points of interest 
for health care workers (physiotherapists in particular) are highlighted and concepts 
for future research are suggested.
I sincerely hope that this doctoral thesis may capture the reader’s attention, contribute 
to the existing domain-specific scientific insights and knowledge, and may improve 
the geriatric clinical practice.
Tine Roman de Mettelinge, 
Ghent, 2013
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31GENERAL INTRODUCTION
BACKGROUND
During the past decades, getting older became the academic scope of many 
researchers in a wide fi eld of sciences. Today, people reach higher ages than ever 
before. Although increased human longevity can be seen as a triumph for research 
and development, it is a double-edged sword as it poses major unique challenges to 
the society. Pension schemes, health care costs and senior accommodations are 
only a few aspects which need to be reconsidered. The main purpose of each 
involved party lies in the ambition to ensure optimal quality of life for the older adult. 
For most older adults, being independent is crucial in terms of quality of life and this 
often assumes the preserved ability to ambulate. These walking abilities can however 
easily be complicated by a very common event in the aged, namely falling. Falls may 
cause a tremendous amount of morbidity, mortality, activity restriction and premature 
nursing home admissions. Different medical health care services, but physiotherapy 
in particular, play a vital role in rehabilitating older adults after a fall and even more in 
preventing (new) falls. Accurate risk detection is always the fi rst step in developing 
and implying successful prevention strategies. This doctoral thesis will therefore 
focus on fall risk detection in older people and more specifi cally in older people 
suffering from Type 2 Diabetes Mellitus (T2DM), a disease that threatens a constantly 
growing subpopulation of the aged.
Figure 1.1  Older (60+) people will outnumber children (0-19) in 2050 across the 
world (A) and before 2025 across the more developed countries (B), 
adapted with permission of the United Nations [1]
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The world is ageing fast and older adults are the fastest growing segment of the 
increasing global population. According to the United Nations approximately 810 
million (11%) persons in the world were aged 60 years or older in 2012 [1]. This number 
is estimated to increase up to more than 2 billion (22%) in 2050, thereby outnumbering 
the proportion of children and youngsters (0-19 years) for the fi rst time in human 
history (Figure 1.1) [1]. A historical take-over is actually already occurring in the more 
developed regions (Figure 1.1) [1]. This global trend can also be observed in Belgium 
in an even superlative gradation: currently 1 out of 4 (24%) people living in Belgium 
are aged 60 years or older and this will grow to 1 out of 3 in 2050 (31%) [1]. 
Due to advanced medical care and improved facilities, many ageing adults currently 
experience good health and enjoy a nice quality of life. Ageing should therefore not 
be considered as a disease in itself. Nevertheless, a substantial proportion of older 
people are confronted with predominating impairments that actually infl uence and 
even undermine their daily activities and quality of life. These impairments are often 
denominated as “geriatric giants” and generally include urinary incontinence, 
depression, memory loss and falls or immobility. It is noteworthy that falls may as well 
exacerbate the other geriatric giants as the others may deteriorate the fall status 
(Figure 1.2). 
Figure 1.2  The interplay of the “geriatric giants”
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Falling is considered a geriatric giant for good reasons. About 35% of the communi-
ty-dwelling older adults (65+) fall at least once a year [2-7]. In residential settings 
incidence may even increase up to 50% [8]. Approximately 30% to a half of the falls 
pass without physical implications. The direct physical consequences of the other 
half to 70% of the falls are divers and range from minor injuries such as superfi cial 
abrasions, bruises, lacerations, strains and sprains to major injuries such as fractures, 
head injuries and even fatalities [9,10]. Tinetti et al. showed in a large prospective 
study that 23% of the fallers experienced serious fall injury events [11]. Of these 
fall-related injuries, the one with the worst outcome is a hip fracture. By 1 year after a 
hip fracture only 35 to 38% of the patients is able to restore independent walking 
[12,13] and 20 to 50% dies [12,14]. Prevalence rates of falls [5,10,15,16] and injurious 
falls [17] increase with age, with an annual incidence increasing up to 50% in older 
adults aged 80 or more [18]. Figure 1.3 shows the proportion of people aged 65 or 
older who participated in our prospective fall study who reported at least one injurious 
or non-injurious fall during a 12-month follow-up period. 
Although the abovementioned numbers are staggering (‘giant’), they are mostly based on 
self-reported data and may therefore even underestimate true fall-related rates. 
Figure 1.3  Proportion of non-injurious and injurious fall events for different age categories 
during a one-year follow-up period (N=173) (Unpublished)
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Besides physical discomfort, fall incidents may also provoke psychological complaints 
such as depression and fear of falling. The psychological consequences of a fall, which 
are often more subtle than the physical consequences, may however seriously affect 
quality of life and may therefore not be ignored. Fear of falling for example may dramatically 
hamper one’s confi dence leading to self-restriction or avoidance of activities and has 
clearly proven to be an independent risk factor for falling itself [19].  
In an attempt to prevent falls and its many consequences, a number of initiatives and 
intervention strategies have been suggested, varying from environmental modifi cation 
and  education to medicinal optimization and exercise programmes. The largest body of 
evidence exists for exercise. From her systematic review including 44 randomized 
controlled trials about exercise and fall prevention, Sherrington et al. concluded that 
exercise can prevent falls in older people [20]. Both group and home-based exercise 
programs, usually containing balance and strength training, have clearly proven to reduce 
the rate of falls and the risk of falling in older adults [6,20,21].
The actual existing framework of the Belgian nomenclature for physiotherapists 
encompasses the opportunity to offer these successful exercise interventions. The 
Belgian Rijksinstituut voor Ziekte- en Invaliditeitsverzekering (RIZIV)-nomenclature 
[22] provides since 2002 a conditional indication for 60 therapeutic sessions per year 
with maximal refund by medical insurance (Fb-nomenclature). To meet this part of 
the nomenclature with the given fi nancial contribution, older (65+) adults with a 
positive fall history additionally need to fulfi ll a given set of future fall prone motor 
criteria with prescribed cut-off scores [22] (Table 1.1).
Table 1.1 Criteria for meeting Fb-pathology
Age The patient is 65 years or older
Fall history The patient fell at least once and is prone to fall again based on the scores 
of some clinical cut-off scores on some common motor assessment tests*
Motor*
Timed Up & Go (TUG) Test score > 20”
AND
Tinetti Test score < 20/28  OR Timed Chair Stands (TCS) Test score > 14” (#)
(#) Both tests should be administered
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Although the criteria of the Belgian nomenclature for physiotherapists are based on 
very useful and reliable tools and as such are appropriate for “generic” older adults, 
one could and should ask whether they are adjusted to specific though potentially 
crucial pathology-related aspects that increase the risk of falling. A number of 
age-related diseases such as hypertension, cardiovascular impairments, cognitive 
decline, cataracts, osteoporosis, osteoarthritis, stroke, Parkinson’s Disease and Type 
II Diabetes Mellitus (T2DM) imply a supplementary risk for falling and fall-related 
injuries. Some of these diseases (such as Parkinson’s Disease, Rheumatoid Arthritis 
and stroke) fit in other sections of the nomenclature (E-pathologies) but others, such 
as diabetes, do not. As T2DM is becoming a major concern in the ageing population, 
one could wonder whether it should not be legitimate to think about integrating this 
disease in any way in the nomenclature. This was one of the incentives to establish 
profound research in this area.
Diabetes is one of the most common age-related diseases, reaching epidemic 
proportions worldwide. According to the World Health Organization (WHO), the 
disease globally affects approximately 347 million people and the diabetes deaths 
will double between 2005 and 2030 [23]. The current prevalence of T2DM in Belgium 
is estimated at 800 000 people [24]. Older individuals with diabetes are at increased 
risk for falls [25-29], injurious falls [26] and hip and other fractures [30]. Maurer et al. 
found that the fall incidence rate for adults aged 70 years or older with and without 
diabetes mellitus was 78% and 30% respectively [31]. Diabetes is a complex disease 
involving many organs and systems of the inner body. A lot of diabetes-related 
complications such as peripheral nerve dysfunction, foot ulcers, visual deterioration, 
urinary incontinence, renal disorders, cognitive decline, … are known as potential 
mechanisms for falls and may therefore also contribute to the increased fall incidence 
rates in this given population. To appropriately treat and manage these complications, 
older adults with diabetes also often take a lot of medications, thereby again 
increasing their fall risk. Given the numerous disease-related complications which 
may contribute to a remarkably increased fall risk, a revision of the existing 
nomenclature for physiotherapy within the scope of T2DM might be justified.
The following three chapters of this General Introduction will outline the existing 
scientific evidence concerning fall risk factors in general, T2DM as morbidity and the 
(potential) interrelationships between them, i.e. T2DM as a potential risk factor for falls.
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Key points
•	The number of age-related diseases such as T2DM increases with the ever-
growing proportion of older people. 
•	Approximately	one	third	of	community-dwelling	older	adults	fall	at	least	once	
a year.
•	Fall	incidence	and	fall-related	injuries	increase	with	age	and	ageing.
•	Falls	may	lead	to	dramatic	physical	and	psychological	complaints.
•	Older	adults	with	T2DM	are	at	increased	risk	for	falls	and	injurious	falls.
•	Current	 nomenclature	 for	 physiotherapeutic	 interventions	 in	Belgium	might	
need some extensions for specific older subgroups with chronic pathologies 
such as T2DM.
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FALL RISK FACTORS
One of the cardinal rules in scientific research lies in clearly describing terms with 
well-founded definitions outlined in the existing literature. Although most researchers 
in this area refer to the same underlying meaning of the word “fall”, lots of definitions 
and descriptions have been suggested to describe the event as such. Currently, the 
most accepted and most frequently used definition of a fall is the one that Tinetti et al. 
proposed in 1988 as “an event, which results in a person coming to rest unintention-
ally on the ground or other lower level, not as a result of a major intrinsic event or 
overwhelming hazard” [2]. More than fifteen years later this definition was confirmed 
and recommended by Lamb et al. on behalf of the Prevention of Falls Network Europe 
(ProFaNE) Consensus [32]. Therefore this definition was also used in this research 
project. Classifications into “fallers” or “non-fallers” are more ambiguous. Per definition a 
“nonfaller” is a person who did not fall and a “faller” is someone who fell at least once 
over a defined time period, mostly covering 6 or 12 months. Some researchers prefer 
to classify individuals who fell twice or more into “recurrent” or “multiple fallers”. This 
approach is based on the fact that single falls are more likely assumed to be 
occasional, meaning that they might be the result of an accident (e.g. environmental 
hazard) whereas multiple falls may be more indicative for subversive intrinsic fall risk 
factors (e.g. physiological predisposition to falling, chronic disease) [33]. Recurrent 
or multiple fallers would therefore benefit most from fall prevention efforts [34], which 
emphasizes the clinical importance of a carefully considered classification of fallers. 
Single fallers have been proven to be more similar to nonfallers than to recurrent 
fallers on a range of medical, physical and psychological risk factors [33,35,36]. 
According to Delbaere et al. single fallers should however not be categorized as 
nonfallers when an injury occurred [37]. Taking into account these considerations, we 
defined a “faller” as an older individual who experienced multiple falls (≥ 2) or a single 
injurious fall during the next 12 months and a “non-faller” as an older individual who 
did not fall or suffered a single non-injurious fall.
Falls in older people are rarely caused by a single risk factor but mostly occur as a 
result of the interplay between intrinsic, extrinsic and situational factors. Intrinsic risk 
factors are characteristics or conditions that are inherent to the individual and not 
seldom may affect postural control (= “subject- or patient-related”). It generally 
concerns age- or disease-related decrements (poor vision, joint stiffness, sarcopenia, 
Parkinson’s disease, …) which complicate the maintenance of balance, thereby 
increasing fall risk. Extrinsic risk factors are the environmental hazards that provoke 
(rather than cause) fall incidents such as a wet floor, darkness, wearing high-heeled 
shoes, ... (= “environment-related”). If no major intrinsic risk factors are present, a 
healthy older adult is generally capable to compensate for the environmental hazards 
10
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in time and prevent a fall. Situational risk factors are related to activities of daily living, 
e.g. rushing to the bathroom or rushing to answer the telephone (= “activity-related”). 
Table 1.2 summarizes several commonly accepted intrinsic, extrinsic and situational 
fall risk factors. Extrinsic and situational risk factors can for the greater part be 
managed by sensitization, recommendations, advices and warnings. On the contrary, 
to deal with (modifiable) intrinsic risk factors more intensive (physio)therapeutic 
interventions are needed. Therefore, this doctoral thesis will mainly focus on intrinsic 
risk factors.
The following paragraphs provide an outline of the most important intrinsic, extrinsic 
and situational fall risk factors and their mechanisms, based on existing evidence.
Intrinsic fall risk factors
In general, the intrinsic risk factors can be divided into functions (“(F)” in Table 1.2) 
needed to maintain postural control and prevent falling, and intrinsic characteristics 
(“(C)” in Table 1.2) that may interfere with the preventive performance of these 
functions. Balance and gait impairments are considered the most important intrinsic 
fall risk factors [38]. Other strong risk factors are fear of falling, previous falls and 
muscle weakness. Therefore, factors as postural control, gait and muscle weakness 
and characteristics as age, gender, previous falls, fear of falling, medications and 
pathological conditions will be shortly discussed.  
Postural control
Postural control is defined as the act of maintaining, achieving or restoring a state of 
balance during any posture or activity [39]. Individuals with a hampered postural 
control are unable to perform the needed action as defined and will as such be at 
increased risk for falling. Since postural control is no ”one-system-one-function” 
human attribute but the result of a complex interaction of input, cognitive analysis and 
interpretation and eventual appropriate output (Figure 1.4.), this human radar might 
easily be violated. 
With regard to the input level, accurate postural control involves a coordinated set of 
sensorimotor processes that continually encode and compare information from 
somatosensory (mainly proprioceptive) (70%), vestibular (20%) and visual (10%) 
feedback [40-42]. If one of these three systems is complicated due to situational (e.g. 
unstable surface) or pathological conditions (e.g. peripheral neuropathy or visual 
deficits) the contribution of the other systems will become more important in the 
maintenance of postural control. The somatosensory system encompasses 
11
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sensations of pain, temperature, tactile sensations (i.e. touch, tickle, pressure, 
vibration) and proprioceptive sensations. Proprioceptive input provides information 
concerning the position and movement of the body segments in relation to each 
other and to the surrounding. The vestibular system is in charge of informing about 
the head position and movements in relation to gravity whereas the visual system 
determines the orientation of the eyes and head in relation to objects in the 
environment [43]. Defi ciencies in the somatosensory, vestibular and visual systems 
occur with ageing [44,45]. Also, age-related deteriorations of muscle structures and 
functions have been shown. The resulting loss of postural control has repeatedly 
been associated with an increased fall risk [2,6,8,41,46-51].
Appropriate muscle responses and functions are required to implement the response 
on integrated and analyzed afferent information. Adequate motor abilities are not only 
essential for the maintenance of static postures and the performance of dynamic 
Table 1.2  Examples of intrinsic, extrinsic and situational fall risk factors.
Intrinsic 
Risk Factors
Extrinsic
Risk Factors
Situational
Risk Factors
Postural Control (F) Environmental Hazards Risky Behaviour
Gait (F) Poor footwear Dual Tasking
Muscle Weakness (F) Type of Dwelling …
Flexibility (F) Lighting
Performance (F) Walking Surface
Loose Carpets
Marital Status
Age (C) Education years
Gender (C) …
Previous Falls (C)
Fear of Falling (C)
Medications (C)
Pathological Conditions (C):
  - Visual deficit
  - Parkinson’s Disease, stroke, …
  - Cognitive disorder, depression
  - Urinary incontinence
  - …
12
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activities, they also play an important anticipatory role by initiating voluntary 
movements or increasing muscle activity in anticipation of a predicted disturbance.
As postural control is a detrimental factor for falls, appropriate assessment in view of 
profi ling the risk for this matter is highly mandatory. A number of clinic balance tests 
such as the Tinetti Test, Berg Balance Scale, Functional Reach, Timed Up & Go 
(TUG), Romberg, tandem stance and one-leg stance can be used to assess postural 
control. These tests are easy to administer and give the practitioner a general idea of 
one’s postural abilities. However, the majority of these tests have only one outcome 
measure or score that not always encompasses the quality of execution. Predictive 
values of clinical measures towards falls are thereby limited to an arbitrary 
categorization of postural control [52-54]. Postural control can also be assessed by 
means of devices such as force platforms or accelerometers. Static or dynamic sway 
analyses by use of force platforms provide valid information of postural control that 
can be used to predict fall risk [55]. Force platforms register location and 
displacements of the Center of Pressure and might yield precise insights in balance 
disturbances due to deliberately varying input (changes in visual, somatosensory or 
vestibular information) and/or conditions (changes in surface or dual tasking). 
Quantitative sway measurements have proven to have high sensitivity in predicting 
Figure 1.4   Postural control (Adapted with permission from Prof. Dr. Måns Magnusson)
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future falls [55-57]. During quiet upright stance conditions, fallers show larger sway 
amplitudes, especially in medio-lateral direction and during standing with the eyes 
closed [50,58-60].
Disturbed posturographic or clinical postural outcomes render an objective appraisal 
of one’s postural abilities. With respect to the interpretation of hampered postural 
control, however, less effort is put in detecting the underlying mechanisms during a 
general fall risk assessment. Aside of eventual testing of output functions such as 
muscle strength or flexibility, the input and central integration is often less integrated 
in any evaluation. Nevertheless, decrements in aspects such as somatosensation or 
cognitive performance may be of great importance for ineffective postural performance. 
They even may substantially interfere in preventive measures aimed to improve 
postural control and should therefore be taken into account during profiling the fall 
risk of older persons with impaired postural abilities.
When postural control is disturbed, crucial questions arise with respect to eventual 
treatment. For this matter it can be mentioned that based on an impressive Cochrane 
Review, Gillespie et al. concluded that multifaceted intervention programs including 
balance exercises have shown to improve postural control and reduce fall incidence 
[6]. As such, pinpointing decrements in postural control abilities is an important asset 
for remediation and prevention of falls.
Gait
Postural control plays a key role in dynamic mobility-related activities such as walking. 
Although walking was previously assumed to be an automated motor task, requiring 
minimal higher-level cognitive input, recent research has provided conclusive 
evidence to the contrary [61-63]. Dual task paradigms (which will be discussed 
further on page 21) and gait analyses in older adults with cognitive impairments have 
proven that gait performance also relies on cognitive functions, especially attention 
and executive functioning.
Despite their multifactorial etiology, falls have one common feature: the majority 
occur during upright transfers and therefore walking [10,64,65]. Similarly to postural 
control, assessment of gait is necessary. Gait can easily be measured using various 
clinical tools such as 10-meter walking test, Tinetti test, … Although indicative and 
feasible in cases of obvious deterioration, more subtle gait changes which are more 
subtly associated with an increased fall incidence cannot be detected by clinical 
observation alone [64]. Technical gait analysis using the GAITRite® electronic 
walkway has proven to be valid and reliable for measuring spatiotemporal gait 
parameters [66-70] and as such was used for gait analyses in our own experiments. 
14
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The GAITRite® System consists of a portable walkway embedded with pressure-acti-
vated sensors. When a subject walks across the walkway, these sensors capture 
footfalls by detecting the timing of sensor activation and the distances between the 
activated sensors. The application software then calculates a wide range of spatial 
and temporal gait parameters. Figure 1.5 gives an overview of several common 
spatial (a) and temporal (b) gait parameters. Spatial (distance) and temporal (timing) 
parameters are expressed or at least calculated as a function of steps or strides. As 
such the step length represents the distance from the heel point of the current footfall 
to the heel point of the previous footfall (left to right or right to left foot) whereas the 
stride length represents the distance between the heel points of two consecutive 
footfalls of the same foot (left to left or right to right) (Figure 1.5 a). 
Figure 1.5   Spatial (a) and temporal (b) gait parameters [64]
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The altered gait pattern of healthy older adults is generally characterized by reduced 
gait speed [71-73], shorter step and/or stride lengths [71,72] and increased gait 
variability [74]. Increased step time, stance time and single or double support time 
have also been reported. An increased gait variability, expressed as increased 
coefficient of variation [(standard deviation/mean) × 100], indicates an unstable gait 
pattern. Gait speed [75,76] and stride-to-stride variability (in both stride length and 
stride time) have repeatedly been identified as independent predictors of falling 
[75,77-79]. Some authors, however, suggested that decreased stride length and gait 
speed and prolonged double support time might be stabilizing compensatory 
adaptations related to the anticipation of fear of falling [77,80]. 
Muscle weakness
As a result of the ageing process, a number of changes in the human muscles can 
be noticed. The degenerative loss of skeletal muscle mass, quality and strength is 
denominated as “sarcopenia”, derived from the Greek words sarx = ‘flesh’ and penia 
= ‘a lack of’ or ‘loss’. The loss of the number of muscle fibers is the principal cause 
of sarcopenia, although fiber atrophy (the loss of muscle mass) of the remaining 
fibers, particularly among fast-twitch type II fibers, is also involved [81]. A lot of other 
age-related morphologic, physiologic and biochemical changes have been identified 
[82]. Furthermore, a recent review demonstrated that not only the muscle itself but 
also the communicating neural pathways to skeletal muscles are impaired with 
advancing age [83]. All these age-related changes result in a progressive loss of all 
muscle functions, i.e. power (explosive strength), strength (maximal amount of force 
exerted in a single attempt) and endurance (capacity to resist muscular fatigue, 
particularly when the resistance is submaximal) [81]. Moreover, muscle strength 
declines 2-5 times faster than muscle mass [84,85] and low muscle strength, but not 
low muscle mass, has been associated with poor physical function in older adults 
[86]. As a result of the decreased muscle power [87], strength [88] and endurance 
[89] older adults are suggested to be more susceptible to accidental falls and 
resultant injuries. Decreased (lower extremity) muscle strength [47,90] has been 
identified as an independent fall risk factor.
Again evaluation of this potential detrimental factor is highly legitimate. Muscle 
function can be measured by clinical tests such as 5-repetition sit-to-stand, by 
manual muscle testing, the use of more objective devices such as dynamometers, or 
by electromyography (EMG). Hand grip strength measured with a hand-held 
dynamometer is very useful in the identification of sarcopenia [91], is a good marker 
of physical performance in older people [92] and can predict falling [16,93,94] and 
recurrent falling [16,95,96]. Therefore, this tool was used in our prospective study. 
16
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Age
Fall rates increase with age [5,15-17] and old age has clearly been identified as an 
important risk factor for falls [16,97,98]. In a way, advanced age can even be 
considered as a main primary intrinsic risk factor since ageing inevitably involves a lot 
of progressing fall-inducing physiological alterations. The substantial age-related 
changes in postural control [44], gait [71-74] and skeletal muscle function [81-85,99] 
and their associations with increased fall risk are described above. 
Gender
Women have higher fall rates than age-matched men [10,16,65,100]. Despite 
contradictory findings in his systematic review, Gama et al. concluded that being a 
woman at an advanced age may actually be a predictor of falls [101]. It might be that 
the substantially smaller lean body mass and concomitant decreased muscle mass/
strength and functional outcome of older women compared to older men [102] 
contributes to this finding. In addition, woman appear to suffer worse fall consequences. 
The increased fracture rate in older females [10] might be attributed to the increased 
prevalence of osteoporosis in this group. Women are also at increased risk of developing 
fear of falling [103]. Finally, female gender has independently been associated with 
functional decline after falling [9].
Previous falls
Older individuals who experienced a fall in the past, are highly susceptible to fall 
again in the future. One or more previous falls may lead to the development of fear of 
falling [103] and is a strong predictor for falls [5,8,16,34,37,95,96,101,104,105]. 
Fear of falling (FoF)
Besides the fall related physical burdens, falls may trouble the mind of an older 
individual, resulting in psychological and emotional complications such as depression, 
being afraid of possible institutionalization and FoF, which in turn may lead to substantial 
activity restriction as a kind of safety coping strategy. Scheffer et al. identified at least 
one previous fall, being female and being older as main risk factors for developing 
FoF [103]. On the other hand, FoF also paradoxically increases falling [19,93,95,106]. 
This might be partly explained by the fact that people with FoF show an adopted 
cautious gait characterized by alterations in spatiotemporal gait parameters [77,80]. 
FoF can thus be considered a major fall consequence as well as a major fall risk 
factor. 
Prevalence of FoF generally varies between 20.8 and 85% [103]. Even though 
previous falls are found to be the main risk factor for developing FoF, FoF is not per 
definition the result of a fall. Over 50% of persons with FoF did not experience a fall 
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before [103]. Legters concluded that FoF is claimed to have an average prevalence 
of 30% or more in older adults who do not have a history of falling and that this rate 
doubles in older adults who have fallen before [107].
Medications
Older adults use more medications because of the co-existence of multiple diseases. 
Both the number and the type of medications may be of importance in relation to 
falls. Groups of medications that have been associated with an increased fall risk are 
those working upon the central nervous system namely anti-epileptics [108-110] and 
psychotropic medications such as benzodiazepines, antidepressants and 
antipsychotics [8,101,105,108-113]. The association of analgesics or cardiovascular 
medications with falls is controversial [109]. 
Besides dosage and duration of these medication intakes, the number of medications 
–regardless of medication class– has also been shown to increase fall risk [34,114-116]. 
An excessive medication intake is called “polypharmacy” and is usually considered 
if ≥ 4 medications are taken. However, recent findings suggest a cut-off of 5 
medications or more in the context of fall risk among older adults [116,117]. 
Pathological conditions
Visual deficits
Although the contribution of the visual system to accurate postural control is 
considered to be relatively low compared to that of the somatosensory (proprioceptive) 
and vestibular system [40-42], impaired vision has been shown to be a risk factor for 
falls [118,119]. Poor visual acuity [120,121], decreased depth perception [47,118,122] 
and lessened contrast sensitivity [118,122] are the visual deficits that have been 
related to falls the most. If a deterioration in one of the postural control systems 
(Figure 1.4) occurs or one system is challenged, the other systems will try to 
compensate for these difficulties in order to maintain stability. As such, visual input 
becomes even more important when a firm and stable surface is replaced by a soft 
and more unstable surface because proprioceptive input from feet and ankles is then 
reduced [122]. Impairments in more than one postural control system e.g. visual and 
sensorimotor system, superimposes fall risk [123]. The contribution of vision in 
postural control is best demonstrated by increased sways when standing with the 
eyes closed.
Neurological impairments
It might not be surprising that older adults who suffer neuromuscular disorders 
affecting gait and balance, such as Parkinson’s Disease [16,104] and stroke [124], are 
at increased risk for falling. 
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Less obvious but epidemiologically very relevant are the associations between falls 
and neuropsychological diseases such as depressions and cognitive deterioration. 
 As one of the geriatric giants, depression can be considered a common problem 
in the older population. Approximately 15% of older community-dwelling people and 
32% of residential care-dwelling people report significant depressive symptomatology 
[125]. Depression and depressive symptoms have repeatedly been identified as 
increased fall risk factors [37,47,94,96]. The underlying mechanisms of this relationship 
are not fully understood so far. Maybe a co-existing general physical disability, poor 
sleep and/or psychotropic drug utilization may contribute to the increased fall risk.
 About 36.5 million people were estimated to live with dementia in 2010 with a new 
case of dementia every 4 seconds [126]. Older persons with dementia are 2 to 3 
times more likely to fall compared to older persons without dementia [101,127,128]. 
The increased fall risk is also true for older adults suffering from mild cognitive 
impairment (MCI) [129], which can be described as an intermediate state between 
normal age-related cognitive changes and dementia. Poor executive functioning has 
clearly been associated with gait alterations [61,130,131]. Executive functions include 
goal-directed behavior, problem solving, planning, organization, the ability to initiate 
and stop actions, anticipate and adapt to changing situations, direct attention and 
working memory. Executive functioning is generally associated with the frontal cortex, 
including the dorsolateral prefrontal cortex, which in turn has been related to dual 
tasking and to gait variability [62], supporting the idea that fall risk partially depends 
on executive functioning [132]. Herman et al. and Mirelman et al. predicted the risk of 
future falls by performance on executive functioning and attention tests conducted 2 
and 5 years earlier respectively [132,133]. 
Musculoskeletal disorders
Musculoskeletal disorders encompass a large group of conditions in which one or 
more parts of the musculoskeletal system is injured. The muscles, joints, bones and/
or surrounding structures might be affected in a chronic way or due to an acute 
trauma. Musculoskeletal disorders such as lower limb tendinitis or osteoarthritis may 
directly increase fall risk by pain-induced alteration of gait performance. Scoliosis, 
foot or other structural lower limb deformations may displace the body center of 
gravity, thereby altering postural control. Musculoskeletal disorders affecting gait and 
posture are quite common and therefore become a potential aggravating fall risk factor.
Internal disorders
With an estimated prevalence of 30 to 50% in community-dwelling women aged 65 
or older [134], urinary incontinence can be considered a geriatric giant for good 
reasons. In contrast to stress incontinence, urge incontinence is significantly 
increases the risk for falling by 26% [135,136] and fractures by 34% [136].
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Chronic kidney disease is also an important risk factor for falls, and the risk correlates 
negatively with creatinine clearance [137-139]. A low creatinine clearance (of <65ml/
min) is associated with a 3.7-fold increased fall risk [139]. The creatinine clearance is 
important for the conversion of calcidiol to the metabolically most active form of 
vitamin D [139]. Since a vitamin D deficiency is associated with decreased muscle 
strength, balance and functional mobility [139], this might explain the findings of an 
impaired renal function as fall risk factor.
Some cardiovascular disorders such as drop attacks, syncope and orthostatic 
hypotension may be responsible for “unexplained falls”. Notwithstanding the fact that 
syncope may lead to a fall, “syncope” and “fall” are generally considered two different 
entities as definitions of falls mostly exclude falls due to loss of consciousness [140]. 
However, extension of current fall definitions is sometimes suggested in order to 
reduce falls without attributable diagnosis and to acknowledge the existing overlap 
between syncope and falls [140]. With respect to cardiovascular disorders orthostatic 
hypotension is often thought to be a strong risk factor for falls. Orthostatic hypotension 
is however found to be a relatively unimportant or rare cause of falls [141]. Furthermore, 
since orthostatic hypotension can be of an intermittent nature, older adults may test 
negatively during fall risk assessment but may nevertheless suffer from postural 
blood pressure drops and falls during a follow-up period [141]. If orthostatic 
hypotension was positively tested, measures may however be taken to prevent falls 
induced by orthostatic hypotension.
Another predominating internal geriatric disease with staggering fall incidence rates 
[31], is T2DM. Since older adults with diabetes are the main target population of this 
doctoral thesis, a comprehensive overview of the disease and its main chronic 
complications will be provided in the next chapter of this General Introduction (page 
23 and further). The increased fall rates in T2DM are commonly accepted, but 
therefore not that well understood. Nevertheless, T2DM is a morbidity in which 
remarkably all above mentioned pathological fall risk factors (visual, neurological, …) 
quite often occur as chronic complications. The potential interrelationships between 
T2DM and falls will therefore be summarized in the final chapter of this General 
Introduction (page 33 and further).
Extrinsic fall risk factors
Among the extrinsic risk factors for falling objects lying around on the floor such as 
loose carpets, toys of grandchildren and electric cords, are the most self-explanatory 
causes provoking a fall. Other environmental hazards that have been associated with 
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falls are poor lighting, wet (slippery) or uneven surfaces [18], lower monthly incomes 
[97], living in a house rather than an apartment [97] and widowhood [142]. Type of 
footwear is also mentioned as an important extrinsic fall risk factor that can easily be 
examined and remedied.
Type of footwear
Gait and balance alterations might occur due to wearing suboptimal shoes, 
consequently increasing fall risk. Altered proprioceptive input and somatosensory 
feedback is suggested to be the underlying mechanism. Walking barefoot [143], in 
socks [143] or with high-heeled shoes [144] has been shown to increase indoor fall 
risk. Nevertheless, the majority of community-dwelling older adults wears slippers 
within their homes and one out of three walks barefoot or with socks [145]. A heel 
height of 2.5 cm or greater nearly doubled fall risk in a prospective study among older 
community-dwelling adults [146]. Menant et al. has shown that high heels or shoes 
with soft soles should be discouraged in older people [147] and that a standard laced 
shoe with a low collar and a slip-resistant sole of standard hardness with or without 
tread grooves should be recommended since this type of shoe has proven to provide 
optimal dynamic stability when walking on even and uneven surfaces [147-149].
From our own assessments we noticed that a lot of preferences and questions 
concerning shoe types exist among the participants. In several cases also apologies 
or explanations were made that their performance would probably be better or at 
least deviant if they should have used other shoes. This rendered us to look for 
comparable experiences or specific advice in literature. The personal experience 
together with the remarkable fact that in published fundamental and clinical evaluation 
of gait appropriate description of footwear was seldom given, inspired us to conduct 
a study regarding the effect of different types of footwear on gait performance. 
Situational fall risk factors
Risky behavior such as climbing a ladder to replace a lamp, consuming too much 
alcoholic beverages or inattentive behavior might provoke fall events. Among older 
adults in general, however, dual tasking is the most common situational factor leading 
to falls. Many activities of daily living are performed simultaneously (e.g. ironing while 
watching a movie, cooking while listening the weather forecast on the radio, having a 
conversation while hanging the wash, moving in busy traffic situations, … ), thereby 
requiring divided attention.
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Dual tasking
The clinical experience of Lundin-Olsson et al. that some frail older patients stopped 
the walking when starting a conversation while walking [150], is probably the birth of 
dual task paradigms in scientific research. They supposed that this gait freeze 
occurred because walking demands attention, just like holding a conversation. 
Instead of doing two things at the same time, the frail older patients only fulfilled one 
task (holding a conversation) at the expense of the other task (walking). This is the 
main principle of dual tasking.
The phenomenon of “stops walking when talking” inspired researchers to reconsider 
the automaticity of walking. If walking would be an automated activity, there would be 
no need to stop walking when talking. Later on, walking has indeed been proven to 
require minimal higher-level cognitive input [61-63]. Because central resources 
decline in older individuals, dual task ability also deteriorates [151]. The introduction 
of dual tasks in gait analyses showed that gait patterns were indeed altered when 
compared to single task conditions (i.e. walking alone). During dual task conditions 
decreases in gait speed and swing time and increases in stride time and swing time 
variability have been observed among older adults [152-154]. These effects have 
been associated with poor executive functioning [152,155], which is a strong fall risk 
factor itself (see above). Dual tasking induced gait changes are significantly 
associated with an increased risk for falling amongst older adults [156].
Dual task walking might be viewed as a functional measure of executive functioning 
[132] as both functions rely on the dorsolateral prefrontal cortex [62]. Both dual task 
walking ability and executive functioning have been related to future falls [132]. When 
two tasks are expected to be performed simultaneously, difficulties can arise if at 
least one task is too demanding or if cognitive reserves and attentional capacities are 
low. Beauchet et al. found that the effects of dual tasks on gait performance depend 
on the type of the given cognitive dual task concordant with the attentional load [153]. 
Generally, arithmetic dual tasks (e.g. counting backwards) cause significantly greater 
gait alterations than verbal fluency dual tasks (e.g. animal naming) [153,157]. As both 
ambulation and the arithmetic dual task rely on the working memory, the increased 
competitive interaction with executive functions might explain this finding. Verbal 
fluency mainly depends on semantic memory. Woollacott et al. concluded that not 
only the type but also the complexity of the second task contributes to an increased 
attentional demand [158]. Alternatively, effects of dual tasks might also be more 
pronounced in older individuals with limited cognitive capacities. Dual task related 
gait decrements are significantly larger in aged groups suffering from MCI [159,160] 
or dementia [160] compared to older adults with intact cognitive abilities.
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Multifactorial etiology 
Mostly, a fall (considering the definition we use) in an older individual is the result of a 
complex interaction of intrinsic, extrinsic and situational factors. As more than 400 
potential risk factors for falling have been identified in previous research [161], one 
must realize that it is utopic and not realistic to administer each fall risk factor and 
predict fall incidence with a 100% sensitivity. However, the risk of falling [2] and 
recurrent falling [162] increases with the number of risk factors. We therefore tried to 
pay attention to the most important intrinsic (gait, balance, previous falls, fear of 
falling, medication intake, …) and extrinsic (shoes, type of dwelling) risk factors in the 
experiments of this doctoral thesis. Furthermore, we simulated situational conditions 
by introducing dual task paradigms in gait analyses. Since the role for physiothera-
pists in preventing falls and rehabilitation after a fall particularly concerns intrinsic fall 
risk factors, these will however receive our main attention.
Key points
•	A	 fall	 is	 defined	 as	 “an	 event,	 which	 results	 in	 a	 person	 coming	 to	 rest	
unintentionally on the ground or other lower level, not as a result of a major 
intrinsic event or overwhelming hazard”
•	Falls	have	a	multifactorial	etiology.
•	Poor	gait	and	postural	control	are	main	risk	factors	for	falling.
•	These	 intrinsic	 risk	 factors	 are	 aggravated	 by	 age,	 type	 and	 number	 of	
medications and pathological conditions (other intrinsic risk factors) and/or 
by type of footwear (extrinsic risk factors).
•	Previous	falls	and	fear	of	falling	are	strong	predictors	for	future	falls.
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TYPE 2 DIABETES MELLITUS
Background 
With about 90% of the people with diabetes having T2DM, this is the most common 
form of diabetes. Worldwide, up to 1 out of 6 adults aged 65 years or over suffers from 
T2DM [163]. In the United States this number increases to as much as 26.9% [164]. 
Furthermore, prevalence rates are likely to be even higher than current estimates 
because a substantial proportion of T2DM patients does not (yet) realize that they 
suffer from T2DM as the onset may occur up to seven years before clinical diagnosis 
[165]. The emerging pandemic can be attributed to the outline of several global 
trends: ageing population, rising levels of obesity and inactivity, and greater longevity 
among T2DM patients due to improved management [166]. T2DM usually develops 
slowly and is associated with overweight and genetic predisposition. It is mostly 
diagnosed in older people which explains the previous name “maturity-onset 
diabetes”. However, since more and more children are diagnosed with T2DM, this 
term is no longer preferred. As persons with T2DM can control their condition by 
other methods than insulin, T2DM is also called “non-insulin-dependent diabetes”. 
Before elucidating the pathogenesis of T2DM it might be useful to bear in mind that the 
maintenance of normal sugar level in the blood is achieved by three ways: (i) derived 
from carbohydrates in the food (largest part), (ii) derived from glycogen if blood sugar 
level falls to much, and (iii) derived from fat- and protein reserves if supply of 
carbohydrates stopped and glycogen stock is exhausted. With the help of insulin, a 
hormone secreted by the β-cells of the pancreas (islets of Langerhans), cells throughout 
the body absorb glucose and use it for energy. Insulin is needed to transport glucose 
from the bloodstream to the cells and to allow glucose to enter body cells. If blood 
glucose levels increase after a meal, the pancreatic islets will react by stimulating insulin 
secretion into the blood to transport glucose to the cells. Like other hormones, insulin 
also acts as a key opening the gate of functions or cells of the human body (activation 
of insulin-receptors). In the case of insulin it concerns the doors of body cells in order 
to stimulate the cellular uptake of glucose from the blood. However, in T2DM the body 
cells of the tissues are less sensitive for insulin due to excess weight in which muscle, 
liver and fat cells do not use insulin properly. Insulin resistance usually precedes the 
development of T2DM by many years and is a consequence of chronic systemic 
inflammatory responses. Obesity, overnutrition and/or inactivity lead to the accumulation 
of lipids and excess storage of lipids in liver and muscles (triglycerides), resulting in 
incomplete oxidation and oxidative stress [167,168]. This lipid accumulation is directly 
associated with insulin resistance. However, recent research hypothesizes that the 
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excess lipid accumulation and concordant oxidative stress can also damage 
mitochondrial function, which is crucial in the pathogenesis of T2DM. Mitochondria are 
located in nearly every body cell and are responsible for producing energy. In T2DM 
mitochondria are smaller and have a decreased function [169]. Failure of complete 
oxidation (mitochondrial dysfunction) can again lead to accumulation of lipid inter-
mediates, incomplete fatty acid oxidation products, and reactive oxygen species 
(ROS), inducing both insulin resistance (muscle, liver, adipose) and altered secretion 
(β-cells) [167]. In response to the decreased insulin sensitivity, the pancreatic β-cells 
produce more insulin. However, after a while they are exhausted and further damaged 
by oxidative stress. Besides the already existing insulin resistance, a defi cient secretion 
of insulin is then a fact. It is therefore suggested that oxidative stress acts as the main 
pathogenic mechanism of both insulin resistance and β-cells dysfunction [168]. 
An insuffi cient insulin secretion or the presence of insulin resistance leads to an 
accumulation of sugar in the blood instead of being absorbed by body cells. Consequently, 
body cells are starved of energy for optimal functioning despite high blood glucose 
levels. The body will try to remove the elevated sugar in the blood by the urine 
(“glycosuria”), which may lead to frequent urination (“polyuria”), thirst and frequent 
drinking (“polydipsia”). If not treated timely, a long-lasting or excessive hyperglycemia 
may result in a diabetic coma. In the early stages of diabetes there might however be 
no symptoms. Lab analyses of blood are thus required to diagnose prediabetes or 
diabetes. The following tests can be used for diagnosis of T2DM: Oral Glucose 
Tolerance Test (OGTT), Fasting Plasma Glucose (FPG) test, HbA1c test. Table 1.3 
gives an overview of the criteria for the diagnosis of T2DM.
Table 1.3  Criteria for the diagnosis of diabetes
Normal Prediabetes Diabetes
OGTT (mg/dL) < 140 140-199 ≥ 200
FPG     (mg/dL) < 100 100-125 ≥ 126
HbA1c (%) < 5.7 5.7-6.4 ≥ 6.5
(mmol/mol) < 39 39-46 ≥ 48
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Chronic complications
T2DM is a chronic disease with particularly chronic complications. However, some 
acute complications might occur, especially in cases of poor adherence to medical 
care and treatment. Hypoglycemia or low blood glucose level (FPG < 70 mg/dL) and 
hyperglycemia or a high blood glucose level (FPG > 126 mg/dL) are the most 
common acute complications. Since some chronic complications have shown to be 
risk factors for falling as single entities (in older adults without T2DM) and can 
therefore be hypothesized to substantially increase fall risk, the chronic complications 
of T2DM will be discussed more elaborately. Chronic complications of diabetes are 
very common in T2DM and present very divers. They are mostly the result of vascular 
damage. A conscientious management of diabetes including strict diet, exercise and 
medical measures (optimizing glycemic and blood pressure control) is fundamental 
to minimize chronic complications.  
Neuropathy
About 50% of all people with diabetes have some form of nerve damage. Prevalence 
increases with age, duration of diabetes and worsening of glucose tolerance. Nerve 
damage generally develops due to long-lasting excessive blood glucose injuring the 
walls of tiny blood vessels that nourish nerves, especially in the legs. 
Figure 1.6 illustrates the different types of nerve fibers (motor, sensory and autonomic; 
myelinated or not; large or small) and their respective functions. Sensory nerves send 
messages to the brain about pain, temperature and touch. Motor nerves tell muscles 
when and how to move and autonomic nerves control body systems that digest food, 
pass urine and regulate blood pressure. 
Diabetic neuropathies are a heterogeneous group of nervous disorders that may 
cause a substantial loss of quality of life. The explanation of all types of diabetic 
neuropathies lies beyond the scope of this thesis. Therefore, only the most common 
form will be elaborated, distal symmetric polyneuropathy, accounting for 75% of all 
diabetic neuropathies [171].
Diabetic distal symmetric polyneuropathy mainly affects feet, legs and hands 
(“stocking-glove distribution”) and may involve small fibers, large fibers, or both. 
Although both motor and sensory nerve conduction is affected, sensory symptoms 
are usually most prominent [172]: burning or electric-like pain, disturbed perception 
of vibration and temperature, increased sensitivity to touch and numbness of the feet. 
People with distal symmetric polyneuropathy sometimes have the apparent paradox 
of numbness and exquisite sensitivity at the same time [172] and often describe 
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feelings of tingling feet (pins and needles), ants running over their feet, stockings 
while barefoot, dead feet, … Which symptom predominates varies substantially from 
patient to patient [172]. In advanced stages, neuropathy can be so predominant that 
patients do not feel pain anymore, rendering a situation in which small injuries may 
remain unnoticed and the “diabetic foot syndrome” (see page 28) is entering the 
clinical picture of T2DM. 
Nerve conduction studies are preferably used to detect diabetic neuropathies. 
However, they are (too) expensive to use in routine clinical practice. Therefore, a 
number of simple and rapid clinical screening instruments have been proposed: 10 g 
Semmes-Weinstein monofi laments, 128 Hz tuning fork, biothesiometry, ankle refl ex, 
Diabetic Neuropathy Symptom (DNS) score, Diabetic Neuropathy Examination 
(DNE) score. In this doctoral thesis information concerning peripheral nerves was 
obtained by participants’ general practitioner, DNS and vibration perception threshold 
(VPT) using the Bio-Thesiometer® (Bio Medical Instrument co, Ohio, USA). 
Figure 1.6   Simplified view of the peripheral nervous system [174]
GIT, gastrointestinal tract; GUT, genitourinary tract
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Nephropathy
High blood glucose levels resulting from the diabetes disease may destroy the 
associated tiny blood vessels (capillaries) of the nephrons in the kidneys. The 
glomeruli thicken and leak more albumin than normal in the urine (“micro-albuminu-
ria”). Usually, this early stage has no symptoms. As diabetic nephropathy progresses, 
increasing numbers of glomeruli are destroyed and urine albumin increases to the 
point that it may be detected by ordinary urinary analyses. These later stages may 
lead to swollen feet and legs and rises in blood pressure, cholesterol and triglyceride 
levels. In advanced stages the kidney may even stop working completely (“end-stage 
renal disease” or “kidney failure”) and the diabetic person needs replacement therapy 
via dialysis or kidney transplant. 
Diabetic nephropathy occurs in 20-40% of patients with diabetes [173].
Retinopathy
Approximately one third of people with diabetes is affected by retinopathy [174,175]. 
It involves damage to the microvasculature of the retina as a result of the prolonged 
exposure to diabetes-induced metabolic changes. 
There are two major types of diabetic retinopathy: nonproliferative and proliferative. 
The less severe nonproliferative form develops first and is the most common form. In 
an advanced stage new blood vessels are created by growth factors in an attempt to 
compensate for the damaged vessels (proliferative stage). Symptoms include blurred 
vision (loss of sharpness and inability to see fine details), slow vision loss over time, 
trouble seeing at night, floaters (tiny particles drifting inside the eye) and shadows or 
missing areas of vision. These visual deficits may hamper postural control with 
potential detrimental effects. Regular eye exams are thus very important.
Again, individuals with diabetes who have poor glycemic control, genetic factors, 
high blood pressure and a longer duration of diabetes are more likely to develop 
retinopathy. Individuals suffering from diabetes are also at increased risk for other eye 
diseases such as glaucoma (increased pressure in the eye) and cataracts (cloudiness 
of the eye lens).
Cardiovascular and atherosclerotic complications
Besides damage to smaller blood vessels or capillaries called “microvascular 
complications” (such as the above-mentioned neuropathy, nephropathy and retinopathy), 
excessive blood glucose levels in T2DM may also affect larger blood vessels: macro - 
vascular complications. It is hypothesized that these cardiovascular complications 
are mainly caused by endothelial dysfunction due to oxidative stress [168], which in 
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turn results from excess lipid accumulation in cases of overnutrition (obesity) and 
decreased physical activity, as explained earlier.
Approximately one out of every three people with diabetes aged 50 or more have 
peripheral arterial disease [164]. This condition is characterized by atherosclerotic 
occlusive disease of the lower extremities. The most common symptom of peripheral 
arterial disease is intermittent claudication, defined as pain, cramping, or aching in 
the calves, thighs, or buttocks that appears reproducibly with walking exercise and is 
relieved by rest [176]. Individuals with peripheral arterial disease are at increased risk 
for lower-extremity amputation and cardiovascular or cerebrovascular disease such 
as heart attack and stroke. 
Heart attacks and strokes (cardiovascular diseases) strike people with diabetes more 
than twice as often as people without diabetes [164]. As much as two out of three 
people with diabetes die from heart disease or stroke [164]. Coronary heart disease 
and cardiomyopathy are other common cardiovascular complications of diabetes.
Diabetic foot syndrome
The diabetic foot syndrome is an umbrella term covering several foot problems that 
may occur as a consequence of diabetes. It generally concerns diabetic foot 
ulcerations, diabetic foot infections and/or neuropathic osteoarthropathies of the heel 
bone and joint. Foot ulcers occur in approximately 15% of patients with diabetes [177] 
and precede about 85% of diabetic foot and lower extremity amputations [178]. They 
are considered to be one of the most expensive diabetes-related complications to 
treat [179]. 
The main intrinsic causes of the diabetic foot lie in two other chronic diabetes 
complications: neuropathy and peripheral arterial disease. As explained earlier, 
peripheral nerve damage may result in a disturbed or significantly attenuated soma-
tosensation. As such, rubbing shoes, pebbles or other small objects in the shoes 
leading to blisters or small injuries may remain unnoticed. Furthermore, the skin of the 
feet is more vulnerable to increased mechanical stress since autonomic neuropathy 
may reduce hydration resulting in less elastic skin properties. On top of that, poor 
blood supply complicates proper healing of open wounds which may easily infect. 
Foot problems may substantially debilitate one’s walking abilities and quality of life.
Apart from good diabetes control, regular (daily) podiatric inspection and care are thus 
essential in order to timely notice and nurse wounds and prevent foot ulcers, gangrene 
and amputations.
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Limited joint mobility (LJM)
LJM is a common complication of T2DM. LJM is often characterized by hand and 
finger stiffness but other (large) joints may also be involved. Glycosylation of collagen 
is believed to be the major underlying mechanism. Although LJM is a painless 
complication, the stiffness and contractures may lead to a substantial mobility 
reduction (decreased range of motion).
Cognitive deterioration and depression
A less self-evident chronic complication of T2DM is cognitive decline. In recent years, 
cognitive deficits have been identified in patients with diabetes [180-182], even at early 
stages of the disease [183]. Several prospective studies have positively associated 
diabetes with cognitive decline [184-186]. Strong associations were found between 
dementia and diabetes, particularly if treated with insulin [187]. Positive relationships were 
found with vascular dementia [187,188] but also with Alzheimer’s disease [187-189] and 
MCI [188], with relative risk ratios of 2.5 (95% CI: 2.1-3.0), 1.5 (95% CI: 1.2-1.8) and 1.2 
(95% CI: 1.0-1.5) respectively [188]. The metabolic syndrome and cardiovascular burden 
caused by diabetes have been associated with reduced cognitive function and structural 
brain abnormalities [190]. However, the underlying mechanisms are still disputable and it 
is suggested that the etiology of cognitive impairment in diabetes may not be restricted 
to vascular pathology [191]. Among others executive functioning [192-195] and attention 
[193,196], which are crucial for adequate gait performance and dual tasking as explained 
earlier, belong to the affected cognitive domains. So far, however, detailed cognitive 
assessments are not routinely carried out among diabetic patients. 
 Besides cognitive impairments and dementia, patients with diabetes are more 
likely to suffer another mental disorder: depression. Depression [197,198] and 
depressive symptoms [199] are significantly more prevalent in older adults with T2DM 
compared to older adults without T2DM. Individuals with diabetes are twice as likely to 
have diagnosed depression [200,201]. The prevalence of depression in diabetes is 
estimated at 30% [199,201] and the presence of depressive symptoms has been 
associated with a significant worsening of glycemic control [199], an increased risk for 
diabetic complications and hyperglycemia [202]. Furthermore, depressive symptoms 
are associated with volume reductions in frontal and temporal brain regions [203] and 
with poor cognitive functioning and cognitive decline, particularly with advancing age 
[204,205]. It is recommended to evaluate both depressive symptoms and cognitive 
functions  because they might influence each other in the given test results.
Falls
Given the markedly increased incidence and prevalence rates of falls in older adults 
with T2DM, falls could be considered a (functional) complication of T2DM. The 
existing and lacking evidence concerning this item will be discussed later (page 33).
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Management
The pathophysiology of diabetes and any of its complications starts with increased 
blood glucose levels. Diabetes management will therefore focus on lowering blood 
glucose levels. The California Healthcare Foundation/American Geriatric Society Panel 
on Improving Care for El ders with Diabetes suggested that a reasonable goal for HbA1c 
in relatively healthy elderly with good functional status should be 7% (53 mmol/mol) or 
lower [206]. For older adults who are frail, have life expectancy <5 years and in whom 
the risk of intensive glycemic control may outweigh its benefit, a less stringent target of 
8% is recommended [206]. Glucose levels should ideally range between 70 and 130 
mg/dL before meals and be less than 180 mg/dL two hours after starting a meal [164]. 
In the very early stages of the disease, changes in lifestyle (diet and exercise) may be 
sufficient to control blood glucose levels but over time, oral agents and even insulin 
injections are needed to manage T2DM. Vijan suggested that if changes in lifestyle in 
those with mild diabetes has not resulted in improved blood sugars within six weeks, 
pharmacological therapy should be initiated [207]. Management of T2DM in the aged 
should be specifically targeted towards the needs of the older adults [202,208].
Glucose-lowering agents
The standard approach for pharmacological T2DM treatment is focused on improving 
glycemic control, as reflected by serum levels of HbA1c. The recommended first-line 
pharmacological treatment of diabetes is metformin because of its effectiveness in 
lowering blood glucose (by sensitizing the liver to insulin), the low risk of hypoglycemia 
and relatively low adverse effect profile [208]. Most patients with diabetes have 
worsening glycemic control over time and will require increased doses or an additional 
agent to maintain adequate glycemic control. There are a lot of anti-diabetic agents 
available but some may cause mild to severe side effects such as hypoglycemia or 
weight gain [202,207]. This is also the case for insulin [209]. Replacing or additional 
insulin injections might be needed if oral agents are no longer sufficient to achieve 
adequate glycemic control. 
Diet
A diabetic diet that promotes weight loss is important. In their review, Davis et al. 
concluded that the best diet type to obtain weight loss in T2DM is controversial [210]. 
Nevertheless, most researchers agree on the beneficial effect of low glycemic index 
(GI) diets to improve glycemic control with significant decreases in HbA1c up to 0.5% 
[211-213]. The GI provides a measure of how quickly blood glucose levels rise after 
eating a particular type of food, relative to consumption of pure glucose (glucose has 
a glycemic index of 100). Examples of food with a low GI (≤ 55) are beans, seeds, 
grains and most vegetables and sweet fruits. 
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Exercise
Besides the direct effects of weight loss on glucose levels, a Cochrane meta-analysis 
comparing exercise with no exercise in T2DM showed that exercise signifi cantly 
improved glycemic control, reduced visceral adipose tissue and reduced plasma 
triglyceride levels even without weight loss [214]. Exercise among adults with T2DM 
improves (i) physical fi tness, (ii) antropometric measures (improved body composition 
by decreasing fat mass and/or increasing lean mass), and (iii) metabolic fi tness 
(improved insulin sensitivity and cardiovascular risk profi le). Aerobic exercise results 
in a decrease in HbA1c and improved insulin sensitivity with better outcomes for more 
vigorous exercise programs [215]. Resistance training is also useful and the 
combination of both types of exercise may be most effective [215,216]. Umpierre et 
al. concluded from his meta-analysis that aerobic and/or resistance exercise can 
lower HbA1c by 0.6-0.8% [217]. There is some evidence that interval training in T2DM 
improves glucose control and increases mitochondrial capacity [218]. According to 
the American Diabetes Association guidelines, people with diabetes should be 
advised to perform at least 150 min/week of moderate-intensity aerobic exercise and 
at least twice per week resistance training [173].
Self-management
Patients are generally advised to monitor fasting and premeal glucose levels at home. 
Education should inform the patient about possible side effects of anti-diabetic 
agents, learn the patient to recognize and treat hypoglycemia and stimulate practicing 
regular self-testing to monitor blood glucose levels at home. People with diabetes 
should learn how diet, exercise and anti-diabetes agents are working. Figure 1.7 
illustrates the importance of a well-balanced diabetes management. 
Figure 1.7   T2DM management: monitoring glycemic control
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Although monitoring blood glucose levels is important in older adults with T2DM, 
evidence suggests that greater reductions in morbidity and mortality may result from 
control of other cardiovascular risk factors (such as dyslipidemia, hypercholesterolemia, 
hypertension and smoking) than from tight glycemic control alone [173]. 
Key points
•	Diabetes	occurs	due	to	(i)	the	inability	of	the	pancreas	to	secrete	(enough)	
insulin, and/or (ii) resistance of the body to insulin, resulting in an accumulated 
blood glucose level and energy deficiency in the cells and organs.
•	Besides	microvascular	(neuropathy,	nephropathy,	retinopathy)	and	macro-
vascular (peripheral artery disease, heart attack, stroke, …) pathologies, a 
third category of underappreciated chronic complications in T2DM including 
cognitive decline, depression and falls, should be considered.
•	Diabetes	 management	 aims	 to	 achieve	 and	 maintain	 glycemic	 control	
through a combination of lifestyle (diet and exercise) and medical measures.
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TYPE 2 DIABETES MELLITUS AND FALLS
Diabetes has repeatedly been identified as risk factor for falls [25-29,31,219-222], 
injurious falls [26], hip and other fractures [30,223]. Prevalence rates of falls in older 
adults with T2DM are however scarce. Fall incidence in older adults with diabetes 
was found to be more than twice the fall incidence rate in older adults without diabetes 
[31]. Despite these staggering numbers, little is known about the underlying 
mechanisms leading to the increased fall rates among older adults with T2DM.
The most common and well-known diabetic complication, i.e. peripheral neuropathy 
and/or its related symptoms, has been associated with an increased fall incidence 
[29,224,225], seemingly based on its interference on the observed disturbances in 
gait and balance in T2DM. 
 Spatiotemporal gait parameters are worse in older adults with diabetes compared 
to older adults without diabetes. Diabetic gait patterns have been characterized by 
decreased gait velocity, step and/or length and cadence and increased stride time, 
stance width, double support time and gait variability [221,226,227]. Based on a 
systematic review, Allet et al. concluded that velocity in patients with diabetes (mean 
age 47.6 to 73.5 years) ranges from 0.7 to 1.24 m/s which is significantly lower than 
that of controls (mean age 43.2 to 73.9 years) where velocity generally ranges from 
0.9 to 1.47 m/s [226]. The presence of diabetic peripheral neuropathy has been 
associated with aggravated alterations in gait (variables) [228,229]. However, other 
authors found no differences in gait performance between diabetic adults with and 
without neuropathy [221,230,231]. 
 As explained earlier in this doctoral thesis, postural control relies on adequate 
somatosensory, vestibular and visual input. Under normal conditions the 
somatosensory system, in particular the proprioceptive input provided by large 
(myelinated) sensory nerves, is the most important afferent contributor for postural 
control. Impaired postural control when standing or walking in T2DM can therefore be 
considered as a functional consequence of peripheral neuropathy, potentially 
resulting in instability and finally in fall events. Similarly to gait performance, postural 
stability is impaired (greater sways) in people with diabetes, especially if their 
condition includes neuropathy [232,233]. Lord et al. found vibration sense to be 
significantly correlated with sway [233]. However, there is still a lack of consensus 
concerning the actual cause (diabetes itself or diabetes-related neuropathy) for 
balance disturbances in T2DM [232]. Bonnet and Ray suggested that perturbations 
in visual or vestibular systems might affect quiet stance even more than diabetic 
neuropathy [234]. 
 Finally, neuropathic processes are suggested to affect (lower limb) muscular 
function in older adults with T2DM [235]. 
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Besides neuropathy, other mediators of peripheral muscle and cardiac muscle 
dysfunction in diabetes hampering exercise capacity, have been suggested: 
inflammatory cytokines [235] and endothelial dysfunction [236]. Furthermore, lower 
VO2peak values have been found to directly correlate with decreased insulin sensitivity 
[236].
Apart from the controversial role of peripheral neuropathy, a lot of other diabetes-re-
lated complications such as foot ulcers, limited joint mobility (musculoskeletal 
disorders), nephropathy (chronic kidney disease), retinopathy (visual deficits), urinary 
incontinence, depression and cognitive decline (neurological impairments) might 
increase fall risk since they are proven risk factors for falls in older adults without 
diabetes (see Intrinsic Fall Risk Factors, Pathological Conditions on page 17-19). 
Therefore, the finding of Schwartz et al. that reducing diabetes-related complications 
may prevent falls [237] is plausible. 
 As explained earlier, the increased fall risk among older adults with T2DM can be 
seen as an (underappreciated) chronic diabetes-related complication. The primary 
strategy to reduce fall risk among older adults with T2DM is therefore probably similar 
as the strategy to minimize other chronic complications and lies in an adequate 
disease management or glucose control. As explained earlier in this doctoral thesis, 
exercise training interventions lower HbA1c. Additionally, exercise programs have 
also been shown to improve exercise performance capacity (VO2peak) [238,239], 
decrease adipose tissue mass [238], reduce arterial blood pressure [240], and even 
enhance pancreatic β-cell function [241]. Exercise can thus improve glucose control 
as well as cardiorespiratory measures, consequently reducing diabetes-related 
complications. Besides lifestyle management, blood glucose can be controlled by 
pharmacological agents such as oral anti-diabetics and insulin injections. However, 
self-management of T2DM in older adults can be complicated by some age-related 
factors such as cognitive dysfunction [242]. Furthermore, hypoglycemia has been 
shown to be more common in older adults because of impaired renal and hepatic 
metabolism, polypharmacy or non-adherence to medications and erratic or poor 
food intake [243]. Also, hypoglycemia may be masked by comorbidities such as 
dementia, depression or stroke [208]. In conclusion, management of T2DM in the 
aged should be set individually and special attention is needed for conditions that 
may complicate self-care and hypoglycemia awareness.
 The existing literature concerning specific fall preventive exercise programs 
among older adults with T2DM is scarce. Allet et al. found that specific training can 
improve gait speed, balance, muscle strength and joint mobility in diabetic patients 
but correctly argued that the influence of these improvements on falls needs to be 
explored in future research [244]. Multifactorial exercise programs, usually containing 
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balance and strength training exercise have been proven to effectively reduce falls in 
older adults [6,20,21]. These findings should however be confirmed for older adults 
with T2DM.
Although diabetes has repeatedly been associated with an increased fall risk, studies 
investigating the underlying mechanisms and potential effects of complications on 
falls in older adults with diabetes are lacking. Therefore, it can be stated that based 
on the available evidence nor diabetes per se, neither the existence of one or more 
diabetes-related complications can be ruled out as causal factor for gait and balance 
disturbances, and thereby falls. Nevertheless, one can hypothesize that the same 
fall-related functions (“F” in Table 1.2) are affected in older adults with T2DM, albeit to 
a greater extent since the intrinsic characteristics (“C” in Table 1.2) might be 
aggravated by diabetes-related complications. This doctoral thesis primarily aims to 
assess this hypothesis by investigating a set of established fall risk factors among 
older adults with and without T2DM.
Key points
•	Diabetes	is	a	risk	factor	for	falls	but	the	underlying	reasons	are	still	unclear.
•	Peripheral	neuropathy	has	been	associated	with	alterations	in	gait,	postural	
control and muscular function but its actual contribution to these hampered 
functional outcomes is controversial.
•	A	lot	of	diabetes-related	complications	might	increase	fall	risk	since	they	are	
proven risk factors for falls in older adults without diabetes.
•	Fall	prevention	 in	older	adults	with	T2DM	starts	with	an	adequate	disease	
management. Specific fall preventive exercise programs are likely to be 
beneficial but should be confirmed in future research.
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AIMS AND OUTLINE
This doctoral thesis aims to identify and understand risk factors for falling among the 
ever-growing population of older adults with T2DM (Part One). Although fall prevention 
has been an area of active research over the past 15 years and multiple useful risk 
strategies have been suggested, some interfering factors are still not incorporated 
into standard fall risk assessments. Therefore, the importance of several often 
proposed but less focused aspects in gait, balance and fall prevention screenings 
will be assessed (Part Two).
Part One: Fall risk factors
For the first time in history, the issue of ageing globally claims attention in different 
domains of the society with inevitable shifts in socioeconomic characteristics and 
changes in health services. Scientific researchers face a huge challenge in investigating, 
understanding and treating age-related normal and pathological conditions. 
During the last decades, one has realized that falling is a major problem in the aged 
population with a number of potentially drastic consequences for the individual and 
health care facilities. Consequently, fall-related research (epidemiology, risk factors, 
consequences, screening, prevention, …) has boomed in the older population and a 
lot of risk factors for falling have been established. However, these studies are mostly 
limited to the general (relatively healthy) older population whereas the sharp rise in 
the ageing population implies a corresponding rise in age-related diseases. 
Extrapolation of data from the given (healthy) general older population to the diseased 
older adults may be inadequate as fall risk profiles may be quite different or contain 
factors that are not as prominent in the average older person. A lot of fall risk factors 
are also chronic complications of T2DM, which raises the hypothesis that older adults 
suffering this age-related disease might be at increased risk for falling. However, 
there is currently too little evidence to confirm this hypothesis. Therefore, the primary 
aim of this doctoral thesis was to administer fall incidence and investigate fall risk 
factors among a mixed cohort of older adults with and without T2DM (Chapter 2).
Part Two: Additional screening as part of fall prevention strategies
Currently, a lot of conflicting results exist concerning the impact of peripheral 
neuropathy on gait, balance and falls. A correct diagnosis of (a type of) peripheral 
neuropathy requires extensive and invasive investigations using nerve conduction 
studies or electromyography. These methods are, however, very expensive and 
unfeasible for everyday clinical practice.  We therefore aimed to assess vibration 
sense, recorded by an inexpensive, portable and easy to use tool, in relation to 
postural control and falls in older people with and without T2DM (Chapter 3). 
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Cognition has unanimously been proven to play a crucial role in gait performance 
and fall risk. Nevertheless, cognitive assessments are still not implemented in routine 
fall risk screenings. Furthermore, cognitive impairment is suggested to be another 
chronic complication of T2DM. So far, however, studies that investigate the potential 
interference of cognitive decrements on physical parameters in this specific older 
subpopulation (T2DM) are lacking. The impact of decrements in the peripheral 
(peripheral neuropathy) and central (cognition) nervous system on gait in older adults 
with T2DM was therefore investigated (Chapter 4).
As explained previously in the general introduction, fall risk might also be enhanced 
or even induced by extrinsic factors like environmental characteristics at home or an 
ever present issue such as the footwear a person is wearing. With respect to this 
latter issue a quite interesting ascertainment was made rendering immediate food for 
thought. During our measurements we established that a lot of participants expressed 
their own ideas and preferences concerning footwear with respect to their gait 
performance in the test and in daily life. We therefore hypothesized that different 
types of footwear could indeed result in different functional outcome measures in gait 
analyses. Although in clinical measurements the influence would probably be 
relatively low, it might be more relevant when technical support is used due to finer 
analysis potential. Since a lot of decisions and predictions are made based on 
marginal differences on cut-off scores of these finer analyzed parameters, footwear 
used during testing could become of greater importance. Cut-off values for gait 
velocity have been determined in relation to falls [76,245], physical performance 
[245-247], sarcopenia [248], frailty [249], risk for hospitalization [250] and even life 
expectancy [251]. Small differences in gait velocity due to inappropriate or 
‘confounding’ footwear might thus imply misinterpretations of one’s walking abilities 
with eventual crucial misclassifications. Still, descriptions of types of footwear often 
seem to be lacking in mobility-related research among older adults. Our last aim was 
therefore to investigate the potential effects of different types of footwear on gait in 
healthy older women and provide recommendations concerning footwear to the 
older individual and researchers (Chapter 5).
The experiments discussed in Chapter 2, 3 and 4 are performed among a mixed 
cohort of older adults with and without T2DM whereas the study of Chapter 5 
considered a different sample, i.e. healthy older women. 
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CHAPTER 2
Abstract
Background Older adults with type 2 Diabetes Mellitus are at increased risk of falling. 
The current study aims to identify risk factors that mediate the relationship between 
diabetes and falls.
Methods 199 older adults (104 with diabetes and 95 healthy controls) underwent a 
medical screening. Gait (GAITRite®), balance (AccuGait® force plate), grip strength 
(Jamar®), and cognitive status (Mini-Mental State Examination and Clock Drawing 
Test) were assessed. Falls were prospectively recorded during a 12-month follow-up 
period using monthly calendars.
Results Compared to controls, diabetes participants scored worse on all physical 
and cognitive measures. Sixty-four participants (42 diabetes vs. 22 controls) reported 
at least one injurious fall or two non-injurious falls (“fallers”). Univariate logistic 
regression identified diabetes as a risk factor for future falls (Odds Ratio 2.25, 95%CI 
1.21-4.15, p=0.010). Stepwise multiple regressions defined diabetes and poor 
balance as independent risk factors for falling. Taking more medications, slower 
walking speed, shorter stride length and poor cognitive performance were mediators 
that reduced the Odds Ratio of the relationship between diabetes and faller status 
relationship the most followed by reduced grip strength and increased stride length 
variability. 
Conclusions  Diabetes is a major risk factor for falling, even after controlling for poor 
balance. Taking more medications, poorer walking performance and reduced 
cognitive functioning were mediators of the relationship between diabetes and falls. 
Tailored preventive programs including systematic medication reviews, specific 
balance exercises and cognitive training might be beneficial in reducing fall risk in 
older adults suffering from diabetes.
Key words Geriatrics; Falls; Type II Diabetes Mellitus
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Introduction
Diabetes Mellitus and falls are common in the older population and can therefore be 
considered ‘geriatric giants’. They both pose major threats to an older person’s 
quality of life. According to the World Health Organization, diabetes globally affects 
approximately 347 million people and diabetes deaths will double between 2005 and 
2030 [1]. Each year, approximately one in three community-dwelling older adults 
aged 65 or over suffers one or more falls [2]. Older women with diabetes are 1.6 times 
more likely to have fallen in the previous year and twice as likely to have had injurious 
falls [3]. Diabetes Mellitus has been identified as a risk factor for falls [4,5] and 
fall-related injuries and fractures [6] in a number of prospective studies. 
Poor balance has been determined as a major risk factor for falls in older adults [7]. 
Many diabetes-related complications, such as peripheral neuropathies [8], cerebro-
vascular accidents [9], sarcopenia [10], poor low-contrast visual acuity and poor 
depth perception [11] have also been associated with reduced balance performance 
[7]. Other complications from diabetes, such as urinary incontinence [12], dementia 
[13], mild cognitive impairment [14] and depressive symptoms [15], have been 
identified as risk factors for falls in older adults without diabetes. However, due to a 
lack of comprehensive prospective studies focusing on fall risk detection in older 
adults with diabetes, it is unclear whether these factors mediate the relationship 
between falls and diabetes. The aims of this study are therefore (i) to establish 
distinguishing factors between older adults with and without diabetes on a range of 
established fall risk factors, (ii) to document fall rates and determine fall risk factors in 
a matched cohort of older adults with and without diabetes, and (iii) to identify 
mediating risk factors of falling that explain the relationship between diabetes and 
falls in older adults. This will assist in designing tailored fall prevention programs in 
this population.
Materials and Methods
Ethics Statement
The Ethical Committee of the Ghent University Hospital gave approval to this study 
and all participants signed an informed consent.
Participants
199 older adults were enrolled in this study. The general practitioner or medical 
specialist of each participant confirmed the presence or absence of type 2 Diabetes 
Mellitus. Inclusion criteria were: (i) aged 60 years and above, (ii) living in the community 
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or residential aged care setting, (iii) able to understand instructions, (iv) able to walk 
independently with or without walking aids, (v) absence of stroke, Parkinson’s disease 
or other major neurological conditions, and (vi) absence of musculoskeletal disorders 
impeding them to walk unaided for 10m (e.g. amputations, major rheumatic conditions 
in the lower extremity). Seventy-two (69.2%) older adults with diabetes and 43 (45.3%) 
healthy controls were recruited from residential aged care settings. Eleven (10.6%) 
community-dwelling older adults with diabetes and 52 (54.7%) community-dwelling 
healthy controls were recruited through online advertising, flyer distribution and by 
word of mouth. Another 21 (20.2%) older adults with diabetes were recruited from the 
Endocrinology Clinic at the Ghent University Hospital, Belgium. 
Personal and Medical History
Socio-demographic data and medical history were recorded by means of a self-report 
questionnaire. Participants were asked about previous falls, fear of falling (yes/no), 
number of medications and pathological conditions potentially interfering with fall risk 
such as depression or urinary incontinence. Peripheral nerve function was assessed 
by determination of the Vibration Perception Threshold, which has proven reliability 
and validity towards assessment of neural dysfunction in people with diabetes [16]. It 
was determined using a Bio-Thesiometer® (Bio Medical Instrument co, Ohio, USA) by 
three measurements on four distinct points (medial malleolus and big toe on both 
feet). For each location the mean of three values was calculated. 
Physical Measurements
Muscle Strength
Grip strength (kg) of the dominant hand was recorded using the Jamar® dynamometer 
(Sammons Preston Rolyan Inc., Bolingbrook, IL) while seated in an armless chair with 
shoulders adducted and neutrally rotated and elbow flexed at 90°, forearms in neutral 
position and wrist between 0 and 30° of dorsiflexion [17]. Participants were instructed 
to squeeze the handle as hard as possible [18]. The maximal grip score of three trials 
was retained.
Gait
Gait velocity (cm/s), stride length (cm) and stride length variability (%) were captured 
by the portable electronic GAITRite® walkway system (8.3m x 0.89m; CIR Systems 
Inc., Havertown, PA, USA) with proven validity [19]. Stride length variability was 
calculated as the ratio of the standard deviation to the mean. Participants were asked 
to walk at a self-selected normal walking speed wearing comfortable footwear with a 
low and wide heel and a thin, grooved and moderately hard sole. Thirty-four percent 
(n=68) used their usual walking aid such as crutches, walkers or canes. Participants 
were instructed to start walking two meters before the GAITRite® mat and keep 
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walking for two meters beyond the mat to minimize acceleration and deceleration 
effects.
Balance
Limits of stability (LOS) were determined by use of a force plate (AMTI® AccuGait, 
Advanced Mechanical Technology Inc., Watertown, MA, USA). Sampling rate was set 
at 50Hz and data were filtered with a cut-off frequency of 5Hz by a 4-th order low-pass 
Butterworth filter. Participants were instructed to position their feet shoulder-with 
apart and lean forward, backward, to the left and to the right as far as possible without 
moving their feet. LOS were expressed as maximal medio-lateral and antero-posteri-
or displacement (cm) of the Center of Pressure (COP) and sway area (cm²). The sway 
area is the surface of an ellipse wherein 95% of the COP samples are predicted to be 
enclosed (95% confidence ellipse).
Cognitive Measurements
The Mini-Mental State Examination (MMSE) was used as a general cognitive 
screening instrument [20]. The Clock Drawing Test (CDT) was done to estimate 
executive functioning. Four items as proposed by Thalmann et al. were selected: item 
2 (12 numbers are present), item 5 (number ‘12’ correctly placed), item 25 (hands 
have correct proportions) and item 34 (participant reads time correctly) [21]. A 
validated algorithm to combine results from the MMSE and the CDT was used to 
estimate executive functioning [21]. MMSE score of 27 or more was coded as 3, and 
MMSE score of 26 or less was coded zero. The four CDT items were coded as 0 or 1 
for items 2, 25 and 34; and as 0 or 3 for item 5. These recoded scores of the MMSE 
and the CDT were then combined to a single score (MMSE-CDT) with a maximum of 
9, representing a good cognitive function. A cut-off score of less than 7 on the 
MMSE-CDT was used to classify participants as having reduced cognitive functioning.
Falls Follow-Up
After baseline measurements falls were monitored during 12 months using monthly 
fall calendars. A fall was defined as “an unexpected event in which the person comes 
to rest on the ground, floor, or lower level” [22]. If a fall occurred, participants were 
telephoned and asked about the circumstances and fall injuries such as bruises, 
lacerations or fractures. Participants who reported multiple (>1) falls or at least one 
fall with injury were categorized as “fallers” whereas participants who experienced no 
fall or one non-injurious fall were considered “nonfallers” [23]. Two participants were 
lost to follow-up (1 control withdrew, 1 diabetes died) and were not included in 
statistical analyses.
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Statistical analyses
Univariate and multivariate logistic regression models were applied to investigate the 
association between diabetes and falls, and between covariates (demographic, 
medical, physical, cognitive) and falls. Covariates with a univariate statistical 
significance of p≤.1 were first entered in separate logistic regression models to 
determine how much they reduced the diabetes-falls Odds Ratio (OR). Covariates 
that mediated this relationship were then combined in a final logistic regression 
model. Marker variables such as “previous falls” were not selected as possible 
predictors in multivariate models as such marker variables often cancel out the 
impact of other risk factors and are therefore not helpful in assisting our understanding 
of why falls occur [24]. Independent Samples t tests (continuous variables) and Chi 
Square tests (categorical variables) were performed to compare healthy controls and 
older adults with diabetes. Data were analyzed using SPSS.20 for Windows (SPSS, 
Inc., Chicago, IL). For reasons of voluntary withdrawal, illness and absence at the 
time of the test procedure eight participants (2 controls and 6 with diabetes) did not 
complete gait analysis, fifteen (2 controls and 13 with diabetes) had no LOS data and 
four (4 with diabetes) performed no grip strength measurement.
Results
Mean age of the 199 participants was 76.9 ± 9.4 (range 60-94) and 126 (63.3%) were 
female. Participants with diabetes (n=104) were older than controls (n=95), with a 
mean age of 78.4 (SD 8.7) and 75.1 (SD 9.9) respectively (Table 2.1). They took 2.1 
(SD 0.7) anti-diabetic agents on average and 44.1% were insulin-dependent. Fifty-six 
(28.4%) participants reported multiple falls during the 12 months follow up, eight 
(4.1%) reported one injurious fall, thirty-two (16.2%) reported 1 non-injurious fall and 
101 (51.3%) reported no falls. Forty-two (40.8%) older adults with diabetes reported 
one single injurious fall or multiple falls compared to 22 (23.4%) healthy controls. 
Univariate analyses showed that those who suffered multiple non-injurious falls or at 
least one injurious fall were more likely to have diabetes mellitus, have urinary 
incontinence, walk with mobility aids, report falls in the previous year and report fear 
of falling compared to nonfallers. Fallers were also older, took significantly more 
medications, performed worse on hand grip strength, walked slower with smaller 
strides and greater variability, had smaller medio-lateral limits of stability and 
performed worse on the MMSE. Participants with Diabetes Mellitus performed 
significantly worse on all physical and cognitive measures when compared to healthy 
controls (Table 2.1).
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Explanatory covariates (p<.1) were separately entered with diabetes into stepwise 
multivariate logistic regression models. The association between diabetes and falls 
remained significant, even after adjusting for CDT (OR=2.13, 95%CI 1.13-4.00), age 
(OR=2.08, 95%CI 1.11-3.90), MMSE (OR=2.08, 95%CI 1.09-3.95), Vibration 
Perception Threshold (OR=2.04, 95%CI 1.04-3.97), medio-lateral LOS (OR=2.03, 
95%CI 1.06-3.88) and MMSE-CDT (OR=2.02, 95%CI 1.06-3.85). The percentage 
reduction of the diabetes/falls odds ratio from the logistic regression analyses was 
less than 10% when controlling for these covariates. Parameters that caused a 
substantial reduction of the diabetes/falls relationship and therefore could be 
considered mediators, were number of medications (20.7%, OR=1.79, 95%CI 
0.82-3.90), stride length (14.9%, OR=1.92, 95%CI 0.99-3.72), gait velocity (14.7%, 
OR=1.92, 95%CI 0.99-3.72), MMSE-CDT categorization (13.8%, OR=1.94, 95%CI 
1.00-3.78), grip strength (11.0%, OR=2.01, 95%CI 1.06-3.79) and stride length 
variability (10.8%, OR=2.01, 95%CI 1.05-3.85).
In a final stepwise logistic regression analysis all explanatory covariates (p≤.1) were 
entered together. The multivariate model identified diabetes (OR=2.03, 95%CI 
1.06-3.88) and medio-lateral LOS displacement (OR=0.70, 95%CI 0.49-0.99) as the 
best predictors of future falls. Therefore, the presence of diabetes and smaller limits 
of stability in the medio-lateral plane are independent predictors of falls in our sample. 
Discussion
This study confirmed that diabetes mellitus is a strong predictor of falls in a mixed 
cohort of older adults with and without diabetes. About 41% (n=42) of the participants 
with diabetes were classified as fallers (35.9% experienced multiple falls and 4.9% 
experienced a single injurious fall). Compared to healthy controls, older adults with 
diabetes perform worse on physical and cognitive tests. Diabetes remained an 
independent risk factor of future falls, even after controlling for poor balance.
Older adults with diabetes often develop a range of long-term complications, which 
can explain why diabetes participants in our sample performed worse on all physical 
and cognitive measures. Our results confirm previous findings which commonly 
report more medication use, reduced peripheral nerve function, and poorer grip 
strength [25], gait performance [26] and balance [27] in older adults with diabetes. 
Similarly, the worse performance on cognitive screening measures in diabetes 
participants is in accordance with previous studies [28]. Older adults with diabetes 
also suffered more falls in the previous year and reported higher levels of fear of 
falling than healthy controls. We further demonstrated that older adults with diabetes 
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were at increased risk of suffering injurious or multiple falls, even after adjusting for 
medical, physical and cognitive covariates.
Poor balance has previously been identified as a major risk factor for falling in older 
adults [7]. Accurate balance performance relies on visual, vestibular and somato- 
sensory systems [7]. Deficiencies in these systems have proven to occur with ageing 
[29] and might thus lead to a loss of balance, possibly resulting in a fall. Older adults 
with diabetes show greater postural sways but there are many conflicting findings 
concerning the underlying mechanisms [30]. Our final regression model suggested 
that diabetes and poor balance were independently associated with falls. 
In this experiment, a substantial proportion of the relationship between diabetes and 
future falls could be explained by more medication use, slowed walking speed and 
reduced cognitive performance, each of which are established risk factors for falls in 
older adults. First, number of medications was the strongest mediator in the diabetes/
falls relationship (20.7% reduction). Previous research has consistently associated 
number of medications with an increased fall risk in older adults [31]. Given the 
multiple complications of the disease, older adults with diabetes often take a high 
number of medications. This was confirmed by our results; older adults with diabetes 
took about nine medications on average compared to four medications in older 
adults without diabetes. Even without medications for diabetes treatment (data not 
shown), the number of medications was still significantly higher for older adults with 
diabetes with an average of about seven medications. Second, walking performance 
mediated the diabetes/falls relationship in this trial and reduced the odds ratio by 
nearly 15 percent. Older adults with diabetes walked slower, took shorter strides and 
had greater stride length variability compared to controls, which confirms previous 
research [26]. Slowed gait can predict falls in healthy older adults [32]. Walking 
velocity reflects overall health and functional status and has been recommended as 
a potentially useful clinical indicator of well-being among older adults. The final 
mediator of the diabetes/falls relationship was poor cognitive performance reducing 
the odds ratio by 14 percent. During the past decade, researchers have provided a 
large body of evidence suggesting that walking performance relies on cognitive 
processing, executive functions and attention [33], thereby countering the former 
assumption of an automated human gait. Older adults with mild cognitive impairment 
or low cognitive reserves indeed show gait abnormalities [34,35] and also an 
increased fall risk [14]. The suggested cognitive decline in patients with diabetes [36] 
might therefore explain why the diabetes/falls relationship is partly mediated by 
reduced cognitive performance. Clinicians should be aware that these factors might 
predispose older patients with diabetes to falling. Future research in larger samples 
should establish whether diabetes patients who use more medications, walk slower 
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and show reduced cognitive performance are more prone to falling compared to 
diabetes patients who do not suffer from these conditions. 
Current guidelines and recommendations on the management of type 2 diabetes in 
the general practice setting include nutrition management and increasing physical 
activity levels, with primary goals of controlling weight and improving metabolic 
control. Additionally, insulin and/or oral anti-diabetic agents are prescribed for 
optimizing glycemic control. Considering our finding that older adults with diabetes 
perform worse on physical and cognitive tests when compared to healthy controls, a 
comprehensive fall risk assessment, involving tests of balance, gait and cognitive 
functioning, should be incorporated into the clinical management of diabetes 
patients. Second, older adults with type 2 diabetes should be encouraged to take 
part in exercise programs that focus on improving balance and gait, in addition to the 
recommended cardiovascular fitness and resistance training. It has been shown that 
a challenging balance training program of adequate intensity and duration can 
successfully reduce fall rates in older adults [37]. Low level aerobic exercise (e.g. 
brisk walking for half an hour per day) is often recommended. Targeted training 
including gait, balance and functional strength exercises has been shown to improve 
gait speed, balance, muscle strength and joint mobility in patients with diabetes [38]. 
Limitations
The main limitation of this study relates to a possible selection bias of the study 
population. Participants were recruited through advertisements or by access to 
patient files at the Endocrinology Clinic. Also, we acknowledge that we excluded 
people with severe diabetic complications that would make them unable to complete 
the assessments. Nevertheless, we feel that our sample does reflect the 
heterogeneous nature of the older adults with diabetes seen in routine practice. Also, 
certain potential mediators were not assessed as part of this trial. For example, poor 
vision has clearly been proven to adversely affect gait [39] and postural control, 
consequently increasing fall risk [11]. Decreased foot strength and foot pain have 
also independently been associated with falls [40]. Future multifactorial prospective 
studies should therefore include more comprehensive assessments to further 
enhance our understanding of the relationship between diabetes and falls.
Conclusions
This study demonstrated that diabetes is an independent risk factor for falling, even 
after controlling for poor balance. Taking higher numbers of medications, poor 
walking performance and reduced cognitive functioning were mediators of the 
64
CHAPTER 2
relationship between diabetes and faller status. These physical and cognitive 
measures were significantly worse in older adults with diabetes compared to older 
adults without diabetes. Preventive programs including systematic medication 
reviews, specific balance exercises and cognitive training might be beneficial in 
reducing fall risk in older adults suffering from diabetes.
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Abstract
Purpose The present study investigates (i) the potential discriminative role of a 
clinical measure of PN in assessing postural performance and fall risk and (ii) whether 
the integration of a simple screening (VPT) for PN in any physical (fall risk) assessment 
among elderly should be recommended, even if they do not suffer from DM.
Methods 195 elderly were entered in a 4-group-model: DM with PN (D+; n=75), DM 
without PN (D-; n=28), non-diabetic elderly with idiopathic PN (C+; n=31) and 
non-diabetic elderly without PN (C-; n=61). Posturographic sway parameters were 
captured during different static balance conditions (AMTI® AccuGait). Vibration 
Perception Threshold, fall data, Mini-Mental State Examination and Clock Drawing 
Test were registered. Multivariate repeated-measures ANOVA was used to compare 
between groups and across balance conditions.
Results The groups with PN demonstrated a strikingly comparable though bigger 
sway and a higher prospective fall incidence than their peers without PN. 
Conclusions The indication of PN, irrespective of its cause, interferes with postural 
control and fall incidence. The integration of a simple screening for PN (like Bio-The-
siometry) in any fall risk assessment among elderly is highly recommended.
Key words Vibration Perception Threshold; Falls; Postural Control; Peripheral Neuro - 
pathy; Diabetes Mellitus; Elderly
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Introduction
Impaired postural control is perhaps the most hazardous common denominator for 
falls in elderly people. It therefore draws with every right and reason explicit attention 
of  rehabilitative researchers and clinicians for fall risk assessment and prevention 
purposes. Postural control is an overall generic construct seen as an essential 
prerequisite for most daily life activities at any age. It maintains, achieves or restores 
a state of balance while a person is stationary, preparing to move, in motion or 
preparing to stop moving. Notwithstanding the given attention it remains one of the 
most complex human abilities to fully embrace its consequences in case of 
impairment. Afferent input from the visual, vestibular and proprioceptive systems has 
to be interpreted, integrated and analyzed by central cognitive processes in view of 
the mandatory appropriate motor responses. Due to this multifaceted nature postural 
control can be undermined at any respective level. Deterioration in vision, vestibular 
input, muscle strength, flexibility, cognitive abilities, … are potential threats for a good 
working balance system and embody fall inducing risks. 
These decrements may occur due to age- or disease-related changes of physical 
functions or inner body processes. As approximately 50% of all patients with diabetes 
suffer from peripheral neuropathy [1], the postural control of these patients might 
partially be hampered due to losses of somatosensory feedback and appropriate 
motor responses.  In older adults with DM the observed increased fall rate has indeed 
repeatedly been shown not to be based on DM as a whole per se but to the existence 
of PN [2-5]. PN describes damage to the peripheral nervous system that results in a 
wide array of afferent symptoms, varying from paresthesia, autonomic deficits, 
sensitivity to touch, burning pain (especially at night) or efferent characteristics like 
muscle weakness and paralysis. Interestingly, structural and functional changes in 
peripheral nerves seem to occur quite commonly in the oldest elderly as a 
phenomenon of aging without any causative mechanism (like in DM), known as 
‘idiopathic PN’ [6-9]. This ascertainment turns PN into a potential contributing factor 
to disturbed balance and falls in the elderly as such [10-13]. 
Assessing the presence of PN and, in a subsequent phase, the implementation of 
somatosensory stimulation in postural rehabilitation seems therefore justified. The 
efferent part may be assessed by motor performance tests or muscle testing, but 
results are often inconclusive due to the wide array of putative underlying mechanisms 
for bad performance for that matter. The afferent part should ideally be assessed by 
nerve conduction and tissue biopsies. However, as suggested by Garrow et al. [14], 
these methods are impractical for routine screening and should be substituted by 
useful clinical alternatives, such as vibration perception threshold (VPT) determination. 
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Although loss of vibratory sensation is commonly accepted as a major clinical 
somatosensory indicative expression of PN in DM, Lord et al. are to our knowledge 
one of the very few researchers proposing to implement peripheral sensation tests in 
fall risk assessment by a measure of joint position sense [15]. 
We hypothesize that detection of VPT, which has proven to be a useful [14] and 
reliable [16] clinical measure, can play an important role in assessing postural 
performance and fall risk detection. This study investigates (i) the potential 
discriminative role of a clinical measure of PN in assessing postural performance and 
fall risk and (ii) whether the integration of a simple screening (VPT) for PN in any 
physical (fall risk) assessment among elderly should be recommended, even if they 
do not suffer from DM.
Methods
Participants
195 elderly were included in this study and entered in a 4-group-model: type 2 DM 
with PN (D+; n=75), type 2 DM without PN (D-; n=28), non-DM elderly controls with 
(idiopathic) PN (C+, n=31) and non-DM elderly controls without PN (C-; n=61). 
Participants comprised both community-dwelling elderly and elderly living in a 
residential care setting and were recruited through online advertising, flyer distribution 
and by word of mouth. Subjects suffering from additional major (gait and cognitive) 
disabling illnesses (e.g. stroke, Parkinson’s disease, …) or musculoskeletal disorders 
that may affect their postural control in a more or less predictable way (foot ulcerations, 
amputations, major rheumatic conditions in the lower extremity, …), were excluded. 
Inclusion criteria were age ≥ 60 years, being able to understand instructions and 
stand independently. The Ethical Committee of the Ghent University Hospital gave 
approval to this study and all participants signed an informed consent.
Personal and medical history
Medical and fall history of the past year were registered. A fall was defined as “an 
event, which results in a person coming unintentionally to rest on the ground or other 
lower level, not as a result of a major intrinsic event or overwhelming hazard” [17]. In 
addition, a follow-up of 8-months for falling took place by collecting monthly fall 
calendars. The attending general practitioners or treating specialists were responsible 
for the medical diagnosis of the presence or absence of DM (fasting glucose levels) 
and in case of DM also for the presence of PN. PN should have been established by 
electromyography or any other kind of nerve conduction examination. 
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Physical measurements
Besides the general practitioners’ diagnosis, the presence of PN in DM was objectified 
by a vibration perception threshold (VPT) of ≥ 25 Volt [18] which is considered as a 
standard for clinical diagnostic indication of diabetic peripheral neuropathy [19]. This 
threshold was the recorded voltage the participant indicated when he or she first felt 
the vibration [20]. It was determined by three measurements on four distinctive points 
(medial malleolus and dorsal side of the big toe on both feet) using a Bio-Thesiome-
ter® (Bio Medical Instrument co, Ohio, USA). For each location the mean of the three 
values was calculated to one VPT. Based on its qualities in DM the VPT was also used 
to clinically indicate the presence of idiopathic PN in the non-diabetic elderly rendering 
the formation of a specific group (C+). With respect to postural control the Center of 
Pressure (COP) measurements during quiet standing were captured using an AMTI® 
AccuGait (Advanced Mechanical Technology Inc., Watertown, MA, USA) portable 
force platform. All data were collected using a sampling rate of 50Hz and exported to 
MATLAB (version 7.12) for calculation of the following parameters: medio-lateral (ML) 
sway, anterior-posterior (AP) sway, sway velocity and sway area. ML and AP sway 
represent the mean sway path length of the ML and AP movement of the COP, while 
sway velocity is the mean speed of the COP displacement. The sway area is the 
elliptic surface in which 95% of the COP samples are predicted to be enclosed (95% 
confidence ellipse). Data were filtered with a cut-off frequency of 5Hz by a 4-th order 
low-pass Butterworth filter. Subjects were instructed to stand quietly on the force 
plate looking straight ahead with the arms comfortably alongside the body. Subjects 
were asked to perform posturography wearing close fitted shoes without heels. The 
maintenance of the upright position was challenged by changing the base of support 
and/or visual feedback. Postural control was measured during following randomly ordered 
conditions: (1) feet at pelvis width (wide base), eyes open (EO), (2) feet at pelvis width 
(wide base), eyes closed (EC), (3) feet together (narrow base) EO, (4) feet together 
(narrow base) EC, (5) semi-tandem EO, (6) semi-tandem EC. Each trial took 25 s, with 
the initial 10 s and last 5 s removed to avoid initial transient and anticipatory effects.
Neuropsychological measurements
Given the fact that DM is a risk factor for cognitive decline [21] and derangement of 
peripheral nerves may coincide with deterioration in the central nervous system, as 
such rendering an additional hazard for disturbed postural control, measurement of 
cognitive state was entered in this assay to assess the eventual relationship in elderly 
without DM and with PN. The Mini-Mental State Examination (MMSE) was used as 
cognitive screening instrument [22,23] and to complementary highlight executive 
functioning [24], the Clock Drawing Test (CDT) was performed. The item score 
proposed by Thalmann et al. was selected to score the CDT (with a maximum of 7) 
as well as their combined ‘MMSE and CDT’-single score with a maximum of 9 [25].
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Statistical analyses
All data were analyzed using SPSS version 20 for Windows (Statistical Package for 
the Social Sciences Inc., Chicago, IL, USA) and statistical signifi cance was assumed 
at P < .05. Descriptive statistics were used to describe the general characteristics 
(Table 3.1). Multivariate repeated-measures ANOVA was used in order to compare 
each sway parameter between the groups and across the six experimental static 
balance conditions. The normality and sphericity assumptions were verifi ed. Pairwise 
comparisons with Bonferroni adjustment for multiple comparisons were performed 
between different experimental conditions. In the case of interaction effects between 
the experimental conditions and the groups, pairwise comparison of conditions was 
produced within each group. As mean age signifi cantly differed between some 
groups, age was introduced as a co-variable. 
Results
Demographic characteristics, fall data and neuropsychological performance of the 
subjects are presented in Table 3.1. The mean age of the elderly with PN (idiopathic 
Table 3.1   Characteristics of the Subjects
C-
(n=61)
C+
(n=31)
D-
(n=28)
D+
(n=75)
Age (yrs)
Male : Female (%)
BMI
Fall incidence (retrospective)
Fall incidence (prospective)
71.3 ± 8.9**
34.4 : 65.6
27.4 ± 4.3
0.35 ± 0.76**
0.37 ± 0.90**
82.5 ± 7.1††
35.5 : 64.5
27.7 ± 4.5
0.54 ± 0.84
1.07± 1.51†
74.3 ± 8.6§§
32.1 : 67.9
31.0 ± 6.7¶§
1.26 ± 2.26¶
1.33± 1.73¶¶
79.8 ± 8.3#
40.0 : 60.0
28.9 ± 5.2
1.33 ± 2.35
1.74± 2.61
MMSE
CDT
MMSE-CDT
27.0 ± 4.1**
5.5 ± 2.0**
7.6 ± 2.5**
26.1 ± 4.1‡
4.5 ± 1.9†
6.1 ± 2.7††
25.3 ± 4.3¶¶
5.2 ± 2.3§
6.6 ± 2.9
24.1 ± 4.2
4.3 ± 2.2#
5.1 ± 2.7#
C- = non-DM elderly controls without PN; C+ = non-DM elderly controls with PN; D- = DM elderly 
without PN; D+ = DM elderly with PN; BMI = Body Mass Index; MMSE = Mini-Mental State 
Examination; CDT = Clock Drawing Test; MMSE-CDT = combined MMSE and CDT single score
**p≤0,001 between C- and D+
†p<0,05 and ††p≤0,001 between C- and C+
‡p<0,05 between C+ and D+
§p<0,05 and §§p≤0,001 between C+ and D-
¶p<0,05 and ¶¶p≤0,001 between C- and D-
#p<0,05 between D- and D+
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and diabetic) was significantly higher than in elderly without PN. All groups were 
gender matched. Prospective fall incidence in C- was significantly lower in comparison 
with all three other groups. Concerning the cognitive state it could be ascertained 
that on average of all 4 groups D+ scored the lowest on every cognitive score. 
Subjects diagnosed with PN (C+ and D+) scored significantly lower on the CDT and 
the joined MMSE-CDT compared to the subjects without PN.
As this study was part of a greater fall risk assessment, not all participants completed 
the whole assessment battery. One C-, two D- and four D+ subjects did not complete 
sway analysis due to illness or absence at the time of sway assessment. Furthermore, 
some sway variables could not be calculated by the software system.
Table 3.2 contains the absolute sway values (mean ± SD) during each experimental 
quiet standing condition. As in depth analysis revealed an interaction effect between 
groups and different standing conditions, results are presented for the separate 
groups. In general, each quiet standing of the PN groups was characterized by larger 
ML and AP sways and higher sway velocities and areas. 
Comparison between the different quiet standing conditions revealed that provocation 
by decreasing the base of support and/or removing visual supervision or feedback, 
adversely influenced postural control. The most significant changes in sway parameters 
occurred when the most challenging condition (semi-tandem, EC) was compared to 
the least challenging condition (wide base, EO).
Comparisons between the four respective groups were made in Table 3.3. Between-
subjects interactions revealed that sway parameters between the groups without PN 
(C- vs. D-) were not significantly different as this was also the case in comparing the 
two groups with PN (C+ vs. D+) (Table 3.3, rectangles). Between C- and C+ AP 
sway, sway velocity and sway area were significantly different. For discrimination 
between the two DM groups ML sway, sway velocity and sway area yielded significant 
different scores. 
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Table 3.2   Balance Outcomes for C-, C+, D- and D+ during the Six Static 
Balance Conditions. Within-Task Comparisons for C-, C+, D- and D+
C- C+ D- D+
Wide base, EO (1)
ML sway (cm) 5.4 ± 2.9 8.3 ± 4.7 7.7 ± 5.2 9.7 ± 5.8 
AP sway (cm) 9.3 ± 4.0  15.7 ± 7.8  12.8 ± 7.3  17.2 ± 9.1  
Sway velocity (cm/s) 1.2 ± 0.5 1.9 ± 1.0 1.7 ± 0.9 2.2 ± 1.1 
Sway area (cm²) 1.5 ± 1.2 3.7 ± 3.1 3.2 ± 2.1 4.9 ± 3.9
Wide base, EC (2)
ML sway (cm) 6.8 ± 3.2* 12.5 ± 10.4 7.7 ± 3.9 14.4 ± 9.1**
AP sway (cm) 15.0 ± 8.2** 24.9 ± 14.3** 17.2 ± 9.2  26.7 ± 13.1**
Sway velocity (cm/s) 1.8 ± 0.9** 3.0 ± 1.8* 2.0 ± 1.0 3.3 ± 1.6**
Sway area (cm²) 2.8 ± 2.2* 8.9 ± 15.2 4.4 ± 4.2 9.8 ± 8.5*
Narrow base, EO (3)
ML sway (cm) 12.7 ± 5.2†† 17.9 ± 9.3†† 15.9 ± 6.6† 20.1 ± 9.4††
AP sway (cm) 12.0 ± 5.9† 19.7 ± 11.0  15.6 ± 6.3  20.9 ± 11.3†
Sway velocity (cm/s) 2.0 ± 0.8†† 3.0 ± 1.5†† 2.5 ± 1.0† 3.2 ± 1.5††
Sway area (cm²) 4.6 ± 3.2†† 10.7 ± 13.5 6.8 ± 5.3† 10.4 ± 12.1††
Narrow base, EC (4)
ML sway (cm) 22.1 ± 11.6**†† 30.4 ± 18.9**†† 23.3 ± 11.2†† 32.9 ± 13.4**††
AP sway (cm) 20.3 ± 10.5**†† 31.9 ± 19.7* 24.0 ± 12.1  33.3 ± 16.3**†
Sway velocity (cm/s) 3.4 ± 1.6**†† 4.9 ± 2.9*† 3.7 ± 1.7†† 5.2 ± 2.2**††
Sway area (cm²) 11.5 ± 10.4**†† 19.9 ± 14.9 15.5 ± 20.7*†† 22.6 ± 16.0**††
Semi-Tandem, EO (5)
ML sway (cm) 15.9 ± 7.9‡‡§ 19.6 ± 7.9‡‡ 17.5 ± 5.6‡‡ 23.1 ± 9.9‡‡
AP sway (cm) 14.4 ± 6.7‡‡§ 21.7 ± 13.3 16.8 ± 5.1  23.5 ± 10.4‡‡
Sway velocity (cm/s) 2.4 ± 1.1‡‡§ 3.2 ± 1.5‡‡ 2.7 ± 0.8‡‡ 3.7 ± 1.5‡‡
Sway area (cm²) 5.0 ± 4.0‡‡ 8.1 ± 6.0 6.0 ± 3.8 9.9 ± 6.9‡‡
Semi-Tandem, EC (6)
ML sway (cm) 27.8 ± 12.3**‡‡ 34.4 ± 14.3**‡‡ 32.2 ± 13.9**‡‡ 36.4 ± 15.8**‡‡
AP sway (cm) 25.3 ± 11.8**‡‡§ 34.0 ± 17.8**‡ 29.4 ± 13.0**‡ 39.2 ± 17.3**‡‡§
Sway velocity (cm/s) 4.1 ± 1.8**‡‡§ 5.3 ± 2.4**‡‡ 4.8 ± 2.0**‡‡ 6.0 ± 2.5**‡‡
Sway area (cm²) 14.6 ± 13.1**‡‡ 18.8 ± 13.3*‡ 17.5 ± 12.0*‡‡ 24.3 ± 14.7**‡‡
C- = non-DM elderly controls without PN; C+ = non-DM elderly controls with PN; D- = DM elderly 
without PN; D+ = DM elderly with PN; ML sway = medio-lateral sway; AP sway = anterior-posterior 
sway; EO = eyes open; EC = eyes closed
*p<0.05 and **p≤0.001 between EO and EC condition. same foot position (effect of visual feedback)
† p<0.05 and ††p≤0.001 between wide and narrow base. same visual feedback (effect of foot position)
‡p<0.05 and ‡‡p≤0.001 between wide base and semi-tandem. same visual feedback (effect of foot 
position)
§p<0.05 between narrow base and semi-tandem. same visual feedback (effect of foot position)
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Discussion
Unhampered input of all participating afferent systems for postural control is essential 
for sound static and dynamic postural and motor performance of human beings. Any 
impairment of any participating system can therefore be estimated as potentially 
interfering in the maintenance of the upright position and consequently the occurrence 
of falls. For the informative fl ow of somatosensation, derangement of peripheral 
nerves like in PN is detrimental. This is the case in DM. The presence of PN in this 
population is generally accepted to be a major complication and a potential 
aggravating risk for falls. In the absence of diabetes, PN is in general not considered 
as a routine entity in daily clinical practice in elderly. This is undoubtedly based on the 
fact that establishment of the presence of PN is labor intensive, highly specialized 
(nerve conduction analysis) and expensive. As the presence of PN might be 
debilitating and its idiopathic form is known to be a widely underestimated problem 
in older people, a quest for alternatives that may be less intensive, easy to use and 
inexpensive, but nevertheless encompass a valid indication of problems seems 
highly justifi ed.   
Therefore this study entered the VPT as an indicative measure of PN in diabetic and 
non-diabetic elderly and revealed that one third of the non-diabetic population could 
be indicated as (potentially) confronted with idiopathic PN. The study enrolled four 
groups of elderly (C-, C+, D- and D+) in an assessment of postural control during 
different quiet standing conditions in conjunction with an 8-month follow-up of fall 
incidents. The overall fi nding is that the postural control of the groups without PN (C- 
and D-) is similar during all conditions. The same is true for the groups with PN, albeit 
that these both groups (C+ and D+) have a less stable postural control than the two 
Table 3.3   Signifi cance of the Between-Subjects Interactions, Corrected for Age 
(P-values)
C- vs. C+ C- vs. D- C- vs. D+ C+ vs. D- C+ vs. D+ D- vs. D+
ML sway (cm)
AP sway (cm)
Sway velocity (cm/s)
Sway area (cm²)
0.056
0.031
0.026
0.011
1.000
1.000
1.000
1.000
< 0.001
< 0.001
< 0.001
< 0.001
0.749
0.858
0.799
0.101
1.000
1.000
1.000
1.000
0.023
0.067
0.026
0.003
C- = non-DM elderly controls without PN; C+ = non-DM elderly controls with PN; D- = DM elderly without 
PN; D+ = DM elderly with PN; ML sway = medio-lateral sway; AP sway = anterior-posterior sway
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groups without PN (C- and D-). Therefore, this study demonstrates that debilitated 
postural control ability in elderly might partially but nevertheless substantially be 
attributed to the existence of PN. The indication of existence of PN seems to go hand 
in hand with increasing age. As sensory functions, such as vibration threshold, 
decline with age [26-28], it is not surprising that the groups with a high VPT are older 
than the groups with a low VPT. 
Static postural control seems to be provoked most in the semi-tandem stance 
position with the eyes closed (condition 6). The removal of vision seems to hamper 
postural control in all groups during all conditions. This is in line with previous results 
[2,4,29-31]. 
It was striking to note that the less postural performing PN groups also have 
significantly worse MMSE-CDT scores than the groups without PN. This ascertainment 
renders an additional interesting discussion concerning the issue that elderly with 
peripheral nerve damage also may struggle with problems in the central nervous 
system. Attention for assessment of these abilities seems therefore also appropriate.
According to previous research, the ML sway should be able to provide valuable 
information in predicting future falls [32,33] and recurrent fallers [33]. In this study, a 
significant correlation between the ML sway (condition 1) and the retrospective and 
prospective fall incidences could be observed (retrospective: Rs²=25,8 and p=0,001; 
prospective: Rs²=29,4 and p<0,001). A dominant shift of COP in the sagittal plane 
(AP) represents use of ankle strategy whereas a dominating shift in the frontal plane 
(ML) implies use of hip strategy [34]. Simmons et al. found that in the most challenging 
conditions DM used hip strategy significantly more than healthy controls [35]. They 
suggested a diminished sensation at the feet as a putative reason [35]. In this study, 
where participants were also matched for PN, this ML shift could be noticed when 
comparing the wide base EO (condition 1) with the semi-tandem EO (condition 5) 
(Table 3.2). Remarkably, the changes are manifest greater in the PN groups (C+ and 
D+). A diminished sensation at the feet might in fact be responsible for the use of a 
different postural control system (hip strategy). Inversely, enhancing somatosensory 
input by (soft) textured insole surface has recently been proven to significantly reduce 
AP and ML sway and effectively may ameliorate age-related deficits in somatosensory 
function [36]. After identification of somatosensory disturbances in fall risk 
assessment, it might therefore be useful to integrate somatosensory stimulation in 
rehabilitation programs designed for fall prevention. The promising results of Qiu et 
al. [36] should however be confirmed by prospective designs implementing this 
somatosensory stimulation in fall prevention rehabilitation programs in high risk 
populations like DM with PN.
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It is surprising that in former research in DM in relation to PN most designs comprised 
only two or three groups lacking a control group with an estimated PN. This may 
imply that the used control groups are probably a mixture of elderly with and without 
(idiopathic) PN entering a bias in discussing comparative sway parameters. 
The fact that the peripheral nerves were only tested on mere one characteristic, 
vibratory sensation, can be assessed as methodological limitation. The assessment 
of other sensory modalities seems appropriate to use the overall-encompassing term 
of “peripheral neuropathy”. Also the lack of formal nerve conductive diagnostics in 
controls can be seen as a flaw. Although based on relationship between diagnosis in 
DM and the VPT and the aim to search for potential routine alternatives for mere 
indicating the presence of eventual problems, this lack can be put in perspective. 
Nevertheless, from these results it can be concluded that the indication of PN based 
on VPT, irrespective of its cause, interferes with postural control. As impaired postural 
control mechanisms are known to generally result in an increased fall risk, which was 
confirmed by fall incidence data in this study, one should aim to assess all potentially 
interfering factors. We therefore agree not only with the importance of early 
determination of abnormal VPT’s in DM patients for its inherent clinical risks [14,37], 
but also like to extend this practice for screening in non-diabetic elderly. The 
significantly higher prospective fall incidence in elderly with indicated PN underpins 
this advice. We suggest that the indication of sensory disturbances based on 
peripheral neuropathies should be assessed in fall risk assessments like Lord et al. 
proposed in their Physiological Profile Assessment [15]. This aim could be established 
with a simple device as a Bio-Thesiometer® as demonstrated in this trial. This portable 
valuable [14] and reliable [16] quantitative measurement is not time-consuming, 
inexpensive and requires minimal training of the assessor. The implementation of a 
simple screening for indication of PN (like Bio-Thesiometry) in fall risk assessments 
among elderly is therefore recommended. 
Implications for Rehabilitation
•		The	indication	of	Peripheral	Neuropathy,	irrespective of its cause, interferes 
with   postural control and fall incidence.
•		Therefore,	 the	 integration	of	a	simple	screening	for	Peripheral	Neuropathy	
(like Bio-Thesiometry) in any fall risk assessment among elderly is highly 
recommended.
•		It	might	 be	 useful	 to	 integrate	 somatosensory	 stimulation	 in	 rehabilitation	
programs designed for fall prevention.
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CHAPTER 4
Abstract
Objective Peripheral neuropathy is a common complication of diabetes mellitus. In 
addition, diabetes has been linked to an increased risk of cognitive impairment in 
older adults. Changes in peripheral neuromuscular transmission and cognitive 
abilities have been associated with impaired motor performance. This study 
investigated the relationship between neuropathy and cognition on gait performance 
in older adults with diabetes.
Design Cross-sectional study.
Setting Community and residential aged care.
Participants 101 older adults (56 diabetics, 28 with peripheral neuropathy and 28 
without peripheral neuropathy; 45 matched controls). 
Interventions Not applicable.
Main Outcome Measures Spatiotemporal gait parameters were recorded under 
three conditions: simple, counting backwards by 3 from 40, and reciting animal 
names. Mini-Mental State Examination and Clock Drawing Test were used to estimate 
cognitive impairment levels. 
Results Compared to controls, older adults with diabetes walked slower, took shorter 
strides during all walking conditions, and showed more gait variability especially 
during dual task conditions. Gait patterns did not differ between diabetic participants 
with and without neuropathy. Compared to normal walking, dual task conditions 
affected all gait parameters similarly in all groups. Backward counting affected gait 
more than animal naming in participants with diabetes but not in healthy controls. 
Additional analyses in older adults with diabetes showed that participants with 
impaired cognitive function walked slower, took shorter strides, had shorter double 
support time and increased gait variability when compared to participants with intact 
cognitive function.  
Conclusions This study showed that gait parameters are affected in older adults 
suffering from type 2 Diabetes Mellitus. Gait was further affected by reduced cognitive 
function, irrespective of the presence of neuropathy.
Key Words   Cognition; Gait speed; Vibration Perception Threshold; Dual Tasking. 
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Introduction
Diabetes Mellitus is a common problem in older adults worldwide. According to the 
American Diabetes Association 26.9% of people aged 65 years or older are currently 
living with diabetes [1], with over 90% suffering from type 2 diabetes [2]. Increasing 
age is a major risk factor for the development of type 2 diabetes but also of more 
severe diabetes-related complications. Diabetes in old age has been associated with 
vision problems, depression, urinary incontinence, dehydration, cerebrovascular 
accidents and with an increased risk of falls. Recurrent episodes of severe 
hypoglycemia and/or chronic hyperglycemia have been associated with more severe 
and accelerated diabetic complications [3]. This might be due to poor disease 
management or delayed diagnosis of the disease. 
Painful peripheral neuropathy is a common and disabling complication, which affects 
approximately 50% of all patients with diabetes [4]. Initially, diabetic neuropathy 
presents with sensory disturbances, resulting in loss of tactile and proprioceptive 
function and slowed reaction times. This can cause inappropriate stepping responses 
following a balance perturbation [5]. At later stages, peripheral neuropathy has been 
associated with weakness of the muscles of the lower leg and foot, resulting in 
impaired motor and gait performance [6]. Diabetes has been associated with slowed 
gait speed, shorter steps, prolonged double support time, increased step width and 
gait variability [7].
In recent years, cognitive deficits have been identified in patients with diabetes 
[3,8-10], even at early stages of the disease [11]. The metabolic syndrome and 
cardiovascular burden caused by the disease have been associated with reduced 
cognitive function and structural brain abnormalities [12]. Affected cognitive domains 
are reduced psychomotor speed [9,13], and impaired memory, executive function 
[13-16] and attention [14,17]. Executive functioning has been associated with 
increased gait variability and postural instability while walking in healthy community-
living older people, especially under dual tasking conditions. The presence of 
cognitive deficits might therefore reduce availability of cognitive resources to 
compensate for diabetic gait disturbances by compromising motor planning in 
complex everyday environments.
The cognitive demand of gait control is commonly explored using a dual task 
paradigm. A number of studies have shown that the effects of a concurrent cognitive 
task on gait are much larger in patients with mild cognitive impairments and in frail 
older adults [18]. The purpose of this study was to explore the effect of peripheral 
neuropathy and reduced cognitive functioning on gait under simple and dual task 
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conditions in diabetic patients. We hypothesized that (i) the presence of diabetes 
affects gait under single task conditions in older adults, (ii) dual task conditions affect 
gait more in older adults with diabetes compared to older adults without diabetes, 
and (iii) reduced cognitive function affects gait in older adults with diabetes. 
Methods
Participants
101 older adults were enrolled in this study: 56 diabetes patients (28 with neuropathy, 
28 without neuropathy) and 45 age and gender matched controls. Diabetes patients 
were recruited through online advertising, flyer distribution, by word of mouth and 
from the Endocrinology Clinic at the Ghent University Hospital, Belgium. Inclusion 
criteria were: (i) aged 60 years and above, (ii) living in the community or residential 
aged care setting, (iii) able to understand instructions, (iv) able to walk independently 
with or without walking aids, (v) absence of stroke, Parkinson’s disease or other major 
neurological conditions, and (vi) absence of musculoskeletal disorders that may 
affect their gait in a predictable way (e.g. amputations, major rheumatic conditions in 
the lower extremity). The 45 age and gender matched control participants were 
recruited through online advertising, flyer distribution and by word of mouth. Inclusion 
criteria were: (i) aged 60 years and above, (ii) living in the community or residential 
aged care setting, (iii) Vibration Perception Threshold < 25V, and (iv) absence of 
diabetes and meeting the inclusion criteria required for the diabetes participants. The 
Ethical Committee of the Ghent University Hospital gave approval to this study and 
all participants signed an informed consent.
Personal and medical history
Socio-demographic data, medical history and falls in the past year were recorded by 
means of a questionnaire. The general practitioner or medical specialist of each 
participant confirmed the presence or absence of diabetes (fasting glucose and 
HbA1c levels) and peripheral neuropathy (based on electromyography, nerve 
conduction studies and/or clinical assessments). 
Physical measurements
Peripheral nerve function was assessed by determination of the Vibration Perception 
Threshold, which has proven reliability and validity towards assessment of neural 
dysfunction in people with diabetes [19,20]. It was determined using a Bio-Thesiom-
eter® (Bio Medical Instrument co, Ohio, USA) by three measurements on four distinct 
points (medial malleolus and big toe on both feet). For each location the mean of 
three values was calculated. Peripheral neuropathy was defined as calculated 
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thresholds of ≥ 25V in one or more locations [21,22]. The Diabetic Neuropathy 
Symptom Score includes four yes/no questions on (1) unsteadiness in walking, (2) 
pain, burning or aching in legs or feet, (3) prickling sensations in legs or feet, (4) 
numbness in legs or feet [23]. Meijer et al. have validated the Diabetic Neuropathy 
Symptom Score and have proven that a total score of 1-4 has high predictive value in 
screening for diabetic polyneuropathy [23]. Diabetes participants were classified as 
having peripheral neuropathy based on two positive criteria: diagnosis by general 
practitioner, a Vibration Perception Threshold score of ≥ 25V, and/or a Diabetic 
Neuropathy Symptom Score of 1-4. In cases where Diabetic Neuropathy Symptom 
Score was missing or general practitioners could not be reached or give a decisive 
answer concerning the existence of peripheral neuropathy, categorization was based 
on Vibration Perception Threshold measurement. This was the case for 11 participants.
Spatiotemporal gait analysis was performed using the portable electronic GAITRite® 
walkway system (8.3m x 0.89m; CIR Systems Inc., Havertown, PA, USA) with proven 
validity [24]. The GAITRite® System calculates a number of spatiotemporal gait 
parameters based on footfall data. The following spatiotemporal gait parameters 
were selected for this study: stride velocity (cm/s), stride length (cm), double support 
time (s) and coefficient of variation (CoV) of stride length (%). The CoV is a measure 
of variability and is expressed as the percentage of the ratio of the standard deviation 
to the mean. Participants were asked to walk at a self-selected normal walking speed 
wearing comfortable footwear with a low and wide heel and a thin, grooved and 
moderately hard sole. They were allowed to use their usual walking aid such as 
crutches, walkers or canes. Three gait conditions were assessed: (i) single task 
walking, (ii) walking while counting backwards by 3 from 40 (arithmetic dual task), 
and (iii) walking while reciting animal names (verbal fluency dual task). Before the 
participant started walking, they were instructed to concentrate equally on walking 
and the cognitive task. The three different walking conditions were offered in a 
randomized order and a two minute rest period was provided between each walk. 
Participants were instructed to start walking two meters before the GAITRite® mat and 
keep walking for two meters beyond the mat to minimize acceleration and deceleration 
effects.
Cognitive measurements
The Mini-Mental State Examination (MMSE) was used as a general cognitive 
screening instrument [25]. The Clock Drawing Test (CDT) was done to estimate 
executive functioning. Four items as proposed by Thalmann et al. were selected: item 
2 (12 numbers are present), item 5 (number ‘12’ correctly placed), item 25 (hands 
have correct proportions) and item 34 (subject reads time correctly) [26]. The scores 
of the MMSE and the CDT (maximum scores of 30 and 7 respectively) were then 
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combined into a single score (MMSE-CDT) with a maximum of 9 [26]. A cut-off score 
of <7 was used to classify people as having reduced cognitive functioning [26].
Statistical analyses
First, a Group(DM) (3) × Condition (3) linear mixed model analysis with random 
intercept was conducted to compare each spatiotemporal gait parameter between 
the three groups (diabetes with neuropathy (n=28), diabetes without neuropathy 
(n=28), matched controls (n=45)) and within the three experimental walking 
conditions. Normality and linearity assumptions were verified and Bonferroni 
adjustment for pairwise comparisons was performed. Second, an additional 
Group(VPT) (2) × Group(MMSE-CDT) (2) × Condition (3) linear mixed model analysis with 
random intercept was conducted in the diabetes group only to investigate the impact 
of reduced cognitive function on gait performance. Spatiotemporal gait parameters 
were compared between participants with MMSE-CDT score <7 (n=28) and 
participants with MMSE-CDT score ≥ 7 (n=26) and within the three experimental 
walking conditions. This analysis was not performed in the control group as 
subdivision resulted in an unequal distribution among groups (only a few participants 
scored below the cut-off).
 Five participants (3 healthy controls and 2 diabetics) had incomplete gait data, 
of which two did not complete any gait condition and three participants completed 
only one or two gait conditions. In the verbal fluency dual task condition, a score of 
three standard deviations above the mean was given for one outlier in stride length 
variability. 
Results
The demographic and medical characteristics of all participants are shown in Table 
4.1. Participants with diabetes had a higher BMI, reported more previous falls, used 
more walking aids and were more likely to live in residential aged care compared to 
the matched healthy controls. There was no significant difference between the 
groups for age or gender. Within the diabetes groups, participants with neuropathy 
complications showed worse cognitive functioning compared to participants without 
neuropathy.
Table 4.2 reports on the spatiotemporal gait parameters under the three conditions 
between diabetes participants with neuropathy, diabetes participants without 
neuropathy and matched controls. There was a significant main effect of Group(DM) for 
all gait parameters (Table 4.3). Participants with diabetes walked slower, took shorter 
strides, had a longer double support phase and walked with increased stride length 
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variability compared to controls. There were no signifi cant differences in gait 
parameters between diabetes participants with neuropathy and diabetes participants 
without neuropathy. Participants with neuropathy walked slower than diabetes 
participants without neuropathy, however this was not statistically signifi cant 
(p=0.057). There was a signifi cant main effect of Condition for all gait parameters 
(Table 4.2 and 4.3). All participants walked slower, took shorter strides, and had 
increased stride length variability while counting backwards and while reciting animal 
names compared to the simple gait condition (Table 4.2). There was a signifi cant 
Group(DM) × Condition interaction effect for stride velocity and borderline signifi cant 
interaction effects for the other mean spatiotemporal gait parameters. When 
comparing the arithmetic task to the verbal fl uency task, stride velocity was affected 
Table 4.1   Clinical characteristics of the subjects
diabetes
with neuropathy 
(n=28)
diabetes
without neuropathy 
(n=28) 
healthy 
controls 
(n=45)
Age (yrs) 74.8 ± 7.5 74.1 ± 8.2 71.3 ± 8.1
Male : Female (n, (%)) 15:13 (53.6:46.4) 10:18 (35.7:64.3) 20:25 (44.4:55.6)
BMI (kg/m²) 31.3 ± 6.3* 30.6 ± 6.9 27.6 ± 4.3
HbA1c (%) 7.7 ± 2.0 7.0 ± 1.0 -
HbA1c (mmol/mol) 60.4 ± 22.3 53.2 ± 10.8 -
Insulin use (n (%)) 14 (50.0) 13 (46.4) -
Walking aids (%)
Community-dwelling (%)
51.9*
28.6*
35.7†
50.0
9.1
64.4
Fall history
Number of falls 1.81 ± 3.09** 1.25 ± 2.22† 0.30 ± 0.77
Faller : Non-faller (%) 63.0 : 37.0** 50.0 : 50.0† 15.9 : 84.1
MMSE 25.5 ± 3.2* 25.1 ± 4.2†† 27.0 ± 3.8
CDT 4.2 ± 1.9**‡ 5.2 ± 2.4 5.6 ± 2.0
MMSE-CDT 5.5 ± 2.7** 6.3 ± 3.1† 7.6 ± 2.5
BMI, Body Mass Index; HbA1C, glycated haemoglobin; 
*p<0,05 and**p≤0,001 between DM with PN and healthy controls
†p<0,05 and ††p≤0,001 between DM without PN and healthy controls
‡p<0,05 between DM with PN and DM without PN
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more while counting backwards in participants with diabetes (DM-PN: p=0.016 and 
DM+PN: p=0.022) but not in controls (p=0.343). 
Table 4.3 reports on the spatiotemporal gait parameters under the three conditions in 
the subsample of older adults with diabetes between participants with neuropathy 
and without neuropathy (Group(VPT)) and between participants with a MMSE-CDT 
score of 7 or above and below 7 (Group(MMSE-CDT)). Pairwise comparisons of this linear 
mixed model are presented in Table 4.4. Participants with impaired cognitive function 
walked slower, took shorter strides, had a shorter double support time and an 
increased gait variability compared to participants with intact cognitive function 
during all walking conditions (Table 4.4). There was no signifi cant Group(MMSE-CDT) × 
Group(VPT) interaction effect for any of the gait parameters (Table 4.3), suggesting that 
reduced cognitive function affects gait in older adults with diabetes, irrespective of 
the presence of neuropathy. There was no signifi cant 2-way or 3-way interaction 
effect between conditions × groups for any of the gait variables, suggesting that gait 
was not affected more in the dual task conditions compared to the simple gait 
condition.
Figure 4.1 illustrates the effect of diabetes mellitus and impaired cognitive function on 
stride length during walking while backward counting. This trend is similar for the 
other gait parameters and conditions.  
Figure 4.1   The effect of diabetes mellitus and impaired cognitive function on stride 
length during walking while backward counting
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Discussion
his study showed that the presence of diabetes affected gait in older adults and that 
dual task conditions relying on attentional resources affected gait more in older 
adults with diabetes compared to older adults without diabetes. Within our sample of 
diabetes participants, reduced cognitive function adversely affected gait, irrespective 
of the presence of neuropathy.
Previous studies have reported that older adults suffering from diabetes mellitus have 
an altered gait pattern. Diabetes has most commonly been associated with reduced 
gait speed and shorter step and/or stride length under simple gait conditions [27-31]. 
Reduced cadence and increased step time, single or double support time and 
stance time have also been reported [7,27,29,31]. The current experiment confirmed 
these previous findings, supporting the hypothesis of a ‘more conservative’ gait 
pattern in older adults with diabetes. The altered gait pattern can be seen as a clinical 
manifestation of the disease. However, as suggested by Stegemoller et al. [32], it 
might also be a well-considered choice of the patient to adopt a compensatory 
strategy to improve or maintain safe dynamic stability during more demanding gait 
conditions. By using a conservative gait, people with diabetes might compensate for 
reduced sensory information about the position and movement of their body and 
limbs [31,33,34]. Gait variability has also been a useful parameter to provide better 
insights of motor control during walking [35] and has been associated with future falls 
[36] and cognitive decline in healthy older adults [37]. An increased gait variability 
has also been identified in patients with diabetes suffering from peripheral neuropathy 
[7,29,33,38], which could be partially explained by a compensatory reduced 
self-selected walking speed [38]. Similar to Allet et al. [39] and Sawacha et al. [30], 
we did not find any differences in gait parameters between diabetic participants with 
and without peripheral neuropathy complications. However, a trend (p=0.057) of 
slower stride velocity for diabetic participants with peripheral neuropathy compared 
to without could be noticed. Further research in larger samples is needed to 
understand the impact of peripheral neuropathy on gait in older adults with (and 
without?) diabetes. 
Dual task conditions relying on attentional resources have been shown to adversely 
affect gait in older adults. However, this has not been commonly investigated in older 
adults suffering from type 2 Diabetes Mellitus. Overall, both backward counting and 
reciting animal names while walking affected gait equally in all participants. In 
participants with diabetes, the arithmetic dual task affected gait more than the verbal 
fluency task, whereas there was no difference between the two dual task conditions 
in the control group. The verbal fluency task depends on semantic memory, while the 
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arithmetic task and gait itself both rely on working memory [40]. Choosing a dual task 
that relies on the same memory as gait may therefore be important to elucidate an 
effect [40]. There is ample evidence indicating that gait utilizes higher cognitive 
processing. Our results suggest that an attentional cognitive dual task can further 
affect gait in older adults with diabetes mellitus.
There is controversy regarding the degree to which cerebral effects of type 2 diabetes 
contribute to slower walking speed, lack of balance and increased fall incidence [41]. 
Reijmer et al. have recently suggested that diabetes is associated with subtle cognitive 
decrements [42], which was confirmed in our study by a worse performance on MMSE 
and the CDT in participants with diabetes compared to controls. The present study 
showed that, in our sample of diabetes participants, based on a simple clinical 
categorization, impaired cognitive functioning was associated with decreased gait speed, 
shortened strides, prolonged double support time and increased gait variability, 
irrespective of the presence of neuropathy. Peripheral and central nerve damage partly 
go hand in hand [10,15,17], which complicates their relation with gait. Further research 
is required to investigate this association in more detail and in larger samples.
Study Limitations and future research
Diagnosing peripheral neuropathy in clinical practice is often a lengthy process, 
including laboratory testing, electromyography, and nerve conduction studies. In the 
present study, we have relied solely on clinical measures to identify and categorize 
people with peripheral neuropathy in combination with GP reports without access to 
the primary data. The Diabetic Neuropathy Symptom Score correlates well with nerve 
conduction studies [23] and has previously been able to discriminate between 
patients with and without diabetic polyneuropathy [43]. Evidence-based clinical 
guidelines have suggested that combined use of the Diabetic Neuropathy Symptom 
Score and Vibration Perception Threshold is sufficient for screening, prevention and 
instruction purposes in clinical practice [43,44]. Future studies should explore 
potential mediating pathways of neuropathy on gait performance, i.e. through joint 
mobility, muscle strength, or other comorbidities. In order to get better insights into 
the subdomains of cognitive functioning that mediate the relationship between 
diabetes and gait, a more extensive neuropsychological screening should also be 
considered.  
Conclusions
This study confirmed that gait parameters are affected in older adults suffering from 
type 2 Diabetes Mellitus, especially under dual task conditions. We showed that 
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irrespective of the well-known diabetes-related complication peripheral neuropathy, 
reduced cognitive function further affects gait in older adults with diabetes. 
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Abstract
Background and Purpose Although the shoe type may influence gait performance 
and is considered to be an extrinsic fall risk factor, little or no attention is paid to it 
when conducting research in this field. Therefore, this study aims to assess the effect 
of various types of footwear under single- and dual-task conditions on spatiotemporal 
gait characteristics in older women. 
Methods Fifty-seven community-dwelling women (68.0±4.6 years) were enrolled in 
this study. Spatiotemporal gait analysis using the GAITRite® walkway was performed 
under 4 footwear conditions (barefoot, slippers, high heels, standard shoes) and 3 
task conditions (single-task, motor dual-task, cognitive dual-task). Multivariate re-
peated-measures ANOVA was conducted. Primary outcomes were velocity, cadence, 
stride time, stride length, and stride length variability.
Results Irrespective of task condition, walking barefoot resulted in a significantly 
slower gait pattern with decreased cadence and stride length, and increased stride 
time and stride length variability compared to walking with the standard shoe. These 
significant gait alterations were also observed when adding a cognitive task to normal 
walking. The effects of footwear were most obvious during the cognitive dual-task 
condition and for the spatiotemporal parameters velocity and stride length.
Conclusions Footwear matters when analyzing gait in older women. It should be 
described in greater detail by gait researchers. Footwear should also be considered 
by clinicians in light of the study findings and its effects on gait. Older women are 
strongly discouraged to walk barefoot since barefoot walking adversely affects gait 
patterns. A well-fitting standard shoe with laces, a low and wide heel, firm heel collar 
and a grooved, moderately hard sole is recommended in research, rehabilitation and 
daily use.
Key words Aged; Gait; Walking; Footwear; Dual Tasking
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Introduction
One of the major complaints and challenges when growing older is the decline in the 
ability to perform activities of daily living. A lot of these activities are mobility related 
and often depend on a safe and appropriate performance of gait. Especially with 
respect to this gait-related-mobility requirement, it is generally accepted that age 
induces important and often limiting alterations in locomotion undermining personal 
and social independence [1-4]. The altered gait pattern of healthy older adults is 
generally characterized by reduced gait speed [5-7], shorter step and/or stride 
lengths [5,6] and increased gait variability [8]. In addition to age- or disease-related 
intrinsic risk factors, gait might supplementary be affected by an essential extrinsic 
risk factor: i.e. footwear. Unless studies are specifically designed to assess the effects 
of footwear, shoes often seem to be overlooked when conducting mobility-related 
research in older adults.
Depending on task conditions or personal preferences, walking occurs with or 
without shoes. Shoes are available in all weights and sizes since they are designed 
for different purposes (activities) and terrains and affected by fashion. Older adults 
who live in the community preferably wear slippers, socks, or no shoes at home [9]. 
In residential settings, as well as with increasing age, the ‘slipper-mania’ is even 
greater [10]. However, these types of footwear (or no footwear) have previously been 
identified as fall risk factors [11-13] and have even been associated with increased 
injurious falls [14,15]. Poorly fitting shoes have been shown to cause foot problems, 
foot ulcerations and pain, consequently increasing indirectly the risk of falling 
[10,16-18] based on altered somatosensory input to the foot and ankle influencing 
postural control and creating instability [10]. 
In the context of gait analyses, numerical and statistical differences are often based 
on marginal differences within the frame of cut-off scores. As such, walking speed 
has been used to make critical judgments about an individual in terms of responsive 
measure for short-term rehabilitation [19], risk of adverse outcome [20], functional 
decline [21], fall prediction [22] and survival [23,24]. Since footwear is hypothesized 
to affect gait (speed), it may also interfere with these outcomes in a decisive way. 
The cognitive demand of gait is commonly explored using dual-task paradigms. 
Walking while performing a cognitive task has been shown to cause gait alterations 
not only in older adults with cognitive impairments [25-27] but also in non-disabled 
older adults [7,28]. The introduction of dual-task conditions in gait analysis might be 
useful to reveal more subtle gait alterations and has previously been suggested to 
become a part of routine evaluations of gait abnormalities and fall risk [29]. The type 
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of footwear worn may complicate gait when walking occurs under conditions of 
increased task complexity brought on by the need to perform two tasks simultaneously.
Based on foregoing facts, clarification regarding the effects of footwear worn by older 
adults on gait is necessary for clinical as well as scientific purposes. Understanding 
the effects of footwear on gait might increase the awareness concerning proper 
footwear of scientists and clinicians on the one hand and older adults and their 
caregivers on the other hand. Therefore, this study aimed (i) to investigate the effect 
of various types of footwear on spatiotemporal gait in older women, (ii) to look into 
these characteristics while walking without and with a dual-task, and (iii) to provide 
recommendations to researchers, health-care workers and older women concerning 
optimal types of footwear in relation to gait performance. 
Methods
Participants
Sixty older women between 60 and 75 years volunteered to participate in this study. 
Individuals older than 75 were not enrolled since women aged 60-75 are more likely 
to wear high-heeled shoes. Other inclusion criteria were (i) living independently in the 
community, (ii) being able to understand instructions (according to clinical diagnosis 
of dementia or other severe cognitive impairment (Mini Mental State Exam score 
<24) [30], (iii) being able to walk independently without walking aids, (iv) absence of 
stroke, Parkinson’s disease or other major neurological conditions, and (v) absence 
of musculoskeletal disorders that may affect their gait in a predictable way (e.g., 
amputations, major rheumatic conditions in the lower extremity). Three participants 
did not meet the inclusion criteria. The Ethical Committee of the Ghent University 
Hospital gave approval to this study and all participants signed an informed consent.
Experimental design
Gait analysis was performed using the portable and reliable electronic GAITRite® 
walkway system (8.3m x 0.89m; CIR Systems Inc., Havertown, PA, USA) [31]. The 
following clinically relevant spatiotemporal gait parameters were considered in this 
study: velocity, cadence, stride time, stride length, and coefficient of variation (CV) of 
stride length. The CV is a measure of variability and is expressed as the percentage 
of the ratio of the standard deviation to the mean. Gait variability has been shown to 
be a useful parameter to provide better insights of motor control during walking [32] 
and has been associated with future falls [33]. Cadence and stride length were 
selected since minimal detectable changes (MDC) have previously been determined 
for these parameters [34]. Participants were asked to walk across the walkway under 
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4 conditions: barefoot, wearing their own open heel slippers, wearing their own high 
heeled (min 3.5cm) shoes, and wearing a standard shoe offered by the investigators. 
The standard shoe was a walking shoe with laces, a low (<2.5cm) slightly rounded 
heel and fi rm heel collar (6.5cm), a shock-absorbing ethylene vinyl acetate (EVA) 
foam midsole and grooved outsole (Figure 5.1) and was provided by Decathlon 
Belgium. The standard shoes were available in different sizes and the investigators 
fi tted each subject into the standard shoes by palpating a thumb’s width of space 
(10-20mm) between the end of the hallux and the end of the shoe [35].
Participants were instructed “to walk at their normal speed” and perform each 
footwear condition in 3 randomly offered task conditions: as a single-task, while 
carrying a tray with a cup of pearls (motor dual-task) and while counting backwards 
by 3’s starting from 50 (cognitive dual-task). The dual-tasks were introduced to 
distract the focus of the single walking task in order to obtain gait patterns similar to 
real life. Before the participants started walking, they were instructed to concentrate 
equally on walking and the dual-task. The different walking conditions were offered in 
a randomized order, and a 2-minute rest period was provided between each walk. 
Participants were instructed to start walking 2 m before the GAITRite® walkway and 
keep walking for 2 meters beyond the walkway to minimize acceleration and 
deceleration effects. In order to avoid practice bias with regard to the dual-tasks, only 
one trial per walking condition was performed. Before the beginning of gait analyses, 
participants were asked to freely walk for 2-3 minutes in the laboratory to realize 
adaptation to the standard shoe and to the laboratory environment.
Figure 5.1   The standard shoe
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Statistical analysis
Spatiotemporal gait parameters were calculated by the GAITRite® software and 
statistical analysis was performed using the Statistical Package for the Social Sciences 
(SPSS) version 20.0 for Windows (Statistical Package for the Social Sciences Inc., 
Chicago, IL, USA). Normality assumptions were verified by Kolmogorov-Smirnov good-
ness-of-fit test. For each gait parameter, multivariate repeated-measures ANOVA 
models were conducted to compare spatiotemporal gait parameters between the 4 
different types of footwear and across the 3 experimental walking conditions. Since 
Mauchly’s Test of Sphericity was violated, Greenhouse-Geisser adjustment was 
applied. Finally, pairwise comparisons with Bonferroni adjustment for multiple 
comparisons were performed. If interaction effects were present, pairwise comparisons 
between the conditions were performed within each group.
Results
Mean age and body mass index (BMI) of the older women (N=57) were 68.0 (SD 4.6) 
and 27.9 (SD 4.5) respectively. Pairwise comparisons were made between types of 
footwear (irrespective of task conditions) and between task conditions (irrespective 
of types of footwear) for velocity, cadence, stride time, stride length and CV stride 
length (Table 5.1). Mean values of the spatiotemporal gait parameters for each type 
of footwear and each task condition are presented in Table 5.2 whereas Table 5.3 
contains the pairwise comparisons of types of footwear within each task condition.
Effects of footwear 
There was a statistical significant main effect of footwear for all gait parameters: 
velocity F(3,430) = 145.24, p < 0.001; cadence F(3,428) = 14.37, p < 0.001; stride 
time F(2,410) = 11.67, p < 0.001; stride length F(3,465) = 281.88, p < 0.001; CV stride 
length F(3,486) = 14.86, p < 0.001. Therefore, only the results of pairwise comparisons 
are included in Table 5.1. Pairwise comparisons between all types of footwear 
resulted in significantly different gait velocities. Compared to shod walking, walking 
barefoot revealed a significantly slower gait velocity with decreased stride lengths 
and increased stride-to-stride variability. All gait parameters were significantly 
different when walking with the standard shoe compared to barefoot walking.
Effects of task condition 
There was a statistical significant main effect of task condition for velocity F(2,168) = 
8.26, p < 0.001; cadence F(2,168) = 18.60, p < 0.001; stride time F(2,168) = 19.70, p 
< 0.001, and CV stride length F(2,168) = 22.12, p < 0.001. The cognitive dual-task 
resulted in a significantly slower gait pattern with decreased cadence, increased 
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stride time, and increased stride-to-stride variability compared to the motor dual-task 
or to the single-task. No signifi cant differences in gait parameters between single-task 
walking and walking while performing the motor dual-task were found (Table 5.1).
 
Interaction effects
Signifi cant interaction effects (footwear × task) were found for velocity F(5,430) = 5.23, 
p < 0.001; cadence F(6,428) = 6.73, p < 0.001; stride time F(6,410) = 6.08, p < 0.001, 
and CV stride length F(6,486) = 3.41, p = 0.003. Therefore, spatiotemporal gait 
parameters obtained for the separate kinds of footwear are presented for the 3 task 
conditions (Table 5.2) and the p-values for the pairwise footwear comparisons are 
reported in Table 5.3. Pairwise task comparisons for each footwear type were not 
listed in a table but described below.
Pairwise footwear comparisons per task condition
Under the single-task condition, gait velocity was signifi cantly slower (p<0.001) and 
stride lengths were signifi cantly decreased (p<0.001) when walking barefoot 
compared to shod walking. Compared to all other footwear types, walking with the 
standard shoe resulted in a signifi cantly faster gait pattern with higher cadence, 
increased stride lengths and decreased stride times. No differences in spatiotemporal 
gait parameters were noted between walking with high heels and walking with slippers.
Table 5.1   Statistically Signifi cant Pairwise Comparisons (P-values) 
of Differences in Temporal and Distance Gait Parameters for the 
Main Effects of Footwear and Task Conditions*
Footwear comparisons and
task comparisons
Velocity Cadence Stride
Time
Stride 
Length
CV Stride 
length
Barefoot vs. Slippers <0.001 0.149 0.751 <0.001 <0.001
Barefoot vs. High heels <0.001 1.000 0.850 <0.001 <0.001
Barefoot vs. Standard <0.001 0.001 0.001 <0.001 <0.001
Slippers vs. High heels 0.002 0.014 0.025 0.104 1.000
Slippers vs. Standard <0.001 <0.001 <0.001 <0.001 1.000
High heels vs. Standard <0.001 0.405 0.007 <0.001 1.000
Single-task vs. motor dual-task 1.000 0.339 0.505 1.000 1.000
Single-task vs. cognitive dual-task 0.005 <0.001 <0.001 0.781 <0.001
Motor vs. cognitive dual-task 0.001 <0.001 <0.001 1.000 <0.001
*Note: For the footwear pairwise comparisons, the three task conditions were collapsed and for the 
task condition pairwise comparisons, the four types of footwear were collapsed.
112
CHAPTER 5
Adding a dual-task, regardless of the type, did not signifi cantly alter spatiotemporal 
gait parameters based on footwear worn. Again, velocity and stride length signifi cantly 
decreased when walking barefoot compared to shod walking. The standard shoe 
yielded a faster gait pattern with increased stride lengths compared to the other kinds 
of footwear or no footwear. Similar to the fi ndings during single-task walking, the gait 
pattern while performing a motor dual-task wearing slippers could not be differentiated 
from that wearing high heels. The addition of a cognitive dual-task, however, induced 
a signifi cantly faster gait pattern with increased cadence and decreased stride times 
when walking with high heels compared to walking with slippers (p=0.001, p=0.002, 
and p=0.011 respectively). Furthermore, the cognitive dual-task condition was the 
only condition in which barefoot walking could be differentiated from high-heeled 
walking and walking with the standard shoe based on all spatiotemporal gait 
parameters.
Table 5.2   Means (SD) of the Spatiotemporal Gait Parameters for each Type of 
Footwear under the Single- and Dual-Task Conditions
Footwear per 
task condition
Velocity 
(cm/s)
Cadence 
(steps/min)
Stride
Time (s)
Stride
Length (cm)
CV Stride
Length (%)
Single-Task
Barefoot 114.6 (17.7) 115.9 (9.3) 1.041 (.085) 118.5 (13.0) 0.021 (0.010)
Slippers 122.1 (15.8) 116.1 (8.1) 1.037 (.073) 126.1 (11.8) 0.018 (0.006)
High heels 123.0 (17.0) 116.4 (8.2) 1.035 (.073) 126.7 (13.0) 0.018 (0.008)
Standard 128.5 (18.9) 118.3 (8.6) 1.018 (.073) 130.2 (14.1) 0.018 (0.008)
Motor 
Dual-Task
Barefoot 119.0 (17.1) 120.9 (8.9) 0.997 (0.075) 118.2 (12.8) 0.020 (0.008)
Slippers 123.6 (16.1) 118.4 (8.4) 1.018 (0.073) 125.3 (11.9) 0.017 (0.007)
High heels 123.9 (17.3) 118.2 (8.6) 1.019 (0.073) 125.7 (12.7) 0.018 (0.008)
Standard 129.1 (17.7) 120.2 (8.4) 1.002  (0.071) 128.9 (13.1) 0.017 (0.007)
Cognitive 
Dual-Task
Barefoot 102.7 (19.0) 107.5 (13.1) 1.133 (0.152) 114.7 (13.8) 0.033 (0.017)
Slippers 110.0 (19.6) 107.4 (12.5) 1.134 (0.156) 123.0 (14.4) 0.025 (0.013)
High heels 115.3 (19.0) 110.7 (10.5) 1.095 (0.112) 124.9 (14.3) 0.022 (0.009)
Standard 119.2 (19.4) 111.6 (11.2) 1.087 (0.123) 128.1 (14.4) 0.023 (0.013)
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Pairwise task condition comparisons per footwear type
For each separate type of footwear (within footwear), cognitive dual-task walking 
revealed different spatiotemporal gait parameters compared to motor dual-task 
walking or single-task walking. The differences were statistically signifi cant for 
velocity, cadence, stride time, and stride-to-stride variability but not for stride length. 
Single-task gait patterns could not be differentiated from motor task gait patterns.
Overall, it can be concluded that walking with the standard shoe resulted in a 
signifi cantly different gait pattern compared to the other types of footwear or no 
footwear. The addition of a dual-task, irrespective of its characteristic (motor or 
cognitive), did not alter footwear effects on gait. Nevertheless, the effects of the 
footwear types could be discriminated the best during the cognitive dual-task 
Table 5.3   Signifi cances (p-values) of the Footwear Pairwise Comparisons for 
Spatiotemporal Gait Parameters within each Task Condition
Task 
condition
Footwear
comparisons
Velocity Cadence Stride
Time
Stride 
Length
CV Stride
Length
Single-Task
Barefoot vs. Slippers <0.001 1.000 1.000 <0.001 0.077
Barefoot vs. High heels <0.001 1.000 1.000 <0.001 0.255
Barefoot vs. Standard <0.001 0.035 0.021 <0.001 0.143
Slippers vs. High heels 1.000 1.000 1.000 1.000 1.000
Slippers vs. Standard <0.001 0.002 0.001 <0.001 1.000
High heels vs. Standard <0.001 0.017 0.017 <0.001 1.000
Motor 
Dual-Task
Barefoot vs. Slippers <0.001 <0.001 0.001 <0.001 0.216
Barefoot vs. High heels 0.001 0.001 0.001 <0.001 1.000
Barefoot vs. Standard <0.001 1.000 1.000 <0.001 0.330
Slippers vs. High heels 1.000 1.000 1.000 1.000 1.000
Slippers vs. Standard <0.001 0.019 0.010 <0.001 1.000
High heels vs. Standard <0.001 0.005 0.001 <0.001 1.000
Cognitive 
Dual-Task
Barefoot vs. Slippers <0.001 1.000 1.000 <0.001 0.008
Barefoot vs. High heels <0.001 0.010 0.010 <0.001 <0.001
Barefoot vs. Standard <0.001 0.002 0.011 <0.001 0.001
Slippers vs. High heels 0.001 0.002 0.011 0.159 0.647
Slippers vs. Standard <0.001 0.001 0.021 <0.001 1.000
High heels vs. Standard 0.009 1.000 1.000 0.001 1.000
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condition. Conversely, irrespective of the type of footwear, cognitive dual-task walking 
revealed a significantly different gait pattern (i.e. slower velocity, decreased cadence, 
increased stride time, and increased stride-to-stride variability) compared to motor 
dual-task walking or walking as a single-task.
Discussion
The results of this study indicate that footwear has a definite influence on gait patterns 
in a healthy older female cohort. First of all, not wearing any kind of footwear caused 
the most unstable gait pattern (highest stride-to-stride variability). Barefoot walking 
also resulted in a significantly slower gait with decreased stride lengths compared to 
walking with slippers and high heels. Walking with the standard shoe was obviously 
characterized by the fastest gait speed, most decreased stride time and most 
increased stride length compared to any other type of footwear or barefoot walking.
Since small changes in spatiotemporal gait parameters might be attributed to 
measurement error or random variability, some researchers have established minimal 
detectable change (MDC) values. Changes in spatiotemporal gait parameters that 
are equal to or greater than the MDC can be considered ‘real’ changes [34]. Youdas 
et al. performed GAITRite® analyses at comfortable self-selected walking speed in 
older adults and determined a MDC of 12.6 cm/s for walking speed, 8.4 steps/min for 
cadence and 7.0 cm for stride length [34]. Although a lot of statistically significant 
differences could be found when comparing the shoe types with each other, MDC 
values were not always reached. All shoe type induced differences of cadence were 
smaller than the MDC of 8.4 steps/min, irrespective of task condition. As for velocity, 
differences between barefoot walking and walking with the standard shoe were 
greater than the MDC of 12.6 cm/s during single-task walking. Walking while counting 
backward revealed a slower velocity for barefoot walking compared to high-heeled 
walking or walking with the standard shoe, which was respectively equal and greater 
than the MDC. The stride lengths while barefoot walking compared to any other shoe 
type exceeded the MDC value of 7.0 cm/s, irrespective of the task condition. 
According to the MDC theory, clinically meaningful differences could thus be retained 
for barefoot walking compared to walking with the standard shoe. It should however 
be noticed that previous MDC calculations were primarily based on changes over 
time. MDC values in the context of different types of footwear have not been 
established so far.
 Considering the effects of dual-tasks on gait, it can be concluded that the 
addition of a cognitive dual-task affects gait resulting in a slower gait pattern, with 
decreased cadence, increased stride times and increased stride-to-stride variability 
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compared to single-task walking and to walking while carrying a tray. Stride lengths 
decreased but did not reach significance level of 0.05. The appearance of adverse 
gait alterations in healthy older individuals when walking while performing a cognitive 
dual-task is a well-documented phenomenon [7,29,36-39]. As cognitive dual-tasks 
are used to assess the influence of attention on gait performance and normal ageing 
is known to be accompanied by a subtle decline of some components of executive 
functioning, such as attention [29], the affected gait pattern during walking while 
backward counting in these healthy older women is not surprising. The CV of stride 
length was significantly higher when barefoot walking was compared to shod walking 
during cognitive dual-task walking but not during single-task or motor dual-task 
walking. Executive functions have previously been associated with stride length 
variability [40] which might explain this finding.
To the contrary, gait abilities were not altered when a motor dual-task was added to 
normal walking. The self-selected gait speed even slightly increased when carrying a 
tray filled with pearls compared to walking as a single-task. Hsiang et al. found that 
wearing a weight with both hands, resulted in a forward movement of the center of 
gravity and a passive increase in the forward pulse generation during the push-off 
phase [41]. A forward shift of the center of gravity, possibly provoked by the tray, 
might thus have led to an increase in velocity. Alternatively, it might be that the 
participants attempted to terminate the task as fast as possible, before the cup with 
pearls would fall and the task should appear to be failed.
 Footwear types altered gait parameters most obviously during cognitive dual- 
task walking. In each task condition and compared to all other types of footwear, 
however, barefoot walking resulted in a significantly slower gait with decreased stride 
lengths, whereas walking with the standard shoe yielded a significantly faster gait 
with increased stride lengths. Barefoot walking has previously been associated with 
an increased fall risk in older adults [11,13]. As plantar pressures are higher when 
walking barefoot [42], the slower velocities and shorter stride lengths might be 
explained by the application of a compensatory strategy to decrease local stress 
(pain sensation) underneath the heel [43]. Inversely, according to Arnadottir et al. 
walking shoes provide a shock absorption allowing people to walk faster without 
increasing the impact loading of the body [44]. When task conditions were compared 
to each other, it could be concluded that cognitive dual-task walking consistently (i.e. 
irrespective of the type of footwear) resulted in a slower gait pattern with decreased 
cadence, increased stride times and increased stride-to-stride variability compared 
to motor dual-task walking or walking as a single-task.
 The finding of a more conservative gait pattern (slower walking speed, decreased 
cadence, increased stride time and decreased stride length) when single-task 
walking with high heels compared to walking with the flat standard shoe is also in line 
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with the existing literature [44-47]. Menant et al. showed that walking with a high-heeled 
shoe can lead to lateral instability [46], consequently reducing velocity, step and 
stride length. Another suitable explanation was suggested by Snow et al. They 
showed that wearing high heels results in a shifting of the total body center of mass 
in anterior direction, thereby modifying plantar pressure distribution and increasing 
tissue stress [48]. Contrary to our findings, Arnadottir et al. [44] and Lord et al. [47] 
found that dress shoes (high heels) yielded slower walking speeds than barefoot 
walking. All 35 older women included in the study of Arnadottir et al. were living in 
assisted living facilities [44] and 25 out of the 30 women of Lord’s cohort were 
recruited in a residential care setting [47], whereas our older women were living 
independently in the community. Furthermore, compared to the two aforementioned 
studies the older individuals of this study were at least 10 years younger on average, 
which may also have some consequences with regard to footwear habituation in 
daily life. The differences in residence and age might represent different states of 
health and/or habits, including fashion preferences. Possibly, the women who 
participated in our study were habituated to wearing high heels, elucidating their 
better performance wearing this type of shoes in comparison with barefoot walking. 
As habituation to wearing high heels was not registered in this study, we will consider 
this in future research.
Based on the clearly adverse effects of barefoot walking on the spatiotemporal gait 
parameters, we recommend older women to wear shoes rather than no shoes and to 
prefer a type of shoe with similar characteristics as the standard shoe used in this 
study. The features of the standard shoe seem generally to be consistent with the 
shoe characteristics recommended as safe footwear for older adults in existing 
scientific literature: a low heel with large contact area, comfortably fitting, with laces 
and an anti-slip moderately hard sole [10,13,15,45,49,50]. Furthermore, walking 
without shoes or with socks has been shown by Menz et al. to increase fall risk 
(indoors) [13]. Similarly, high heels have been associated with an increased risk of 
falling [50]. As this type of shoes in our study indeed induced some significant 
adverse gait alterations, we prefer the standard shoe above all else. The fact that the 
slippers and high heeled shoes were brought by the participants, potentially provided 
good generalizability of habitual daily living performance. However, characteristics of 
these footwear types lacked standardization, which can be considered a limitation. 
Another limitation of this study lies in the fact that the arithmetic cognitive task was not 
measured as a single-task. This might have allowed the investigators to assess which 
task was prioritized by the participants during dual-task walking.
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Conclusions
Gait alterations occur depending on the type of footwear and are most pronounced 
when walking barefoot. Footwear effects are similar when dual-task walking 
compared to walking as a single-task. We advise healthy older women to wear shoes 
rather than no shoes and if possible to choose for a well-fitting standard shoe with 
laces, a low and wide heel, firm heel collar and a grooved, moderately hard sole. 
Researchers evaluating gait in older individuals should provide a precise description 
of the participants’ shoes. The use of a more uniform shoe may serve standardization 
of any research protocol, even if participants are not immediately familiar with this 
kind of shoe. This accounts also for clinicians who clinically assess gait on a regular 
basis and for them it is recommended to at least assess gait always wearing the 
same shoes as diversity implies different outcome measures.
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SUMMARY
The major purpose of this doctoral thesis was to contribute to the understanding of 
falling among older adults with T2DM. Part One identified fall risk factors among a 
mixed cohort of older adults with and without T2DM and assessed factors that mediated 
the relationship between T2DM and falls. In Part Two intriguing and potentially interfering 
factors in gait, balance and fall risk assessments were elucidated.
Part One: Fall risk factors
Chapter 2 showed that the fall incidence among T2DM was nearly twice that of 
controls (Answer Research Question 1a). Older adults with T2DM were found to have 
more than a two-fold higher risk for experiencing multiple falls or at least one injurious 
fall compared to older adults without T2DM (Answer Research Question 1a). Apart 
from T2DM, univariate risk factors for falling among a mixed cohort of older adults 
with and without T2DM can be summarized as increasing age, using walking aids, 
increasing number of medications, urinary incontinence, fear of falling, previous falls, 
lower grip strength, poor gait and balance performance and cognitive decrements 
(Answer Research Question 1b). A higher vibration perception threshold and lower 
CDT score were borderline significant. All these risk factors, except for urinary 
incontinence, appeared significantly worse in older adults with T2DM compared to 
controls (Answer Research Question 1c). 
Beyond identifying individual risk factors, it is important to understand the underlying 
mechanisms that are responsible for cause-effect relationships. Therefore, we 
applied mediational analyses in our prospective study. Explanatory variables that 
mediated (reduced) the relationship between T2DM and falls the most were the 
increased number of medications, a poor gait performance and a reduced cognitive 
functioning (Answer Research Question 1d). As illustrated in Figure 6.1, a mediational 
model hypothesizes that the independent variable (here T2DM) influences the mediator 
variable (here number of medications, gait and cognition), which in turn influences 
the dependent variable (here falls). The relationship between the independent and 
dependent variable is then no longer significant. Thus, the mediators serve to clarify 
the nature of the relationship between the independent and dependent variables. 
Multivariate logistic regression considering all covariates that reduced the T2DM/falls 
relationship, retained T2DM and poor balance as independent risk factors for falling 
among older adults.
 In this experiment, a substantial proportion of the relationship between diabetes 
and future falls could be explained by more medication intake, slowed walking speed 
and reduced cognitive performance. Previous research and our own results have 
clearly demonstrated that older adults with T2DM take a higher number of medications 
126
CHAPTER 6
(even when diabetic agents are ignored), show greater gait alterations and cognitive 
decrements. As number of medications [1], poor walking [2] and poor cognitive 
performance [3] have previously been associated with an increased fall risk in healthy 
older adults, it might not be surprising that these variables mediate the relationship 
between diabetes and the faller status. Based on the fi ndings of this study, it is 
recommended that these mediators should be addressed in assessments and 
preventive strategies among older adults with T2DM. 
Part Two: Intriguing interfering factors for assessments 
The role of diabetic peripheral neuropathy in gait and balance performance and in fall 
risk is very controversial. Chapter 3 investigated peripheral nerve function by 
measuring vibration perception threshold in both older adults with and without T2DM. 
Based on this outcome participants were categorized as T2DM with peripheral 
neuropathy, T2DM without peripheral neuropathy, no-T2DM with peripheral 
neuropathy and no-T2DM without peripheral neuropathy. Not only diabetic subjects 
with peripheral nerve dysfunction (“diabetic neuropathy”) but also non-diabetic 
subjects with peripheral nerve dysfunction (“idiopathic neuropathy”) showed greater 
sways during quiet standing assessments compared to their peers without peripheral 
neuropathy. It can thus be concluded that peripheral neuropathy (based on an 
indicative measurement) interferes with postural control (quiet standing performance) 
(Answer Research Question 2a). Furthermore, these “neuropathic” subjects had a 
higher prospective fall incidence (Answer Research Question 2a). 
 In the absence of diabetes, peripheral neuropathy is generally not considered as 
a routine entity in daily geriatric clinical practice or in mobility-related research. This 
study found that the presence of peripheral neuropathy, irrespective of its cause, 
interferes with postural control. These results support the idea that idiopathic 
neuropathy is a widely underestimated problem in older people. The implementation 
of a simple screening for indication of peripheral neuropathy (such as determining 
Figure 6.1   Statistical mediatonal model
Mediator 
(number of medications,
gait, cognition)
Dependent 
variable 
(falls) 
Independent 
variable  
(T2DM)
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the vibration perception threshold) in fall risk assessments among older adults is 
therefore highly recommended (Answer Research Question 2b).
Chapter 4 demonstrated that gait was affected in T2DM (Answer Research Question 
3a) but this was not majorly based on the well-known diabetic complication, peripheral 
neuropathy (Answer Research Question 3b). However, reduced cognitive function, 
an often unrecognized and denied diabetes-related complication, significantly 
worsened gait in older adults with T2DM (Answer Research Question 4a). Dual task 
conditions resulted in altered gait patterns among all participants (Answer Research 
Question 4b). The type of dual task mattered in older adults with T2DM but not in 
healthy controls (Answer Research Question 4c). 
 The altered gait pattern of older adults with T2DM can be seen as a clinical 
manifestation of the disease. However, it might also be a well-considered choice of 
the patient to adopt a compensatory strategy for interfering comorbidities such as 
reduced sensory information. In our study, no significant differences in gait parameters 
between diabetes participants with and without neuropathy could be noticed. 
However, a trend of slower stride velocity for diabetic participants with peripheral 
neuropathy compared to without could be noticed. Reduced cognitive performance 
(based on a simple clinical categorization) clearly affected gait among older adults 
with T2DM, irrespective of peripheral neuropathy. There is some evidence that 
peripheral and central nerve damage partly go hand in hand [4-6], which complicates 
their relation with gait. Further research in larger samples is needed to understand 
these potential interrelationships and their impact on gait. From this study could be 
concluded that cognitive screenings and dual task conditions should be implemented in 
gait analyses and fall risk assessments, especially in older adults suffering from T2DM.
In contrast to the gait study (Chapter 4), the indication of peripheral neuropathy, 
whether associated with diabetes or not, clearly interfered with postural control and 
fall incidence (Chapter 3). This discrepancy might be explained by several factors. At 
first, the different categorization criteria in both studies might have led to different 
results. In the gait study (Chapter 4) diabetes participants were classified as having 
peripheral neuropathy based on a minimum of two positive criteria: diagnosis by 
general practitioner, Vibration Perception Threshold score of ≥ 25V, and/or Diabetic 
Neuropathy Symptom score of ≥ 1/4. Only subjects with an intact vibratory perception 
(< 25V) were allocated to the control (no T2DM) group. On the contrary, the postural 
control study (Chapter 3) considered an additional fourth group, which included 
subjects without T2DM but with a hampered Vibration Perception Threshold (≥ 25V). 
Classification was based on one clinical measure, i.e. Vibration Perception Threshold. 
Therefore, this study mainly focussed on large fiber dysfunction whereas in the gait 
study (Chapter 4) also subjects with small fiber dysfunctions might have been 
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included. Postural control analysis is intrinsically more focused on the contribution of 
proprioception (and somatosensation in general) to the given attribute than this is the 
case for analysis of gait performance. As explained in the General Introduction 
(Chapter 1) somatosensory (mainly proprioceptive) feedback accounts for 70% of the 
input for accurate postural control [7-9]. Furthermore, it should be noticed that the 
sample size (N=101) of the gait study (Chapter 4) was smaller than the sample size 
(N=195) of the postural control study (Chapter 3). Still, a trend for adverse effects of 
peripheral neuropathy on gait could be seen in Chapter 4. Future research is needed 
to elucidate the effects of (different types of) peripheral nerve dysfunction on gait and 
balance in older adults with and without T2DM.
Previous clinical research taught us that differing opinions concerning the impact of 
(sub)optimal footwear on walking (dis)abilities and safety feelings exist among older 
adults. Although generally accepted as an extrinsic fall risk factor, a lot of studies pay 
little or no attention to the type of footwear during gait or balance assessments as 
such or as part of fall risk assessments. However, classifications and predictions are 
often based on marginal differences within the frame of gait velocity cut-off scores as 
mentioned earlier. From Chapter 5 it could be concluded that the type of footwear 
indeed significantly influences gait performance (Answer Research Question 5a). 
From the four types of footwear (barefoot, slippers, high heels and a standard shoe), 
gait patterns were most altered when wearing no shoes (barefoot walking). The 
standard shoe (a well-fitting shoe with laces, a low and wide heel, firm heel collar and 
a grooved, moderately hard sole) yielded the most fluent gait pattern characterized 
by a faster walking speed, increased cadence and stride length and decreased stride 
time and stride length variability (Answer Research Question 5a). Footwear effects 
were similar in motor (carrying a tray with a cup of pearls) or cognitive (backward 
counting) dual task walking compared to walking as a single task (Answer Research 
Question 5c). The cognitive dual task resulted in a significantly worse gait pattern 
compared to the motor dual task or the single task (Answer Research Question 5b). 
No significant differences in gait parameters between single task walking and walking 
while performing the motor dual task could be retained (Answer Research Question 
5b). The self-selected gait speed even slightly increased when carrying a tray filled 
with pearls compared to walking as a single task (Answer Research Question 5b).
 The effects of the motor and cognitive dual tasks on gait performance might be 
explained by forward movement of the center of gravity induced by carrying the tray 
with pearls (increasing gait speed) and the age-related structural changes of the 
brain (decreasing gait speed) [10] respectively. Gait speed is a crucial determinative 
and prognostic feature for development of disabilities and general health problems, 
which highlights the importance of (accurate) gait (speed) analysis. Researchers 
often omit descriptions of footwear used during mobility analyses whereas they 
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should describe more accurately the used shoes because (i) different types of shoes 
(or no shoes) may substantially influence gait performance, and (ii) risk profiles use 
cut-off levels for gait variables and are based on small differences, which may render 
abusive categorization of older adults as (not) being at risk. As changes in gait could 
be masked when different types of shoes are used in consecutive measurements it 
is advisable to monitor the used type during assessment and re-assessment. With 
respect to the most stable, fluent and less risky gait, a standard shoe with a low and 
wide heel and a grooved, moderately hard sole is recommended in research as well 
as in daily use among healthy older women.
 It should, however, be emphasized that this study considered a different research 
population (healthy older women) than the previous studies from Chapter 2, 3 and 4 
and that these specific results can therefore not be generalized to male or female 
older adults with T2DM. Nevertheless, the generalizability of the concept, i.e. the role 
of shoes in assessing and interpreting gait assessment, may be seen as of common 
importance.
Conclusions
Older adults:
•	Poor	balance	and	T2DM	are	both	independent	fall	risk	factors
•	Peripheral	neuropathy	affects	static	postural	control	performance	
•	The	type	of	shoe	influences	gait	patterns
•	Older	women	should	be	discouraged	to	walk	barefoot
Older adults with T2DM:
•	The	relationship	between	T2DM	and	falling	can	partly	be	explained	by	(i)	number	
of medications, (ii) cognitive decrements and (iii) poor walking performance 
•	Peripheral	neuropathy	affects	static	postural	control	performance	
•	Gait	alterations	are	more	manifest	if	a	semantic	cognitive	dual	task	is	added	
to single walking
•	Impaired	cognitive	functions	further	affect	gait	patterns
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CLINICAL IMPLICATIONS
The overall objective of scientific research is not only to contribute to unravel 
unexplained observations but also and perhaps even the ultimate aim for society; to 
implement the findings into clinical practice. The clinical implications of this doctoral 
thesis will be outlined below.
Suggestions for fall risk assessment 
More than 400 potential risk factors for falling have been identified in the past [11] and 
albeit that in this context the saying “the more (investigated), the better” probably 
holds true, this is not a realistic message for the physiotherapist in everyday clinical 
practice. Still, since the risk of falling has proven to linearly increase with the number 
of risk factors [12], fall risk assessments should be multifactorial. In an attempt to 
stimulate the clinician in tackling the difficult clinical challenge of fall prevention, a 
flowchart for fall risk detection in older adults will be introduced at the end of this 
section.
Older adults
About ten years ago, Lord et al. developed the Physiological Profile Assessment 
(PPA) [13]. The PPA consists of simple tests of vision, vestibular function, peripheral 
sensation, muscle strength, reaction time and balance [13]. Chapter 2 of this doctoral 
thesis confirmed that balance is an independent risk factor for falling. As balance 
relies on visual, vestibular and somatosensory systems, we completely agree with the 
assessments included in the PPA. Furthermore, the tests of the PPA have proven to 
be valid and reliable and can be administered quickly and with portable equipment 
[13]. However, another independent risk factor was identified in Chapter 2: T2DM. 
Also, previous falls and fear of falling were strong univariate risk factors for falling 
(Chapter 2), which is in line with previous research. From Chapter 3, it could be 
concluded that the integration of a simple screening for peripheral neuropathy (like 
biothesiometry) should not be limited to older adults with T2DM but could also be 
useful to measure in the so-called “healthy” older adults as consequences (impaired 
balance) were similar in both populations. Apart from that, the finding that a substantial 
proportion of “healthy” non-diabetic controls appeared to have hampered vibration 
sense, illustrates that peripheral nerve dysfunction is not necessarily a complication 
of the older adult with T2DM. The significantly older age of non-diabetic participants 
with peripheral neuropathy compared to non-diabetic participants without peripheral 
neuropathy confirmed the age-related trend of idiopathic neuropathies, which has 
previously been proven by Verghese et al. [14]. We therefore suggest to minimally 
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administer the following items in fall risk assessments among the aged population: 
balance, vibration perception, T2DM, previous falls and fear of falling.
Older adults with Type 2 Diabetes Mellitus
All physical (muscle strength, gait, balance) and cognitive measures that were 
identified as risk factors for falling in our prospective study, indeed appeared to be 
significantly worse in older adults with T2DM compared to controls (Chapter 2). 
Walking slower and with shorter strides, performing worse on cognitive tests and 
taking more medications substantially mediated the relationship between T2DM and 
faller status (Chapter 2).
Older adults with T2DM had an increased vibration perception threshold compared 
to controls but this parameter was only borderline significantly associated with an 
increased fall risk among older adults with and without T2DM (Chapter 2). Chapter 4 
revealed that gait performance in T2DM was further affected by reduced cognitive 
function but not by peripheral neuropathy. To the contrary, a hampered vibration 
perception significantly interfered with postural control in older adults with and without 
T2DM (Chapter 3). 
For older adults with T2DM we therefore suggest to extend “regular” fall risk assessment 
by analyzing gait and cognitive performance and recording the number of medications. 
Although the role of peripheral neuropathy in fall risk remains unclear, we nevertheless 
suggest to measure peripheral nerve function if possible (e.g. by a simple screening 
instrument like the Bio-Thesiometer®).
Flowchart fall risk detection
Inspired by the suggestions of Ganz et al. [15] and the results of this doctoral thesis, 
we developed a flowchart for fall risk detection in older adults (Figure 6.2). We thereby 
hope to provide the clinician with an easy tool to narrow the gap between the 
numerous existing guidelines and everyday clinical practice and take the first step to 
fall preventive initiatives and strategies. 
We suggest to start risk detection by asking two simple questions: (i) “Have you had 
any falls in the past year?” and (ii) “Do you suffer from T2DM?”. 
If both questions are answered negatively, a short screening of gait and balance should 
be performed. An impaired mobility and balance can be objectified by the Timed Up & 
Go (TUG) Test. If the older individual is able to fluently complete this test in less than 14 
seconds and no other pre-existent fall inducing pathologies are present, an increased 
fall risk based on physical performance might be ruled out. If more than 14 seconds are 
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needed to complete the test or an irregular/unstable gait pattern can be observed or 
the older individual cannot execute this test due to cognitive or physical reasons, a 
multifactorial fall risk assessment is recommended. This screening is in line with the 
practical guidelines for fall prevention in community-dwelling older adults developed 
by the “Expertisecentrum Val- en fractuurpreventie Vlaanderen (EVV)” [16].
Figure 6.2   Suggested fl owchart for fall risk detection in older adults
“Have you had any falls in the past year?”
“Do you suffer from T2DM?”
2x No
Increased
Fall Risk
≥1x Yes
Screening:
- Gait & Balance (TUG)
Multifactorial Fall Risk Assessment:
- Medication Review
- Orthostatic Hypotension
- Gait- Balance
- Muscle Strength
- Vision
- Cognition
- Vibration Perception Threshold
- Fear of Falling
Specific Domain-related
Physiotherapeutic Interventions
(Preventive Strategies)
+
Fall PreventiveAdvises
No Impairments
No Increased
Fall Risk
Fall Preventive
Advises
Impairments
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An older individual who experienced one or more previous falls and/or suffers from 
T2DM, needs a more extended multifactorial fall risk assessment including medication 
reviews, evaluation of orthostatic hypotension and testing of gait, balance, muscle 
strength, vision, cognition, vibration perception threshold and fear of falling. Assessing 
these fall risk factors will supply clinicians with specific treatment goals. As mentioned 
earlier, medications can increase fall risk when a large number (≥5) or specific types 
of medications (i.e. psychotropic medications and antihypertensive agents [17]) are 
used. In these cases, reconsideration of medication schemes in consultation with the 
general practitioner is recommended. The prevalence of orthostatic hypotension is 
significantly higher in older adults with compared to older adults without T2DM and 
orthostatic complaints have been associated with an increased fall risk [18]. We 
therefore recommend to evaluate orthostatic hypotension conform the instructions 
included in the Appendix. Besides the TUG Test, gait can be assessed by the 
Tinetti-Test (Gait Evaluation) or by introducing dual tasks while walking (“Stops 
Walking When Talking Test”) [19]. Balance can be evaluated by the Tinetti-Test 
(Balance Evaluation), Four Test Balance Scale or Functional Reach Test whereas the 
Timed Chair Stand-Test or measuring grip strength can be used for assessing muscle 
strength. Visual acuity can be measured using a letter chart. The assessment of other 
visual abilities (contrast sensitivity, depth perception, …) are described elsewhere 
[20]. The MMSE and CDT can be used to obtain an idea of general cognitive 
performance. However, as the load in former testing is carried by the CDT and dual 
tasking is a crucial issue the Montreal Cognitive Assessment (MoCa) might be a 
good alternative since this test focuses even more on executive functioning, which is 
suggested to play a key role in gait and dual tasking. Furthermore, T2DM has 
repeatedly been associated with impaired executive functioning [21-23]. The MoCa is 
available in Dutch and also takes into account the educational level. Before measuring 
vibration perception (e.g. using the Bio-Thesiometer®), footwear and feet should be 
inspected. In our studies major neurological or musculoskeletal disorders that may 
have interfered on gait in a predictable way (such as amputations or major ulcers), 
were excluded. Podiatry assessment (foot deformations, ulcers, ingrown nails, …) 
and treatment is however important in fall risk assessment of older adults with T2DM. 
Fear of falling and related activity restriction should be recorded. The older adult can 
immediately be provided by advises concerning proper footwear and fear of falling. 
As explained earlier in this doctoral thesis clinicians are strongly advised to carefully 
inspect footwear in view of accurate mobility assessment and reassessment. 
The clinical tests that were proposed for fall risk assessment (TUG Test, evaluation of 
orthostatic hypotension, Tinetti Test, Four Test Balance Scale, Functional Reach Test, 
Timed Chair Stand-Test, MMSE, CDT, MoCa) are generally in accordance with the 
suggested tests of the EVV [16], except for the cognitive tests. In our studies gait and 
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balance were assessed by means of expensive electronic devices such as the 
GAITRite® System and AMTI® force platform. These instruments are preferable for 
research as they provide more objective and very detailed data which are essential 
for understanding and determining the impact of diseases or challenging conditions 
on physical performance. However, they are not suitable for clinical practice. We 
therefore proposed tests that are relatively inexpensive, not time-consuming and 
easy to administer and interpret for daily practice. The tests with description and 
interpretation are appended at the end of this doctoral thesis.
Ideally, the two screening questions at the top of this flowchart are embedded in an 
initial anamnesis. In the case of previous fall(s), further details should be obtained 
concerning the circumstances of the fall(s). This may reveal important information for 
future interventions and preventive advises. Also, urinary incontinence should be 
asked. Activities of daily living and fear of falling are not included in the flowchart by 
means of the existing B-ADL, I-ADL and FES-(I) instruments since some of these 
questions are not applicable for older adults living in residential care settings and our 
aim was to develop a flowchart that can be used for all older adults. Nevertheless, 
these items can sharpen the picture of the older individual and his/her behavior. It is 
therefore advised to obtain this information in the anamnesis or whenever the 
opportunity presents itself.
 
In view of specific and individual rehabilitation/preventive exercises, it is recommended 
that physiotherapists evaluate fall risk factors such as gait, balance, muscle strength 
and fear of falling. While other fall risk factors may require other areas of competence, 
other health care workers may become essential in a congruent and complementary 
fall risk assessment. The multifactorial nature of fall risk detection and prevention 
demands an inter- and transdisciplinary approach, especially in cases of T2DM 
where multiple bodily systems and functions are involved. However, one should 
realize that this ideal theoretical framework is not always achieved due to various 
reasons. We therefore aimed to select clinical tests that are valid and relevant but 
nevertheless quite simple to administer for a variety of health care workers. If other 
disciplines cannot be involved in the multifactorial fall risk assessment, a short 
training period should be sufficient for the physiotherapist to adequately administer 
all suggested tests and gain information that outreaches his/her familiar domains but 
may reveal important insights.
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Nomenclature for Type 2 Diabetes Mellitus?
About 800 000 people in Belgium suffer from T2DM [24]. It is likely that global trends 
will be followed also in Belgium and that this number will only increase in the future. 
As stated in the general introduction of this doctoral thesis, the Belgian RIZIV-nomen-
clature [25] for physiotherapists is not specifically suitable to older adults suffering 
from T2DM due to its rather generic character, thereby being less sensitive for the 
specific disease-related challenges. It renders undoubtedly generic potential but this 
may nevertheless be insufficient for the given population.
This doctoral thesis clearly demonstrated that older adults with T2DM have a 
significantly increased fall incidence compared to older adults without T2DM (Chapter 2). 
Also, the hypothesized increased fall risk of older adults with T2DM [26-30] was confirmed 
and mediating factors were identified (Chapter 2). Taking a high number of medications 
(Chapter 2), poor gait performance (Chapter 2 and 4), poor balance (Chapter 2 and 3), 
impaired vibration perception (Chapter 2 and 3) and poor cognitive performance (Chapter 
2 and 4) were associated with T2DM and with an increased fall risk. 
Because of its major eye-catching comorbidities, the increased fall risk of older 
adults with T2DM is perhaps considered of minor attention demanding importance. 
However, based on (i) the epidemic challenge, (ii) the multiple drastic fall 
consequences, and (iii) the results of this doctoral thesis, we think that for this matter 
T2DM perhaps deserves more specific attention in treatment strategies and as a 
consequence in the Belgian nomenclature for physiotherapists. By doing so an 
increasing amount of correct fall risk profiled older adults may be retrieved rendering 
the potential of specific preventive care to tackle growing costs when injuries have to 
be treated or residential care becomes necessary. Further research is needed to 
prove this hypothesis and to determine clinical cut-points for number of medications, 
vibration perception threshold, and performance of gait, balance and cognition. 
Suggesting specific adaptations to the nomenclature lies beyond the scope of this 
doctoral thesis. Whether T2DM should be added to the list of E-pathologies or 
whether the criteria for meeting F-pathology should be adapted based on the 
aforementioned risk factor for falls, can however be considered in the future.
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STRENGTHS AND LIMITATIONS
The major aim of this doctoral thesis was to gain better insights into the hypothesized 
increased risk of falling among older adults suffering from T2DM (Chapter 2). Also, we 
investigated some often overlooked though potentially interfering aspects in clinical 
gait, balance and fall risk assessments (Chapter 3, 4, 5).
To our knowledge, we were the first to conduct an extensive fall risk study among 
older adults, focusing on T2DM and using mediational models (Chapter 2). In addition 
to the prospective design of this study, this might be considered the main strength of 
this doctoral thesis. Previous studies considering fall risk factors in T2DM included 
only older adults with T2DM without a non-diabetic control group [30-33], only women 
[28,29,34], only older adults living in residential settings [35], only older adults living 
in the community [27-31,34], or had no prospective design [27,32,33].
We have tried to match participants with and without T2DM for age and sex. If matching 
was lost due to classification of the participants into different categories, corrections 
were applied in statistical analyses to avoid potential confounding bias (Chapter 3). 
We only imposed an inclusion criterion for minimum age (60 years old) in Chapter 2, 
3 and 4, which yielded (very) wide age ranges (up to 94 years old). This factor 
complicated age-matching during the recruitment process but resulted in a 
representative sample of older adults as such, allowing extrapolation of the results to 
the broader population. The unequal distribution of participants living in a residential 
care setting versus in the community (a greater proportion of T2DM lived in residential 
care settings compared to controls), can be seen as limitation. However, this is a 
realistic reflection of dwelling in the aged, which favors extrapolation.
Although a lot of scientific research has focused on T2DM in relation to peripheral 
neuropathy, we were surprised to notice that nearly all designs comprised only two or 
three groups, lacking a control group with peripheral neuropathy. To our opinion this 
is a remarkable observation as one could imagine that this lacking group is essential 
when aiming to assess whether either T2DM or peripheral neuropathy causes 
alterations in physical performance. The addition of a fourth group in our postural 
control study (Chapter 3), can therefore be seen as a strength. 
Another strength of the research in this doctoral thesis is that simple screening 
measures that were used, appeared to be of clinical importance. As such, 
performance of the MMSE and CDT, two widespread and well-known cognitive 
screening instruments, was associated with gait (Chapter 4) and fall risk (Chapter 2). 
Similarly, using a portable Bio-Thesiometer® could distinguish balance performance 
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and fall incidence among older adults with or without T2DM (Chapter 3). Furthermore, 
this outcome measure (vibration perception) was identified as univariate risk factor 
for falling, albeit that the significance was borderline (Chapter 2). Finally, the type of 
footwear has proven to affect gait in healthy older women (Chapter 5). This is a very 
easy adjustable though often ignored item for both researchers and health care 
workers to pay attention to. The above described examinations are not only of clinical 
importance but they are also relatively inexpensive, easy to administer, not 
time-consuming and therefore applicable in everyday practice. 
At the same time, the simple screenings of peripheral and central nervous function 
(vibration perception and MMSE/CDT respectively) are limitative in what they (do not) 
measure. As illustrated by Figure 1.6, the peripheral nervous systems comprises a 
spectrum of fiber types and functions. By determining vibration perception threshold 
only sensory nerves with large, myelinated fibers were measured. We did not measure 
any small fibers or motor nerves. By measuring vibration, however, the same large 
(myelinated) sensory fibers that are responsible for proprioception (position sense) 
are measured. This is an important remark because postural control mainly depends 
on the somatosensory system and particularly on the proprioceptive input, as 
explained in the introduction. Similarly, the MMSE is a measure for global cognitive 
functioning and the CDT for visuospatial and executive functioning and attention. 
However, a lot of other cognitive domains could have been assessed by available 
screening instruments. Also educational level should have been registered as this 
might influence cognitive test scores. Furthermore, neuropsychological tests are 
unable to provide specific information about the neural structures responsible for any 
dysfunction identified [36]. In an attempt to get better insights in the type of nerves 
and cognitive domains that are affected, more extensive screenings should have 
been applied. However, Nilsson et al. concluded that cognitive deficits associated 
with diabetes in very old age may be detected with the MMSE [37]. Furthermore, as 
mentioned in the previous paragraph, the simple screenings that were used in this 
doctoral thesis (VPT, MMSE, CDT) appeared to have enough discriminative value for 
our purposes.
Although the visual system is considered to be a less important input for the postural 
control system than the vestibular and somatosensory (proprioceptive) system, the 
major limitation of the research in this doctoral thesis probably lies in the lack of 
screenings of the visual abilities. Some studies failed to find associations between 
visual impairments and falls [15,27,35] but other studies clearly related visual deficits 
[20,38], especially poor visual acuity [13,39], decreased depth perception [20,40,41] 
and lessened contrast sensitivity [20,40] to falls. About 30% of people with diabetes 
suffers from retinopathy [42,43]. In our postural control study (Chapter 3), we have 
138
CHAPTER 6
tried to imitate visual dysfunction by asking participants to close their eyes during the 
different quiet standing conditions. The removal of vision significantly hampered 
postural control. Nevertheless, we have to admit that visual screenings should have 
been applied in order to better understand the impact on the postural control system. 
Another important covariate that was not implemented in our studies is the duration 
of the (T2DM) disease or the year wherein T2DM was diagnosed. Per definition, 
chronic complications progressively develop over time. A longer disease duration 
might therefore interfere in clinical outcomes. Due to the large proportion of missing 
values (particularly of participants living in residential settings), it was statistically 
unwarranted to include this parameter in our analyses.
A final limitation lies in the recruitment method. Participants were recruited through 
online advertising, flyer distribution, by word of mouth and from the Endocrinology 
Clinic at the Ghent University Hospital. This may have led to a potential volunteer bias 
related to the fact that only those participants who were actually willing to participate, 
entered the studies. Also, there may have been an under-reporting of falls due to 
recall bias. Poorer recall of falls is hypothesized to more likely occur in cases of less 
severe (non-injurious) falls and among older adults with cognitive impairments. 
However, these hazards are hard to avoid and monthly fall records are recommended 
by the ProFaNE [44].
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FUTURE RESEARCH DIRECTIONS
Although during the last decades an incredible amount of studies has been 
accomplished in the area of fall risk detection and prevention strategies among 
healthy older individuals, further research is needed in older adults suffering from 
T2DM. The mediating factors of the diabetes/falls relationship should be confirmed 
and extra attention should be paid to visual functioning. Additionally, as suggested 
earlier, future research should be elaborated to determine clinical cut-points for these 
mediating factors (i.e. number of medications, gait and cognition). This would allow 
researchers to formulate specific and applicable proposals for adjusting the Belgian 
nomenclature for physiotherapists, thereby making it more convenient for older 
adults with T2DM.
Our findings concerning the role of peripheral nerve dysfunction were somewhat 
inconsistent (Chapter 3 vs. Chapter 4) and inconclusive (Chapter 2). This might be 
due to fact that only one objective measure for peripheral neuropathy was used in our 
trials. Therefore, it would be of interest to further investigate the potential relationship 
between peripheral neuropathy and gait, balance and falls. An extensive assessment 
of peripheral neuropathy, preferably with the inclusion of specialized tools (electrodi-
agnostic methods) is suggested in order to differentiate between different types of 
peripheral nerve dysfunctions. Aiming to (cor)relate specific peripheral nerve 
dysfunctions to functional outcomes (e.g. gait, balance, falls) would be of clinical 
importance. Taking into account the feasibility of measuring vibration perception, it 
would also be of interest to validate this test to more complex nerve conduction 
analysis on a large scale. Some researchers hypothesized that peripheral and central 
nerve damage may partly go hand in hand. Unraveling this putative interrelationship, 
although potentially challenging, would be very interesting. The potential impact of 
limited joint mobility in T2DM on gait, balance and/or falls has never been investigated 
so far and could form another intriguing research focus.
Further, it would be of interest to find out more about the cognitive decrements in 
older adults with T2DM and their impact on physical abilities. Discovering the affected 
domains and functions is crucial for early pharmacological and rehabilitation 
regimens. In a next step, the effect of different (specific) intervention strategies on 
physical and cognitive performance should be evaluated. Again, a four-group design 
could be applied; (i) no intervention, (ii) physical training, (iii) cognitive training, (iv) 
physical and cognitive training. Similar intervention studies have been suggested [45] 
previously in healthy older adults. However, it might be the case that older adults with 
T2DM benefit more from other modalities (e.g. higher intensities) to compensate for the 
increased physical and cognitive deprivation due to diabetes-related complications.
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As exemplified in the General Introduction (Chapter 1), certain types of medications 
have been proven to increase fall risk among older adults. In older adults with T2DM 
renal function might be affected (nephropathy), which in turn may influence the 
effects of medications in these individuals. It would therefore be of great interest to 
assess the effects of certain groups of medications on fall risk among older adults 
with T2DM and compare the results to those among older adults without T2DM. 
Renal function should then be incorporated in the assessments since it might be a 
potential mediating factor in the medication/faller status.
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FINAL CONCLUSIONS
This doctoral thesis demonstrated that older adults with T2DM have a two-fold 
increased fall incidence and fall risk compared to older adults without T2DM. T2DM, 
increased age, walking aids, higher number of medications, urinary incontinence, 
fear of falling, previous falls, increased vibration perception thresholds, lower grip 
strength, poorer gait, balance and cognitive performance are risk factors for falling in 
older people. Clinicians must be aware that all the aforementioned risk factors, except 
for urinary incontinence, are significantly worse in older adults with T2DM compared 
to controls. Although we cannot conclude whether T2DM itself on the one hand or 
T2DM-related complications on the other hand are responsible for the increased fall 
rates in this older subpopulation, it is likely that the same major fall risk factors as 
found in older adults without T2DM (i.e. gait and balance impairments) are affected, 
albeit to a greater extent.
Some clinical implications can be derived from our findings. At first, we wish to issue 
some points of interest regarding fall risk assessment. Our results justify the 
implementation of peripheral neuropathy assessment in any balance or fall risk 
assessment. In everyday clinical practice the use of a simple screening instrument 
such as a biothesiometer might be sufficient to give an indication of peripheral nerve 
dysfunction, prompting to be cautious in terms of impaired mobility and increased fall 
risk. Although large amounts of evidence suggest that older adults with dementia are 
at increased fall risk and cognitive performance is related to gait and falls, cognitive 
screenings are generally not a primarily part of fall risk profiles. This doctoral thesis 
showed that impaired cognitive performance was a risk factor for falling and further 
affected gait in older adults with T2DM. Furthermore, the diabetic participants in 
our studies had poorer cognitive performance compared to controls. Cognitive 
deterioration has previously been shown to be a chronic complication of T2DM. We 
therefore suggest to include cognitive screening(s) in fall risk assessment, especially 
in older adults suffering from T2DM. A final recommendation for researchers and 
health care workers is to pay attention to the type of shoes the older adult wears 
during physical assessments and in daily life. Poor footwear (slippers, high heels or 
walking barefoot) causes gait alterations and older adults should be advised to wear 
a good fitting shoe with a low and wide heel and a thin, grooved and moderately hard 
sole.
 Besides these clinical implications, adaptation of the Belgian nomenclature for 
physiotherapists for the benefit of older adults with T2DM might be useful. Further 
research is however needed to formulate specific suggestions for adaptation.
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Volgens de Verenigde Naties zal rond 2050 het aantal ouderen in de wereld het aantal 
kinderen voor het eerst in de geschiedenis overstijgen. In de ontwikkelde landen is 
deze wijziging van de bevolkingssamenstelling nu reeds aan de gang. Hoewel de 
 levenskwaliteit van ouderen over het algemeen aanzienlijk is verbeterd, neemt met de 
leeftijd ook het aantal ouderdomsgerelateerde ziektes en verschijnselen toe.
Vallen is één van die verschijnselen en wordt, gezien de impact op diverse domeinen, 
terecht bestempeld als een groot geriatrisch probleem of een zogenaamde “geriatric 
giant”. Deze problematiek wordt meestal veroorzaakt door een combinatie van 
multipele omgevings- en/of persoonsgebonden factoren. Een dergelijke val kan 
dramatische gevolgen hebben voor het oudere individu, variërend van lichamelijke 
letsels (schaafwonden, kneuzingen, fracturen, hoofdletsels, …) tot psychosociale 
(depressie, valvrees, vermijdingsgedrag, sociale isolatie, …) en socio-economische 
(immobilisatie, medische kosten, ziekenhuisopname, vroegtijdige institutionalisering, 
…) consequenties. Ernstige valpartijen kunnen leiden tot blijvende invaliditeit of zelfs 
overlijden. Ondanks de verbluffende feiten en cijfers en de veelheid aan wetenschap-
pelijk bewijsmateriaal, wordt het belang van valpreventie nog al te vaak onderschat. In 
het licht van de preventieve mogelijkheden die vandaag zijn aangetoond en redelijk 
toegankelijk zijn, wordt er overeenkomstig nog steeds ontoereikend aandacht aan 
gegeven door zowel zorgverstrekkers als de ouderen zelf. Zo is het potentieel van 
oefenen en oefentherapie als één van de meest afdoende strategieën waarbij de kinesi-
therapeut een cruciale rol kan vervullen, vandaag nog onvoldoende geëxploiteerd. 
Sensibilisering van alle betrokkenen is vandaag echter op kruissnelheid aan het komen, 
waardoor promotie en verfijning van de kennis en inzichten essentieel is geworden. 
Hoewel elke oudere moet worden gesensibiliseerd om door eigen initiatief (aandacht, 
voorzorg en gedrag) verantwoordelijkheid te nemen voor valpreventie, moeten structurele 
en georkestreerde preventiemaatregelen minimaal worden voorzien voor de ouderen 
met een verhoogd valrisico. Factoren die bijdragen aan een dergelijk verhoogd 
risicoprofiel zijn de aanwezigheid van een valhistoriek, schrik om te vallen, toenemende 
leeftijd, fysieke zwakte (“prefraile” en “fraile” ouderen), alsook de aanwezigheid van 
bepaalde aandoeningen zoals onder andere een beroerte, de Ziekte van Parkinson en 
dementie. Bij zwakke ouderen en ouderen met specifieke ziektebeelden neemt de 
kans op vallen meestal toe door de sterk valbevorderende aanwezigheid van 
spierzwakte of stoornissen in gang en/of evenwicht. In de regel hebben deze mensen 
gestructureerde ondersteuning nodig om het vallen het hoofd te bieden.
Hoewel gangbaar minder courant als risicofactor opgenomen in diverse overzichten, 
wordt Diabetes Mellitus type 2 (T2DM) ook beschouwd als een aandoening waarbij 
het risico op vallen is verhoogd. Deze geringe focus is mogelijk toe te schrijven aan 
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het feit dat andere complicaties bij deze aandoening meer de aandacht trekken of als 
ernstiger worden beschouwd. Feit is echter ook dat er nog veel onduidelijkheden 
heersen betreffende de onderliggende mechanismen van het verhoogd valrisico 
binnen deze specifieke deelpopulatie. Dit maakt dat vandaag zowel generiek als 
specifiek naar de valproblematiek in de kinesitherapeutische regelgeving geen 
gewag wordt gemaakt van deze aandoening en haar specifieke karakteristieken. 
De criteria voor valpreventie tegen regulier terugbetalingstarief voorzien door de 
Belgische nomenclatuur voor kinesitherapie van het Rijksinstituut voor Ziekte- en In-
validiteitsverzekering (RIZIV) zijn vrij generiek en als dusdanig gericht naar de oudere 
populatie zonder specifieke risicobeïnvloedende morbiditeiten. De afwezigheid van 
morbiditeiten en hun rol naar het vallen wordt mogelijk voor een aantal van hen 
opgevangen door hun aanwezigheid in andere secties van de nomenclatuur (bv. 
beroerte en Ziekte van Parkinson in E-nomenclatuur). Voor de epidemiologisch 
steeds wilder om zich heen grijpende aandoening T2DM is dit vandaag echter nog 
niet het geval. Op zich, kan dit worden beschouwd als een confirmatie van het niet 
(er)kennen van bovenstaand probleem.
Met dit doctoraal proefschrift werd de aandacht gevestigd op de valproblematiek bij 
ouderen met T2DM teneinde betere inzichten te verschaffen in de mechanismen die 
ten grondslag liggen aan deze perfide relatie. Vooreerst werden daartoe de valrisico-
factoren bij ouderen zonder en met T2DM geïdentificeerd en onderzocht (Deel Een). 
Verder werden een aantal potentieel interfererende doch systematisch onvoldoende 
gewaardeerde factoren in screenings van gang, evenwicht en vallen, op gecontroleerde 
wijze onderzocht (Deel Twee). 
Deel Een omvat een prospectieve studie waarin een groep van 199 ouderen na het 
doorlopen van een uitgebreide testbatterij gedurende 1 jaar werd opgevolgd naar 
valincidenten (Hoofdstuk 2). Iets meer dan de helft van deze ouderen hadden T2DM. 
Uit deze studie kon worden weerhouden dat ouderen die lijden aan T2DM bijna 
dubbel zo vaak vallen dan ouderen zonder T2DM. Opvallend was dat alle onderzochte 
parameters (met uitzondering van urinaire incontinentie) die werden geïdentificeerd 
als univariate risicofactoren voor vallen, significant slechter bleken te zijn bij de 
ouderen met T2DM in vergelijking met de ouderen zonder T2DM. Wanneer deze 
univariate risicofactoren afzonderlijk werden toegevoegd aan een T2DM/val-model, 
konden 3 factoren worden weerhouden die deze relatie (T2DM~vallen) “afzwakten” 
en dus beschouwd konden worden als verklarende factoren of onderliggende 
mechanismen van deze relatie. Het betrof een verhoogd medicatiegebruik en 
geringer performante gang en cognitie. Hieruit kon dus worden afgeleid dat bij 
ouderen met T2DM in het kader van valrisicodetectie systematisch nazicht van 
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medicijnen (met het oog op eventuele aanpassingen inzake gebruik of dosis van 
medicijnen die bijvoorbeeld niet meer noodzakelijk zijn) en onderzoek van gang en 
cognitie zinvol zijn. Uit multifactoriële analyses konden de aanwezigheid van T2DM 
op zich alsook een zwak evenwicht worden weerhouden als onafhankelijke 
risicofactoren voor vallen.
Gezien de demografische wijzigingen werd gedurende de afgelopen decennia 
terecht veel wetenschappelijk onderzoek verricht rond de valproblematiek in al zijn 
facetten. Heel wat intrisieke (persoonsgebonden) en extrinsieke (omgevingsgebonden) 
risicofactoren werden daarbij bepaald en tal van nuttige instrumenten werden daartoe 
ontwikkeld. Toch viel het op dat bepaalde weliswaar vaak aangehaalde risicofactoren 
systematisch over het hoofd worden gezien bij evaluatie, en dit zowel door onder - 
zoekers als door clinici. Deel Twee trachtte daarom na te gaan of deze factoren al dan 
niet terecht minder aandacht krijgen. 
In een eerste studie werd aandacht gegeven aan een mediërende dimensie van de 
somatosensoriek op het evenwicht van de oudere (Hoofdstuk 3). Hiertoe werden 
proefpersonen op basis van een gekende cut-off voor vibratiezin ingedeeld in vier 
groepen: T2DM met perifere neuropathie, T2DM zonder perifere neuropathie, niet- 
T2DM met perifere neuropathie (een minder logische groep gezien het ontbreken van 
een manifeste pathologische factor) en niet-T2DM zonder neuropathie (waarbij men 
er vaak vanuit gaat dat hierin alle ouderen zonder T2DM zouden zitten). Niet alleen de 
groep T2DM met perifere neuropathie (“diabetische neuropathie”), maar ook de 
minder courant omschreven groep niet-T2DM met perifere neuropathie (“idiopathische 
neuropathie”) vertoonde gelijkaardige, significant grotere afwijkingen tijdens statische 
evenwichtsanalyses in vergelijking met de respectieve groepen zonder perifere 
neuropathie. Hieruit kon bijgevolg worden afgeleid dat niet diabetes per se, maar wel 
het aanwezig zijn van perifere neuropathie cruciaal is voor evenwichtsprestaties. 
Bovendien hadden de groepen met perifere neuropathie een hogere prospectieve 
valincidentie. Het onderzoeken van perifere zenuwfuncties lijkt in deze context dus 
niet alleen zinvol bij ouderen met T2DM maar ook bij de “gezonde” ouderen (zonder 
T2DM).
De rol van diabetische perifere neuropathie op gang- en evenwichtsprestaties is zeer 
controversieel. Uit de studie in Hoofdstuk 4 bleek dat niet de bekendste complicatie 
van T2DM (perifere neuropathie) maar wel één van de minst gekende complicaties, 
zijnde een verminderde cognitieve functie, het gangpatroon van ouderen met T2DM 
verder aantast. Stappen met een cognitieve dubbeltaak leidde tot significante 
veranderingen in het gangpatroon van alle ouderen waarbij het type cognitieve 
dubbeltaak niet van belang was bij ouderen zonder T2DM maar wel bij ouderen met 
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T2DM. Cognitieve deterioratie kan zijn weerslag hebben op het stappatroon van 
ouderen met T2DM en cognitieve screenings en/of dubbeltaak condities zouden dus 
deel moeten uitmaken van ganganalyses en onderzoeken in het kader van valrisico-
detectie. 
 In een laatste studie werd de invloed van de extrinsieke risicofactor ‘schoeisel’ 
op het stappen onderzocht in een groep gezonde oudere vrouwen (Hoofdstuk 5). 
Schoeisel wordt vaak als een compromitterende valrisicofactor gezien, maar globaal 
wordt hier -zowel in de kliniek als in het onderzoek- bijvoorbeeld bij screenings relatief 
weinig of geen aandacht aan gegeven. Het type schoeisel beïnvloedde echter 
overduidelijk het gangpatroon. Van de vier types ‘schoeisel’ (blootsvoets, pantoffels, 
schoenen met hakje en een standaardschoen) werd het gangpatroon het meest 
beïnvloed indien geen schoenen werden gedragen. Stappen met een standaard-
schoen leverde het meest vloeiende en derhalve veiligste gangpatroon op, en dit 
zowel tijdens het stappen als enkeltaak, stappen met motorische dubbeltaak (een 
dienblad met een tas vol parels dragen) als stappen met cognitieve dubbeltaak 
(achterwaarts tellen). Onderzoekers moeten dus rekening houden met het type 
schoen dat proefpersonen dragen, te meer gezien sommige risicoprofielen cut-off 
waarden gebruiken die veelal zijn gebaseerd op minimale verschillen. Het al dan niet 
dragen van een bepaalde schoen zou er dus voor kunnen zorgen dat een oudere net 
boven of net onder zo’n waarde valt en aldus verkeerdelijk wordt gecategoriseerd. In 
deze context is voorzichtigheid ook geboden in het kader van herevaluaties. Zowel 
voor onderzoeksdoeleinden als voor dagelijks gebruik wordt zonder tegenindicatie 
een standaardschoen met lage en brede hiel en dunne, matig harde en gegroefde 
zool aanbevolen. Blootsvoets stappen, in andere wetenschappelijke studies reeds 
meermaals geassocieerd met een verhoogd valrisico, lijkt ook op basis van de 
resultaten uit deze studie te moeten worden afgeraden (aan oudere dames).
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Conclusies
Oudere populatie:
•	Een	zwak	evenwicht	alsook	de	aanwezigheid	van	T2DM	zijn	beide	onafhankelijke	
valrisicofactoren
•	De	aanwezigheid	van	perifere	neuropathie	 tast	statische	evenwichtsprestaties	
aan
•	Het	type	schoen	beïnvloedt	het	gangpatroon
•	Vrouwen	moeten	worden	afgeraden	om	blootvoets	te	stappen	
Oudere populatie met T2DM:
•	Het	 aantal	 medicaties,	 alsook	 prestaties	 van	 cognitie	 en	 gang	 verklaren	
deels de relatie tussen T2DM en vallen
•	De	aanwezigheid	van	perifere	neuropathie	 tast	statische	evenwichtsprestaties	
aan
•	Afwijkingen	van	het	gangpatroon	worden	manifester	bij	toevoeging	van	een	
semantische cognitieve dubbeltaak
•	Verminderde	cognitieve	functies	tasten	het	gangpatroon	verder	aan
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Valkalender
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Testen Flowchart
Timed Up & Go (TUG) Test
1. Instructies
Afname: De te onderzoeken patiënt zit op een stoel met een rugleuning en de armen 
steunen op de armleuningen. Hij wordt verzocht recht te staan, drie meter te wandelen 
tot aan een lijn of een merkteken, zich 180° om te draaien, terug te komen naar de 
stoel en te gaan zitten. Het gebruik van een hulpmiddel (bijvoorbeeld een wandelstok 
of een looprek) is toegestaan. De patiënt mag dat hulpmiddel met de handen 
vasthouden bij het begin van de test. De test begint op het startsein van de 
onderzoeker en de tijd wordt stopgezet wanneer de patiënt terug met de rug tegen 
de rugleuning van de stoel zit.
Scoring: De test is positief indien de oudere 14 seconden of langer doet over de test 
(verhoogd valrisico) of een afwijkend gangpatroon vertoont tijdens de test. Het 
gangpatroon wordt als afwijkend beschouwd wanneer de oudere een ongelijkmatig/
onevenwichtig gangpatroon vertoont; slentert, schuifelt of sloft; van de lijn afwijkt; 
onvaste, wankele stappen neemt. Bij ouderen die omwille van cognitieve of fysieke 
redenen de test niet kunnen uitvoeren, wordt de test automatisch als positief 
beoordeeld.
•	 www.riziv.be 
•	 www.valpreventie.be 
•	 Podsiadlo	D,	Richardson	S.	The	timed	“up	and	go”:	A	test	of	basic	functional	mobility	for	frail	elderly	
persons. JAGS 1991; 39:142-148
•	 Shumway-Cook	A,	Brauer	S,	Woollacott	M.	Predicting	the	probability	for	falls	in	community-dwelling	
older adults using the Timed Up & Go Test. Phys Ther 2000; 80(9):896-903
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Evaluatie van orthostatische hypotensie
1. Instructies
Screenende vragen:
- “Heeft u soms last van duizeligheid of draaierigheid?”
- “Heeft u dit bij het rechtstaan uit bed, stoel of zetel, of bij het bukken?”
- “Heeft u dit al gehad binnen het uur na een maaltijd?” (postprandiale hypotensie)
Afname: Meet de bloeddruk en pols na een liggende houding van minimaal 5 (liefst 
10) minuten, bij voorkeur ’s morgens of na de middagrust. Laat de oudere vervolgens 
rechtstaan. Meet de bloeddruk en pols opnieuw onmiddellijk na het rechtstaan en na 
drie minuten rechtstaan. Bevraag de aanwezigheid van eventuele symptomen.  
Scoring: De test is positief indien een systolische bloeddrukdaling van ≥ 20 mmHg 
of een diastolische bloeddrukdaling van ≥ 10 mmHg wordt vastgesteld onmiddellijk 
na het rechtstaan of na drie minuten.
•	 www.valpreventie.be 
•	 Consensus	statement	on	the	definition	of	orthostatic	hypotension,	pure	autonomic	 failure,	and	multiple	
system atrophy. The Consensus Committee of the American Autonomic Society and the American 
Academy of Neurology. Neurology 1996; 46(5):1470. 
•	 Gupta	V	&	Lipsitz	LA.	Orthostatic	hypotension	in	the	elderly:	diagnosis	and	treatment.	Am J Med 2007; 
120(10):841-847
•	 Irvin	DJ	&	White	M.	The	importance	of	accurately	assessing	orthostatic	hypotension.	Geriatr Nurs 2004; 
25(2):99-101
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Tinetti-test BALANS
1. Instructies, afname en scoring
De proefpersoon zit op een harde stoel zonder leuningen.
Taak Beschrijving Score
1)   Zitbalans 0 = hangt in de stoel of glijdt weg
1 = veilige, stabiele houding
2) Rechtstaan 0 = onmogelijk zonder hulp
1 = mogelijk met hulp van armen
2 = mogelijk zonder hulp van armen
3) Pogingen om recht te staan 0 = onmogelijk zonder hulp
1 = mogelijk in meer dan 1 poging
2 = mogelijk in 1 poging
4) Evenwicht in stand  
onmiddellijk na het rechtstaan 
(eerste 5 sec)
0 =  onstabiel (wankelt, voet- en/of  
romp bewegingen)
1 =  stabiel, met gebruik van steun  
(rollator, stok, …)
2 = stabiel, zonder extra steun
5) Evenwicht in stand 0 = onstabiel
1 =  stabiel, met voeten > 10 cm uit elkaar  
of armsteun
2 = voeten gesloten, zonder steun
6) Drie keer duwen met de 
 handpalm op het sternum met 
voeten tegen elkaar
0 = begint te wankelen
1 = wankelt, maar herstelt zichzelf
2 = stabiel
7) Ogen dicht met de voeten  
tegen elkaar
0 = onstabiel
1 = stabiel
8) 360° graden draaien 0 =  beweging niet vloeiend (onregelmatige 
stapjes)
1 = vloeiende beweging (regelmatige stapjes)
0 = onstabiel (wankelt)
1 = stabiel
9) Gaan zitten 0 =  onveilig (valt in stoel, afstand mis 
 ingeschat)
1 = veilig en vlot mits gebruik van armen
2 = veilig en vlot zonder extra steun
Evenwichtsscore (max. 16) /16
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Tinetti-Test GANG
1. Instructies, afname en scoring
De proefpersoon staat samen met de onderzoeker; hij/zij stapt in de gang of in de 
kamer, eerst aan een gewoon tempo, dan op de terugweg in een snellere maar 
veilige pas (hij/zij gebruikt eigen hulpmiddelen zoals een stok of een looprek).
Taak Beschrijving Score
1) Initiatie gang na 
“start”
0 = aarzeling of verschillende pogingen 
1 = zonder aarzeling
2) Staplengte en 
-hoogte
0 = rechter ‘zwaaivoet’ passeert linker ‘standvoet’ niet 
1 = rechter ‘zwaaivoet’ passeert linker ‘standvoet’
0 = rechtervoet komt niet volledig los van de vloer
1 = rechtervoet komt volledig los van de vloer
0 = linker ‘zwaaivoet’ passeert linker ‘standvoet’ niet 
1 = linkervoet ‘zwaaivoet’ passeert linker ‘standvoet’
0 = linkervoet komt niet volledig los van de vloer
1 = linkervoet komt volledig los van de vloer
3) Stapsymmetrie 0 = linker- en rechter staplengte zijn niet gelijk
1 = linker- en rechter staplengte zijn gelijk
4) Continuïteit van  
de stap
0 = haltes (stoppen) of discontinuïteit tussen stappen
1 = stappen lijken continu (vloeiend)
5) Afwijkende gang 0 = opvallende afwijking
1 = middelmatige afwijking of gebruik van hulpmiddel
2 = rechtuit zonder hulpmiddel
6) Romp 0 = uitgesproken rompbeweging of gebruik van hulpmiddel
1 = geen rompbeweging maar flexie van knieën of rug, 
of spreiden van de armen tijdens stappen
2 = rechtop zonder hulpmiddel
7) Walking distance 
(voetafstand)
0 = hielen uit elkaar
1 = hielen raken elkaar bijna tijdens stappen
Gangscore (max. 12) /12
TOTAALSCORE = Evenwicht + Gangscore (max. 28) /28
Totaalscore < 20/28: valrisico x5
•	 Tinetti	M.	Performance	oriented	assessment	of	mobility	problems	in	elderly	patients.	J Am Geriatr Soc 
1986; 34:119-126
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Four Test Balance (FTB) Scale
1. Instructies
Afname: Vraag aan de oudere om elk van de vier posities van de Four Test Balance 
Scale gedurende 10 seconden aan te nemen (zie onderstaande fi guur). Voor de 
vierde positie mag de oudere kiezen op welk been hij zal staan.
Deze test wordt uitgevoerd zonder hulpmiddel of schoeisel. De onderzoeker mag de 
oudere helpen om de juiste positie aan te nemen. Vervolgens moet de oudere 
aangeven wanneer hij klaar is om de test zonder hulp uit te voeren. Oefenen is niet 
toegelaten. Plaats een stoel achter de oudere. De vier condities worden aangeboden 
in de volgorde van toenemende moeilijkheidsgraad. 
Scoring: De test eindigt en is positief van zodra men een van de vier posities geen 
10 seconden kan aannemen, bijvoorbeeld: de oudere beweegt zijn voeten, de 
hulpverlener moet de oudere vastnemen om een val te voorkomen, of de oudere 
raakt de muur, tafel of stoel om het evenwicht te behouden. 
•	 www.valpreventie.be
•	 Gardner	MM,	Buchner	DM,	Robertson	MC,	Campbell	AJ.	Practical	implementation	of	an	exercise-based	
falls prevention programme. Age Ageing 2001; 30(1):77-83
•	 Rossiter-Fornoff	JE,	Wolf	SL,	Wolfson	LI,	Buchner	DM.	A	cross-sectional	validation	study	of	the	FICSIT	
common data base static balance measures. Frailty and Injuries: Cooperative Studies of Intervention 
Techniques. J Gerontol A Biol Sci Med Sci 1995; 50(6):M291-297
 
   
 
 
 
 
Parallelle stand Semi-tandem-
stand
Tandemstand Unipodale stand
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Functional Reach Test (FRT)
1. Instructies
Afname: De oudere neemt met de voeten op schouderbreedte plaats naast de 
lintmeter en houdt de dominante arm het dichtst tegen de muur met gebalde vuist 
horizontaal met de lintmeter. De oudere reikt zo ver mogelijk voorwaarts zonder het 
evenwicht te verliezen. De voeten mogen niet worden verplaatst, de hielen moeten op 
de grond blijven en de romp mag niet draaien. De reikafstand (de afstand tussen de 
begin- en eindpositie van metacarpaal 3) wordt gemeten en bepaalt de testscore. 
Deze test wordt uitgevoerd zonder hulpmiddel of schoeisel.
Scoring: De test is positief indien de reikafstand ≤ 25 cm bedraagt; 
 > 25 cm:  geen verhoogd valrisico
 15-25 cm:  verhoogd valrisico
 ≤ 15 cm:  sterk verhoogd valrisico
•	 www.valpreventie.be 
•	 Duncan	PW,	Studenski	S,	Chandler	J,	Prescott	B.	Functional	reach:	predictive	validity	in	a	sample	of	
elderly male veterans. J Gerontol 1992; 47(3):M93-98
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Timed Chair Stand (TCS) Test
1. Instructies
Afname: De te onderzoeken oudere zit met de armen gekruist over de borstkas op 
een stoel met een rugleuning en zonder armleuningen. Om veiligheidsredenen wordt 
de rugleuning van de stoel tegen een muur geplaatst. De oudere wordt verzocht 
vijfmaal na elkaar zo snel mogelijk recht te staan en te gaan zitten zonder de armen 
te gebruiken. Het gebruik van een hulpmiddel is niet toegestaan. De test begint op 
het startsein van de onderzoeker en de tijd wordt stopgezet bij de vijfde keer dat de 
oudere rechtop staat.
Scoring: De test is positief indien de oudere hiervoor 14 seconden of meer nodig 
heeft of indien hij niet in staat is de test uit te voeren. 
•	 www.riziv.be 
•	 Guralnik	JM,	Ferrucci	L,	Simonsick	EM,	Salive	ME,	Wallace	RB.	Lower-extremity	function	in	persons	
over the age of 70 years as a predictor of subsequent disability. N Engl J Med 1995; 332(9):598-599
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Mini-Mental State Examination (MMSE)
1. Instructies en Test
(i) Oriëntatie in tijd en ruimte
In welk jaar zijn we?    Jaar 
In welk seizoen zijn we?    Seizoen 
De hoeveelste zijn we vandaag?   Datum 
Welke dag is het vadaag?    Dag 
In welke maand zijn we?    Maand 
In welk land leven wij?    Land 
In welke provincie zijn we?    Provincie 
In welk dorp zijn we?    Dorp 
In welk centrum bent u?    Centrum 
Op welke verdieping bent u?    Verdieping 
(ii) Inprentingsvermogen
Ik noem u drie woorden. Als ik ze gezegd heb,    Sigaar 
moet u ze alledrie herhalen.    Bloem 
Lees de woorden voor aan 1 woord per seconde.    Deur 
Laat ze daarna herhalen en noteer elk correct woord.
Als de patiënt ze niet correct herhaalt,
lees ze dan opnieuw voor en herhaal eventueel tot 6 maal toe.
Onthoud deze woorden goed, want ik ga ze u straks nog eens vragen.
(iii) Aandacht
Wilt u van het getal 100 zeven aftrekken? Van de uitkomst trekt    93 
u dan telkens weer zeven af en zo verder tot wanneer ik ‘stop’ zeg.  86 of -7 
Elke juiste aftrekking levert 1 punt op.    79 of –7 
    72 of –7 
    65 of –7 
Wilt u het woord kamer van achteren naar voren spellen?    R 
    E 
    M 
    A 
    K 
Vergelijk de twee vorige testen. Weerhoud enkel de test met de hoogste score. 
Schrap de andere en tel die niet mee in de eindscore.
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(iv) Geheugen
Welk waren de drie woorden die u moest onthouden?    Sigaar
    Bloem
    Deur
(v) Taal
Wat is dit? Wijs een horloge aan.   Horloge
Wat is dit? Wijs een potlood aan.    Potlood 
Wilt u de volgende zin herhalen: Geen als, en of maar.    Correct 
Neem dit papier met de rechterhand,    Neemt papier 
vouw het in twee en leg het op uw schoot.    Vouwt papier 
    Legt op schoot
Lees wat op dit papier staat en doe wat gevraagd wordt.    Sluit ogen 
Hou het papier omhoog, waarop staat ‘sluit uw ogen’.
Kan u voor mij een zin opschrijven.    Zin 
De zin moet een onderwerp en werkwoord bevatten en betekenis hebben.
(vi) Constructieve vaardigheid
Kan u deze fi guur natekenen?    Figuur
Toon de twee vijfhoeken. Voor een correct antwoord moeten er 10 hoeken zijn, 
waarvan er 2 kruisen.
Interpretatie:
- > 26/30: geen cognitieve beperking
- 24-26/30:  milde cognitieve defi cieten
- < 24/30:  matige tot ernstige cognitieve beperkingen
•	 Folstein	MF,	Folstein	SE,	McHugh	PR.	“Mini-mental	state”.	A	practical	method	for	grading	the	cognitive	
state of patients for the clinician. J Psychiatr Res 1975; 12(3):189-198
TOTAALSCORE MMSE: ............../ 30
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SLUIT UW OGEN
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Clock Drawing Test (CDT)
1. Instructies
Afname: “Wilt u een klok tekenen alstublieft? Vul alle getallen en wijzers in.
Proefpersonen mogen zelf kiezen welke tijd de klok aangeeft.
Als de proefpersoon aangeeft klaar te zijn met het tekenen van de klok, zeg dan: 
“Schrijf hieronder de tijd neer die uw klok aangeeft.”
Scoring CDT:
- Item 2: 12 nummers zijn aanwezig  ja: 1 punt neen: 0 
- Item 5: nummer ‘12’ is correct gepositioneerd   ja: 2 punten  neen: 0 
- Item 25: wijzers hebben juiste proportie   ja: 2 punten  neen: 0 
-  Item 34: proefpersoon kan de tijd correct aflezen   ja: 2 punten  neen: 0  
Scoring gecombineerde MMSE-CDT:
Test MMSE CDT MMSE-CDT
Scoring ≥ 27 3
< 27 0
Item 2
0 0
1 1
Item 5
0 0
2 3
Item 25
0 0
2 1
Item 34
0 0
2 1
Max. score 30 7 9
Cut-off score <24 < 6 < 7
•	 Thalmann	 B,	 Spiegel	 R,	 Stähelin	 HB,	 Brubachner	 D,	 Ermini-Fünfschilling	 D,	 Bläsi	 S,	 Monsch	 AU.	
Dementia screening in general practice: Optimised scoring for the Clock Drawing Test. Brain Aging 
2002; 2(2):36-43
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2. Test
 
Wilt U een klok tekenen? Vul alle cijfers in, alsook de wijzers van de klok. 
 
 
 
 
 
Schrijf hieronder de tijd neer die uw klok aangeeft
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Montreal Cognitive Assessment (MoCa)
1. Instructies
(i) Alternerende Trail Making: 
Afname: “Teken een lijn, van een cijfer naar een letter en in oplopende volgorde. Begin 
hier (wijs naar 1) en teken een lijn van 1 naar A, dan naar 2 en zo verder. Stop hier (wijs 
naar E).” 
Scoring: 1 punt wordt toegekend indien de proefpersoon het volgende patroon 
correct tekent: 1-A-2-B-3-C-4-D-5-E, zonder dat de lijnen elkaar kruisen. Een fout die 
de proefpersoon niet direct zelf verbetert, krijgt een score 0. 
(ii) Visuo-constructieve vaardigheden (Kubus): 
Afname: “Teken deze figuur zo nauwkeurig mogelijk na, in de ruimte hieronder”. 
Scoring: Er wordt 1 punt toegekend voor een correcte tekening. De tekening moet 
driedimensionaal zijn, alle lijnen moeten zijn getekend, er mag geen extra lijn worden 
toegevoegd en de lijnen moeten relatief parallel lopen en van gelijke lengte zijn 
(rechthoekige prisma’s worden geaccepteerd). Indien aan één van bovenstaande 
criteria niet wordt voldaan, is de score 0. 
(iii) Visuo-constructieve vaardigheden (Klok): 
Afname: “Teken een klok. Plaats er alle cijfers in en zet de wijzers op 10 over 11”. 
Scoring: Er wordt één punt toegekend voor elk van de volgende 3 criteria: 
- Omtrek (1 pt.): de omtrek van de klok moet een cirkel zijn. Hooguit een kleine 
afwijking is acceptabel (b.v., een kleine onvolkomenheid bij het sluiten van de cirkel); 
- Cijfers (1 pt.): alle cijfers van de klok zijn aanwezig, zonder toevoeging van extra 
cijfers; de cijfers staan in de juiste volgorde en moeten ongeveer in de kwadranten 
van de klok geplaatst zijn; Romeinse cijfers zijn toegestaan; de cijfers mogen aan 
de buitenkant van de cirkel worden geplaatst; 
- Wijzers (1 pt.): er moeten twee wijzers zijn die samen de correcte tijd aangeven; de 
uurwijzer moet duidelijk korter zijn dan de minutenwijzer; de wijzers moeten in de 
klok worden getekend en elkaar ongeveer in het midden van de cirkel kruisen. 
Er wordt geen punt toegekend voor een element indien aan de bovenstaande criteria 
niet wordt voldaan.
(iv) Benoemen: 
Afname: Wijs vanaf links ieder figuur aan en zeg: “Hoe heet dit dier?”. 
Scoring: Voor elk van de volgende antwoorden wordt 1 punt gegeven: (1) leeuw, (2) 
neushoorn, (3) kameel of dromedaris. 
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(v) Geheugen: 
Afname: Onderzoeker leest een rij van 5 woorden voor met een snelheid van één 
woord per seconde en geeft hierbij de volgende instructies: “Dit is een geheugentest. 
Ik ga een rij woorden voorlezen die u moet onthouden, nu maar ook straks. Luister 
goed. Als ik klaar ben, vertelt u me alle woorden die u hebt onthouden. Het maakt niet 
uit in welke volgorde u ze opnoemt”. Zet een kruisje in de aangegeven ruimte voor 
ieder woord dat de proefpersoon tijdens deze eerste aanbieding reproduceert. 
Wanneer de proefpersoon aangeeft dat hij/zij klaar is (alle woorden heeft herinnerd), 
of zich geen woorden meer weet te herinneren, lees dan de lijst met woorden een 
tweede keer voor met de volgende instructie: “Ik ga dezelfde lijst een tweede keer 
voorlezen. Probeer zo veel mogelijk woorden te onthouden en vertel ze me, ook de 
woorden die u de eerste keer hebt opgenoemd.” Zet een vinkje in de aangegeven 
ruimte voor ieder woord dat de proefpersoon zich herinnert na de tweede aanbieding. 
Vertel de proefpersoon aan het einde van de tweede aanbieding dat later nogmaals 
naar de woorden gevraagd zal worden, door te zeggen: “Ik zal u aan het eind van 
deze test opnieuw vragen welke woorden u zich nog weet te herinneren.” 
Scoring: Er worden géén punten gegeven voor aanbiedingen één en twee. 
(vi) Aandacht: 
Afname Cijferreeksen vooruit: “Ik ga een aantal cijfers opnoemen en als ik klaar 
ben, moet u ze in dezelfde volgorde nazeggen als ik ze heb gezegd”. Lees de vijf-cijfer 
reeks met een snelheid van één cijfer per seconde. 
Afname Cijferreeksen achteruit: “Nu ga ik weer cijfers opnoemen, maar zodra ik 
klaar ben, moet u ze in omgekeerde volgorde nazeggen.” Lees de drie-cijfer reeks 
met een snelheid van één cijfer per seconde. 
Scoring: Er wordt 1 punt gegeven voor elke correct nagezegde reeks, (N.B.: het 
correcte antwoord voor cijferreeksen achteruit is 2-4-7). 
Afname Volgehouden aandacht: De onderzoeker leest de rij letters voor met een 
snelheid van één letter per seconde. “Ik ga u een reeks letters voorlezen. Iedere keer 
dat ik de letter A noem, tikt u eenmaal met uw hand op tafel. Wanneer ik een andere 
letter noem, tikt u niet met uw hand op tafel”. 
Scoring: Geef 1 punt bij nul of één fout (een fout is een tik bij de verkeerde letter of 
geen tik bij de letter A). 
Afname Seriële 7’s: “Wilt u van 100 zeven aftrekken en van wat overblijft weer zeven 
aftrekken en zo doorgaan tot ik stop zeg?” Geef deze instructie zo nodig tweemaal.
Scoring: Op dit item zijn maximaal 3 punten te behalen. Geef geen (0) punten indien 
geen enkele correct is, 1 punt voor één correcte aftreksom, 2 punten voor twee of drie 
correcte aftreksommen, en 3 punten indien vier of vijf aftreksommen juist zijn 
gemaakt. Tel iedere juiste aftrekking van 7, beginnend bij 100. Iedere aftreksom wordt 
individueel beoordeeld; dit houdt in dat indien een proefpersoon met een foutief getal 
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antwoordt, maar vervolgens correct doorgaat met hier 7 van af te trekken, er een punt 
voor iedere correcte som wordt gegeven. Een proefpersoon kan bijvoorbeeld 
antwoorden: “92 – 85 – 78 – 71 – 64” waarbij de “92” fout is, maar alle volgende 
getallen correct zijn afgetrokken. Dit is één fout en het item krijgt een score van 3. 
(vii) Zinnen nazeggen: 
Afname: “Ik ga u een zin voorlezen. Zeg deze na zodra ik klaar ben, precies zoals ik 
hem heb gezegd [pauze]: Ik weet alleen dat Jan vandaag geholpen zou worden.” Na 
het antwoord zegt u: “Nu ga ik u een andere zin voorlezen. Zeg deze na, precies zoals 
ik hem heb gezegd [pauze]: De kat verstopte zich altijd onder de bank als er honden 
in de kamer waren.” 
Scoring: Ken 1 punt toe voor iedere correct herhaalde zin. De herhaling moet precies 
hetzelfde zijn. Wees alert voor omissies (b.v., “alleen”, “altijd” vergeten) en 
vervangingen of toevoegingen (b.v., “Jan is degene die vandaag heeft geholpen”; 
“verstopte” vervangen door “verstopt”, meervoud veranderen, etc.). 
(viii) Verbale fluency: 
Afname: “Noem zo veel mogelijk woorden als u kunt bedenken die beginnen met een 
bepaalde letter van het alfabet. Ik zal u de letters straks vertellen. U mag ieder woord 
noemen dat u wilt, behalve namen, cijfers, of woorden die met hetzelfde voorstukje 
(voorvoegsel) beginnen, zoals bijvoorbeeld lief, liefde, liefdevol. Na één minuut vraag 
ik u te stoppen. Bent u er klaar voor? [pauze] Noem zo veel mogelijk woorden als u 
kunt bedenken die beginnen met de letter D. [tel 60 sec af]. Stop.” 
Scoring: Ken 1 punt toe indien de proefpersoon 11 woorden of meer kan opnoemen 
in 60 seconden. Noteer de antwoorden onderaan het blad, of in de kantlijn. 
(ix) Abstractie: 
Afname: De onderzoeker vraagt de proefpersoon uit te leggen wat ieder woordpaar 
gemeenschappelijk heeft. Begin met het voorbeeld: “Kunt u mij vertellen in welke 
opzicht een sinaasappel en een banaan aan elkaar gelijk zijn, wat is de overeenkomst 
tussen beide?”. Wanneer de proefpersoon een concreet antwoord geeft, zeg dan 
slechts één keer extra: “Weet u nog een andere overeenkomst?”. Indien de 
proefpersoon niet het correcte antwoord geeft (fruit), zeg dan, “Ja, en het is beide 
fruit.” Geef geen extra instructies of verduidelijking. 
Na de oefenafname, zegt u: “In welk opzicht zijn een trein en een fiets aan elkaar 
gelijk?”. Nadat het antwoord gegevens is, stelt u een tweede vraag: “Vertel me nu in 
welk opzicht een liniaal en een horloge aan elkaar gelijk zijn”. Geef geen extra 
instructies of aanmoedigingen. 
Scoring: Alleen de laatste twee itemparen worden gescoord. Geef 1 punt voor ieder 
correct beantwoord itempaar. Deze antwoorden worden goedgekeurd: 
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Trein-fiets = vervoermiddelen, manieren om te reizen, je kunt met beide tochten 
maken; 
Liniaal-horloge = meetinstrumenten, worden gebruikt om te meten. 
De volgende antwoorden worden niet goedgekeurd: Trein-fiets = zij hebben wielen; 
Liniaal-horloge = zij hebben cijfers.
(x) Uitgestelde recall: 
Afname: “Ik heb u eerder een rij met woorden voorgelezen, en ik vroeg u ze te 
onthouden. Vertel me zo veel mogelijk woorden die u zich kunt herinneren.” Zet een 
vinkje in de daarvoor bestemde ruimte (√) voor ieder correct woord dat de 
proefpersoon zich spontaan, zonder aanwijzingen, heeft weten te herinneren. 
Scoring: Ken 1 punt toe voor ieder woord dat spontaan wordt herinnerd zonder 
aanwijzingen.
(xi) Oriëntatie: 
Afname: “Vertel me de datum van vandaag”. Indien de proefpersoon een onvolledig 
antwoord geeft, moedig hem dan aan door te zeggen: “Vertel me het [jaar, maand, 
precieze datum, en dag van de week].” Zeg vervolgens: “Vertel nu: hoe heet dit 
gebouw en in welke stad/plaats zijn we nu?” 
Scoring: Geef 1 punt voor ieder correct beantwoord item. De proefpersoon moet de 
exacte datum en het exacte gebouw noemen (naam van het ziekenhuis, kliniek, 
kantoor). Er worden geen punten toegekend als de proefpersoon er één dag naast zit 
wat betreft de dag van de week en de datum (dag van de maand). 
TOTALE SCORE: Tel alle subtestscores die aan de rechterkant staan bij elkaar op. 
Tel er 1 punt bij op voor personen die 12 jaar of minder formele opleiding hebben 
gehad (gerekend vanaf leeftijd 6 jaar), zodat een maximum van 30 punten mogelijk 
is. Een uiteindelijke score van 26 of hoger wordt beschouwd als normaal.
•	 www.mocatest.org 
•	 Nasreddine	ZS,	Philips	NA,	Bédirian	V,	Charbonneau	S,	Whitehead	V,	Collin	I,	Cummings	JL,	Chertkow	
H. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J 
Am Geriatr Soc 2005; 53(4):695-699
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2. Test 
PUNTEN
TOTAAL
GEHEUGEN
BENOEMEN
VISUOSPATIEEL/EXECUTIEF
AANDACHT
TAAL
ABSTRACTIE
UITGESTELDE RECALL
ORIËNTATIE
Lees de woorden op, proef-
persoon moet ze nazeggen. 
Neem 2 maal af. Laat ze na 5 min. opnieuw opnoemen. 
   
Proefpersoon moet ze in dezelfde volgorde nazeggen [    ] 2 1 8 5 4
Proefpersoon moet ze in omgekeerde volgorde nazeggen [    ]   7  4  2 
Lees de rij letters op. De proefpersoon moet bij iedere letter A met zijn hand op de tafel tikken  Geen punten bij ≥  2 ft
[   ]  F B A C M N A A J K L B A F A K D E A A A J A M O F A A B
Serieel 7 aftrekken, beginnend bij 100 [   ]  93 [   ]  86 [   ]  79 [   ]  72 [   ]  65
Zeg na: Ik weet alleen dat Jan vandaag geholpen zou worden.  [    ]
De kat verstopte zich altijd onder de bank als er honden in de kamer waren. [    ]
Overeenkomst tussen bijv. banaan en sinaasappel = fruit   [    ] trein-fiets [    ] horloge-liniaal
Teken een klok (tien over elf)Kopieer
de kubus
__/5
__/3
Geen
punten
1e afname 
2e afname
GEZICHT FLUWEEL KERK MADELIEF ROOD
__/5
__/2
__/1
__/3
__/2
Fluency: Noem binnen één minuut zo veel mogelijk woorden die beginnen met de letter D  [     ] (N ≥ 11 woorden) __/1
__/2
__/6
__/30
B
Begin
Eind
5
E
1
A
2
4 3
C
D
Lees de rij cijfers op (1 cijfer/sec).
Geboortedatum:
Jaren opleiding:
Geslacht:
Naam:
Datum:
© Z.Nasreddine MD  2004, translated to Dutch by P.L.J. Dautzenberg and J.F.M. de Jonghe
www.mocatest.org
Normaal ≥ 26 / 30
Tel er 1 pt bij op indien ≤ 12 jr opleiding
MONTREAL COGNITIVE ASSESSMENT (MOCA) 
[    ] Datum [    ] Maand [    ] Jaar [    ] Dag [    ] Locatie [    ] Plaats
[     ]
Omtrek
[     ][     ] [     ]
Cijfers
[     ]
Wijzers
[   ] [   ] [   ]
4 of 5 goed: 3 pt,  2 of 3 goed: 2 pt, 1 goed: 1 pt,  0 goed: 0 pt    
(3 punten)
Categoriecue
Punten alleen voor  
recall zonder cue
worden zonder cue
Optioneel
Woorden moeten herinnerd
Meerkeuzecue
GEZICHT   FLUWEEL KERK MADELIEF ROOD
[   ] [   ] [   ] [   ] [   ]
 Nederlandse versie
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LIST OF ABBREVIATIONS
List of abbreviations
ANOVA:  Analysis of Variance
AP:  Anterior-Posterior
B-ADL: Basic Activities of Daily Living
BMI: Body Mass Index
BOF:  Bijzonder Onderzoeks Fonds
CDT:  Clock Drawing Test
COP: Center of Pressure
CoV: Coefficient of Variation
CV: Coefficient of Variation
DM:  Diabetes Mellitus
DNE: Diabetic Neuropathy Examination
DNS:  Diabetic Neuropathy Symptom score
EMG: Electromyography
EC:  Eyes Closed
EO:  Eyes Open
EVA:  Etylene Vinyl Acetate
EVV: Expertisecentrum Val- en fractuurpreventie Vlaanderen
FES:  Falls Efficacy Scale
FES-I: Falls Efficacy Scale International
FoF: Fear of Falling
FPG: Fasting Plasma Glucose
FRT: Functional Reach Test
GI: Glycemic Index
GP:  General Practitioner
HbA1c: Glycated Haemoglobin
I-ADL:  Instrumental Activities of Daily Living
LJM:  Limited Joint Mobility
MCI:  Mild Cognitive Impairment
MDC:  Minimal Detectable Change
ML:  Medio-Lateral
MMSE:  Mini-Mental State Examination
MoCa: Montreal Cognitive Assessment
OGTT: Oral Glucose Tolerance Test
OR: Odds Ratio
PN: Peripheral Neuropathy
PPA: Physiological Profile Assessment
ProFaNE: Prevention of Falls Network Europe
RIZIV:  Rijksinstituut voor Ziekte- en Invaliditeitsverzekering
ROS: Reactive Oxygen Species
SD: Standard Deviation
SPSS:  Statistical Package for the Social Sciences
T2DM:  Type 2 Diabetes Mellitus
TCS: Timed Chair Stand test
TUG: Timed Up & Go test
VPT:  Vibration Perception Threshold
WHO:  World Health Organization
Scenes so lovely must have been gazed upon by angels in their flight
Dr. Livingstone discovering the Victoria Falls
